0001437749-17-013836.txt : 20170804 0001437749-17-013836.hdr.sgml : 20170804 20170804170734 ACCESSION NUMBER: 0001437749-17-013836 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20170624 FILED AS OF DATE: 20170804 DATE AS OF CHANGE: 20170804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GIGA TRONICS INC CENTRAL INDEX KEY: 0000719274 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942656341 STATE OF INCORPORATION: CA FISCAL YEAR END: 0330 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14605 FILM NUMBER: 171009411 BUSINESS ADDRESS: STREET 1: 4650 NORRIS CANYON ROAD CITY: SAN RAMON STATE: CA ZIP: 94583 BUSINESS PHONE: 9253284650 MAIL ADDRESS: STREET 1: 4650 NORRIS CANYON ROAD CITY: SAN RAMON STATE: CA ZIP: 94583 10-Q 1 giga20170624_10q.htm FORM 10-Q giga20170624_10q.htm

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[ X ]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended

June 24, 2017

  OR  

[     ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from

 

to

 

 

Commission File No. 001-14605

 

GIGA-TRONICS INCORPORATED

(Exact name of registrant as specified in its charter)

 

California

 

94-2656341

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

5990 Gleason Drive, Dublin CA 94568

 

(925) 328-4650

(Address of principal executive offices)

 

Registrant’s telephone number, including area code

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:

Yes [ X ]     No [    ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [ X ]     No [    ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

[     ]

 

Accelerated filer

[     ]

Non-accelerated filer

[     ]

 

Smaller reporting company

[ X ]

(Do not check if a smaller reporting company)

 

Emerging growth company

[     ] 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2).

Yes [    ]     No [ X ]

 

There were a total of 10,142,153 shares of the Registrant’s Common Stock outstanding as of August 1, 2017.  

 

 
1

 

 

INDEX

 

 

 

Page No.

PART I - FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements 

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Balance Sheets as of June 24, 2017 and March 25, 2017

4

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statements of Operations, Three Month Periods Ended June 24, 2017 and June 25, 2016

5

 

 

 

 

 

 

 

 

Unaudited Condensed Consolidated Statements of Cash Flows, Three Month Periods Ended June 24, 2017 and June 25, 2016

6

 

 

 

 

 

 

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

7

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

18

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

23

 

Item 4.

Controls and Procedures

23

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

23

 

Item 1A.

Risk Factors

23

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

 

Item 3.

Defaults Upon Senior Securities

23

 

Item 4.

Mine Safety Disclosures

24

 

Item 5.

Other information

24

 

Item 6.

Exhibits

24

 

 

 

 

    SIGNATURES

25

 

 

 

 

 

 

Exhibit Index

 

 

 

31.1 Certification of CEO pursuant to Section 302 of Sarbanes-Oxley Act.

 

 

 

31.2 Certification of Principal Accounting Officer pursuant to Section 302 of Sarbanes-Oxley Act.

 

 

 

32.1 Certification of CEO pursuant to Section 906 of Sarbanes-Oxley Act.

 

 

 

32.2 Certification of Principal Accounting Officer pursuant to Section 906 of Sarbanes-Oxley Act.

 

 

 
2

 

 

FORWARD-LOOKING STATEMENTS

 

This report on Form 10-Q contains forward-looking statements about Giga-tronics Incorporated (the “Company”) for which it claims the protection of the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include, but are not limited to: (i) projections of revenues, expenses, income or loss, earnings or loss per share, capital structure and other financial items; (ii) statements of plans, objectives and expectations of the Company or its management or board of directors, including those relating to products, revenue or cost savings; (iii) statements of future economic performance; and (iv) statements of assumptions underlying such statements.  Words such as "believes", "anticipates", "expects", "intends", "targeted", "projected", "continue", "remain", "will", "should", "may" and other similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.

 

These forward-looking statements are based on Management’s current knowledge and belief and include information concerning the Company’s possible or assumed future financial condition and results of operations. A number of factors, some of which are beyond the Company’s ability to predict or control, could cause future results to differ materially from those contemplated. These factors include but are not limited to risks related to (1) the Company’s potential inability to obtain necessary capital to finance its operations and to continue as a going concern; (2) the Company’s ability to develop competitive products in a market with rapidly changing technology and standards; (3) the results of pending or threatened litigation; (4) risks related to customers’ credit worthiness/profiles; (5) changes in the Company’s credit profile and its ability to borrow; (6) a potential decline in demand for certain of the Company’s products; (7) potential product liability claims; (8) the potential loss of key personnel; and (9) U.S. and international economic conditions. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations. The reader is directed to the Company's annual report on Form 10-K for the year ended March 25, 2017 or further discussion of factors that could affect the Company's business and cause actual results to differ materially from those expressed in any forward-looking statement made in this report. The Company undertakes no obligation to update any forward-looking statements in this report.

 

 
3

 

 

PART I – FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

 

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) 

(In thousands except share data)

 

June 24,

2017

   

March 25,

2017

 

Assets

               

Current assets:

               

Cash and cash-equivalents

  $ 1,137     $ 1,421  

Trade accounts receivable, net of allowance of $45, respectively

    748       954  

Inventories, net

    4,989       4,811  

Prepaid expenses and other current assets

    377       452  

Total current assets

    7,251       7,638  

Property and equipment, net

    1,052       528  

Other long term assets

    175       175  

Capitalized software development costs

    582       733  

Total assets

  $ 9,060     $ 9,074  

Liabilities and shareholders' equity

               

Current liabilities:

               

Line of credit

  $ 582     $ 582  

Accounts payable

    666       1,107  

Loan payable, net of discounts and issuance costs

    1,315        

Equity forward, at estimated fair value

    46        

Accrued payroll and benefits

    427       583  

Deferred revenue

    3,447       3,614  

Capital lease obligations

    51       50  

Deferred liability related to asset sale

    375       375  

Other current liabilities

    710       707  

Total current liabilities

    7,619       7,018  

Warrant liability, at estimated fair value

    222       222  

Long term deferred rent

    451        

Long term obligations - capital lease

    100       114  

Total liabilities

    8,392       7,354  

Commitments and contingencies

               

Shareholders' equity:

               

Convertible preferred stock of no par value Authorized - 1,000,000 shares; Series A - designated 250,000 shares; no shares at June 24, 2017 and March 25, 2017 issued and outstanding

           

Series B, C, D- designated 19,500 shares; 18,533.51 shares at June 24, 2017 and March 25, 2017 issued and outstanding; (liquidation preference of $3,540 at June 24, 2017 and March 25, 2017)

    2,911       2,911  

Common stock of no par value; Authorized - 40,000,000 shares; 10,139,653 shares at June 24, 2017 and 9,594,203 shares at March 25, 2017 issued and outstanding

    24,596       24,390  

Accumulated deficit

    (26,839 )     (25,581 )

Total shareholders' equity

    668       1,720  

Total liabilities and shareholders' equity

  $ 9,060     $ 9,074  

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

 
4

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

   

Three Months Ended

 

(In thousands except per share data)

 

June 24,

2017

   

June 25,

2016

 

Net sales

  $ 1,991     $ 3,442  

Cost of sales

    1,525       2,517  

Gross margin

    466       925  
                 

Operating expenses:

               

Engineering

    452       530  

Selling, general and administrative

    1,171       1,305  

Total operating expenses

    1,623       1,835  
                 

Operating loss

    (1,157 )     (910 )
                 

Gain on sale of product line

          802  

Gain/(loss) on adjustment of warrant liability to fair value

          46  

Interest expense:

               

Interest expense, net

    (79 )     (29 )

Interest expense from accretion of loan discount

    (22 )     (11 )

Total interest expense, net

    (101 )     (40 )

Loss before income taxes

    (1,258 )     (102 )

Provision for income taxes

           

Net loss

  $ (1,258 )   $ (102 )
                 

Loss per common share - basic

  $ (0.13 )   $ (0.01 )

Loss per common share - diluted

  $ (0.13 )   $ (0.01 )
                 

Weighted average common shares used in per share calculation:

               

Basic

    9,715       9,550  

Diluted

    9,715       9,550  

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

 
5

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

   

Three Months Ended

 

(In thousands)

 

June 24,

2017

   

June 25,

2016

 

Cash flows from operating activities:

               

Net loss

  $ (1,258 )   $ (102 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    247       91  

Share based compensation

    46       72  

Adjustment of warrant liability to fair value

          (46 )

Capitalized software development costs

          (334 )

Estimated equity forward

    46        

Accretion of discounts on debt

    22       11  

Change in deferred rent

    451       (32 )

Gain on sale of product line

          (802 )

Changes in operating assets and liabilities:

               

Trade accounts receivable

    206       304  

Inventories

    (178 )     (553 )

Prepaid expenses and other assets

    75       63  

Accounts payable

    (441 )     (173 )

Accrued payroll and benefits

    (156 )     81  

Deferred revenue

    (167 )     1,101  

Other current liabilities

          (270 )

Net cash used in operating activities

    (1,107 )     (589 )
                 

Cash flows from investing activities:

               

Cash received from sale of product lines

          1,225  

Purchases of property and equipment

    (620 )     (30 )

Net cash (used in) provided by investing activities

    (620 )     1,195  
                 

Cash flows from financing activities:

               

Principal payments on capital leases

    (13 )     (11 )

Proceeds from borrowings, net of issuance costs

    1,456        

Repayments of debt

          (130 )

Net cash provided by (used in) financing activities

    1,443       (141 )
                 

(Decrease)/Increase in cash and cash-equivalents

    (284 )     465  
                 

Beginning cash and cash-equivalents

    1,421       1,331  

Ending cash and cash-equivalents

  $ 1,137     $ 1,796  
                 

Supplementary disclosure of cash flow information:

               

Cash paid for income taxes

  $     $  

Cash paid for interest

  $ 39     $ 23  
                 

Supplementary disclosure of noncash investing and financing activities:

               

Common stock issued in connection with debt issuance

  $ 156     $  

Fully depreciated equipment disposal

  $ 377     $ 67  

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

 
6

 

 

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

(1)          Organization and Significant Accounting Policies

 

The condensed consolidated financial statements included herein have been prepared by Giga-tronics Incorporated (the “Company”), pursuant to the rules and regulations of the Securities and Exchange Commission. The consolidated results of operations for the interim periods shown in this report are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments (consisting of normal recurring entries) necessary to make the consolidated results of operations for the interim periods a fair statement of such operations. For further information, refer to the consolidated financial statements and footnotes thereto, included in the Annual Report on Form 10-K, filed with the Securities and Exchange Commission for the year ended March 25, 2017.

   

Principles of Consolidation The consolidated financial statements include the accounts of Giga-tronics and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.

  

Derivatives The Company accounts for certain of its warrants and embedded debt features as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of these instruments to fair value. 

 

Software Development Costs Development costs included in the research and development of new software products and enhancements to existing software products are expensed as incurred, until technological feasibility in the form of a working model has been established. Capitalized development costs are amortized over the expected life of the product and evaluated each reporting period for impairment.

 

Discontinued Operations The Company reviews its reporting and presentation requirements for discontinued operations in accordance with the guidance provided by ASC 205-20 as it moves to newer technology within the test and measurement market from legacy products to the newly developed Advanced Signal Generator. The disposal of these product line sales represent an evolution of the Company’s Giga-tronics Division to a more sophisticated product offered to the same customer base. The Company has evaluated the sales of product lines (see Note 9, Sale of Product Lines) concluding that each product line does not meet the definition of a “component of an entity” as defined by ASC 205-20.The Company is able to distinguish revenue and gross margin information as disclosed in Note 9, Sale of Product Lines to the accompanying financial statements however, operations and cash flow information is not clearly distinguishable and the Company is unable to present meaningful information about results of operations and cash flows from those product lines.

 

New Accounting Standards In November 2015, the FASB issued ASU 2015-17 – Income Taxes (Topic 740): “Balance Sheet Classification of Deferred Taxes”. Topic 740 is effective for public business entities for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. For all other entities, the amendments are effective for financial statements issued for annual periods beginning after December 15, 2017, and interim periods within annual periods beginning after December 15, 2018. The amendments may be applied prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The amendments in ASU 2015-17 eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

 

In March 2016, the FASB issued ASU 2016-09 (“ASU 2016-09”), Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 simplifies several aspects of the accounting for employee share-based payments, including accounting for income taxes, forfeitures, statutory tax withholding requirements, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after December 15, 2016, with early adoption permitted. The Company adopted this standard in the first quarter ended June, 24, 2017, the adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

 

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09 (“ASU 2017-09”), Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in this ASU are effective for annual periods beginning after December 15, 2017. The Company does not expect that the standard will have a material effect on its consolidated financial statements and will apply this guidance to applicable transactions after the adoption date.

 

In February 2016, the FASB issued ASU 2016-02 (“ASU 2016-02”), Leases. ASU 2016-02 requires that lessees recognize assets and liabilities for the rights and obligations for leases with a lease term of more than one year. The amendments in this ASU are effective for annual periods ending after December 15, 2018. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on its consolidated financial statements.

 

In May 2014, the FASB issued ASU 2014-09 (“ASU 2014-09”), Revenue from Contracts with Customers. ASU 2014-09 establishes a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this principle, an entity identifies the contract with a customer, identifies the separate performance obligations in the contract, determines the transaction price, allocates the transaction price to the separate performance obligations and recognizes revenue when each separate performance obligation is satisfied. ASU 2014-09 was further updated in March, April, May, and December 2016 to provide clarification on a number of specific issues as well as requiring additional disclosures. ASU 2014-09 may be applied either retrospectively or through the use of a modified-retrospective method. The full retrospective method requires companies to recast each prior reporting period presented as if the new guidance had always existed. Under the modified retrospective method, companies would recognize the cumulative effect of initially applying the standard as an adjustment to opening retained earnings at the date of initial application. On July 9, 2015, the FASB approved a one year deferral of the effective date of ASU 2014-09 to annual reporting periods beginning after December 15, 2017. The Company has not yet completed its evaluation of the impact of ASU 2014-09 on its past and future revenue recognition and related disclosure.

 

 
7

 

 

(2)          Going Concern and Management’s Plan

 

The Company incurred net losses of $1.3 million and $102,000 in the first quarter of fiscal 2018 and fiscal 2017, respectively. These losses have contributed to an accumulated deficit of $26.8 million as of June 24, 2017. The Company used cash flow in operations totaling $1.1 million and $589,000 in the first quarter of fiscal 2018 and 2017, respectively.

 

The Company has experienced delays in the development of features, receipt of orders, and shipments for the new Advanced Signal Generator (“ASG”). These delays have contributed, in part to a decrease in working capital. The new ASG product has shipped to several customers, but potential delays in the development of features, longer than anticipated sales cycles, or uncertainty as to the Company’s ability to efficiently manufacture the ASG, could significantly contribute to additional future losses and decreases in working capital.

 

To help fund operations, the Company relies on advances under the line of credit with Bridge Bank which expires on May 6, 2019. The agreement includes a subjective acceleration clause, which allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company’s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender’s judgement. As of June 24, 2017, the line of credit had a balance of $582,000.

 

These matters raise substantial doubt as to the Company’s ability to continue as a going concern.

  

To address these matters, the Company’s management has taken several actions to provide additional liquidity and reduce costs and expenses going forward. These actions are described in the following paragraphs. 

     

 

On April 27, 2017, the Company entered into a new loan agreement with PFG. Under the terms of the agreement, PFG made a term loan to the Company in the principal amount of $1,500,000, with funding occurring on April 28, 2017. The loan has a two-year term, with interest only payments for the term of the loan. However, as of June 24, 2017, the Company was not in compliance with certain revenue and shareholders’ equity covenants. On August 2, 2017, the Company and PFG entered into a short-term forbearance arrangement (through the end of August) with respect to such noncompliance. No assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. The default interest rate associated with the forbearance agreement is 6%. The Company will most likely be required to raise additional capital to rectify the noncompliance. No assurance can be given that the Company will be able to raise sufficient capital on timely basis.

 

 

 

 

In July 2016, Microsource received a $1.9 million non-recurring engineering order associated with redesigning a component of its high performance YIG filter used on an aircraft platform. The Company delivered NRE services for approximately $314,000 during the first quarter of fiscal 2018 and we expect to continue such services over the next nine to twelve months.

 

 

 

   

In March 2017 and July 2017, Microsource received two orders totaling $875,000 associated with its high performance YIG filter used on an aircraft platform; we expect to start shipping the filters in the second quarter of fiscal 2018.

     

 

In July 2017, the Giga-tronics Division received a $1.7 million order from the United States Navy for the Real-Time Threat Emulation Systems (“TEmS”) which the Company expects to ship in fiscal 2018. 

 

 

 

 

With the elimination of Giga-tronics Switch, Power Meter, Amplifier, and Signal Generator legacy product lines resulting from the Asset Purchase Agreements with Spanawave and Astronics, (see Note 9, Sale of Product Lines), the Company has been able to reduce expenses, while providing additional cash for operations from the proceeds of the sales. The Company is also expecting longer term reductions in overhead costs by the relocating of its operations into a smaller facility beginning in the first quarter of fiscal 2018.

 

 

 

 

In the first quarter of fiscal 2016, the Company’s Microsource business unit also finalized a multiyear $10.0 million YIG production order (“YIG Production Order”). The Company started shipping the YIG Production Order in the second quarter of fiscal 2017, and we expect to ship the remainder through fiscal 2020.

 

 

 

  

● 

To assist with the upfront purchases of inventory required for future product deliveries, the Company entered into advance payment arrangements with certain customers, whereby the customers reimburse the Company for raw material purchases prior to the shipment of the finished products. In the first quarter of fiscal 2018, the Company entered into advance payment arrangements totaling $160,000. The Company will continue to seek similar terms in future agreements with these customers and other customers.

 

Management will continue to review all aspects of the business in an effort to improve cash flow and reduce costs and expenses, while continuing to invest, to the extent possible, in new product development for future revenue streams.

 

Management will also continue to seek additional working capital through debt, equity financing or possible product line sales, however there are no assurances that such financings or sales will be available at all, or on terms acceptable to the Company.

 

 
8

 

 

The Company’s historical operating results and forecasting uncertainties indicate that substantial doubt exists related to the Company’s ability to continue as a going concern. Forecasting uncertainties exist with respect to the ASG product line due to the potential longer than anticipated sales cycles as well as with potential delays in the refinement of certain features, and/or the Company’s ability to efficiently manufacture it in a timely manner. The accompanying Consolidated Financial Statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result if the Company were unable to do so.

   

(3)         Revenue Recognition

 

The Company records revenue when there is persuasive evidence of an arrangement, delivery has occurred, the price is fixed and determinable, and collectability is reasonably assured. This occurs when products are shipped or the customer accepts title transfer. If the arrangement involves acceptance terms, the Company defers revenue until product acceptance is received. The Company limits the amount of revenue recognition for delivered elements to the amount that is not contingent on the future delivery of products or services, future performance obligations or subject to customer-specified return or refund privileges. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. On certain large development contracts, revenue is recognized upon achievement of substantive milestones. Determining whether a milestone is substantive is a matter of judgment and that assessment is performed only at the inception of the arrangement. The consideration earned from the achievement of a milestone must meet all of the following for the milestone to be considered substantive:

 

a. It is commensurate with either of the following:

1. The Company’s performance to achieve the milestone.

2. The enhancement of the value of the delivered item or items as a result of a specific outcome resulting from the Company's performance to achieve the milestone.

b. It relates solely to past performance.

c. It is reasonable relative to all of the deliverables and payment terms (including other potential milestone consideration) within the arrangement.

 

Milestones for revenue recognition are agreed upon with the customer prior to the start of the contract and some milestones will be tied to product shipping while others will be tied to design review. In fiscal 2015 the Company’s Microsource business unit received a $6.5 million order from a major aerospace company for non-recurring engineering services to develop a variant of its high performance fast tuning YIG filters for an aircraft platform and to deliver a limited number of flight-qualified prototype hardware units (the “NRE Order”) which is being accounted for on a milestone basis. The Company considered factors such as estimated completion dates and product acceptance of the order prior to accounting for the NRE Order as milestone revenue. There was no revenue recognized during the three-month period ended June 24, 2017 as the Company had delivered all milestones associated with this contract. During the three-month period ended June 25, 2016, revenue recognized on a milestone basis were $145,000.

  

On certain contracts with several of the Company’s significant customers the Company receives payments in advance of manufacturing. Advanced payments are recorded as deferred revenue until the revenue recognition criteria described above have been met.

 

Accounts receivable are stated at their net realizable value. The Company has estimated an allowance for uncollectable accounts based on analysis of specifically identified accounts, outstanding receivables, consideration of the age of those receivables, the Company’s historical collection experience, and adjustments for other factors management believes are necessary based on perceived credit risk.

 

The Company provides for estimated costs that may be incurred for product warranties at the time of shipment. The Company’s warranty policy generally provides twelve to eighteen months depending on the customer. The estimated cost of warranty coverage is based on the Company’s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Adjustments are made as new information becomes available.

 

(4 )           Inventories

 

Inventories net of inventory reserves totaling $3.4 million at June 24, 2017 and March 25, 2017, respectively consisted of the following:

 

(In thousands)

 

June 24,

2017

   

March 25,

2017

 

Raw materials

  $ 1,411     $ 1,775  

Work-in-progress

    2,931       2,155  

Finished goods

    239       473  

Demonstration inventory

    408       408  

Total

  $ 4,989     $ 4,811  

 

 
9

 

 

(5 )          Software Development Costs

 

On September 3, 2015, the Company entered a software development agreement with a major aerospace and defense company whereby the aerospace company developed and licensed its simulation software to the Company. The simulation software (also called Open Loop Simulator or OLS technology) is currently the aerospace company’s intellectual property. The OLS technology generates threat simulations and enables various hardware to generate signals for performing threat analysis on systems under test. The Company licenses the OLS software as a bundled or integrated solution with its Advanced Signal Generator system.

 

The Company paid the aerospace company software development costs and fees for OLS of $1.2 million in the aggregate (this includes an amendment to the software development agreement for additional features and functionality), which was paid in monthly installments as the work was performed by the aerospace company through the third quarter of fiscal 2017. The OLS technology is a perpetual license agreement that may be terminated by the Company at any time as long as the Company provides a notice to the aerospace company and pays for the development costs incurred through the notice termination date. The Company is also obligated to pay royalties to the aerospace company on net sales of its Advanced Signal Generator product sold with the OLS software equal to seven percent of net sales price of each ASG system sold and subject to certain minimums. The Company expenses research and development costs as they are incurred. Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release to customers.

 

As of June 24, 2017 and March 25, 2017, capitalized software costs were $582,000 and $733,000, respectively. The Company began amortizing the costs of capitalized software to cost of sales in third quarter of fiscal 2017 using the straight-line methodology over an estimated three-year amortization period. During the fourth quarter of fiscal 2017, the Company changed its estimated amortization period from three years to two years due to the longer than anticipated procurement cycle associated with the ASG TEmS product line. The Company also amortized capitalized software costs using the estimated percentage of revenue approach (which was greater than straight-line amortization) in the fourth quarter of fiscal 2017. During the first quarter of fiscal 2018, the Company had no revenues associated with its ASG TEmS product line and therefore amortized capitalized software costs on a straight-line basis. Amortization of capitalized software costs recorded during the first quarter of fiscal 2018 were $151,000. There was no amortization recorded in the first quarter of fiscal 2017 as the Company had not yet released its ASG TEmS units.

 

 (6)      Accounts Receivable Line of Credit

 

On June 1, 2015 the Company entered into a $2.5 million Revolving Accounts Receivable Line of Credit agreement with Bridge Bank. The agreement provides for a maximum borrowing capacity of $2.5 million of which $2.0 million is subject to a borrowing base calculation and $500,000 is non-formula based. On May 23, 2017, the Company renewed this credit line (which expired on May 7, 2017) through May 6, 2019.

  

The loan agreement is secured by all assets of the Company including intellectual property and general intangibles and provides for a borrowing capacity equal to 80% of eligible accounts receivable. The loan matures on May 6, 2019 and bears an interest rate, equal to 1.5% over the bank’s prime rate of interest (which was 4.25% at June 24, 2017 resulting in an interest rate of 5.75%). Interest is payable monthly with principal due upon maturity. The Company paid an annual commitment fee of $12,500 in May 2017. The loan agreement contains financial and non-financial covenants that are customary for this type of lending and includes a covenant to maintain an asset coverage ratio of at least 150% (defined as unrestricted cash and cash equivalents maintained with Bridge Bank, plus eligible accounts receivable aged less than 90 days from the invoice date, divided by the total amount of outstanding principal of all obligations under the loan agreement). While the Company maintained the asset coverage ratio, the Company was in a cross default at June 24, 2017, as a result of the PFG noncompliance described in Note 7 below.

 

The line of credit requires a lockbox arrangement, which provides for receipts to be swept daily to reduce borrowings outstanding at the discretion of Bridge Bank. This arrangement, combined with the existence of the subjective acceleration clause in the line of credit agreement, necessitates the line of credit be classified as a current liability on the balance sheet. The acceleration clause allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company’s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender's judgment. As of June 24, 2017, the Company’s total outstanding borrowings under the Bridge Bank line of credit were $582,000. 

 

( 7 )        Term Loans, Revolving Line of Credit and Warrants  

 

On April 27, 2017, the Company entered into a new loan agreement with PFG (Partners For Growth V, L.P.). Under the terms of the agreement, PFG made a term loan to Giga-tronics in the principal amount of $1,500,000, with funding occurring on April 28, 2017.

  

The loan has a two-year term, with interest only payments for the term of the loan. The principal amount of the loan plus any accrued interest will be due upon maturity. The loan bears interest at an aggregate per annum rate equal to 16% per annum, fixed, which is comprised of cash interest reflecting a 9.5% per annum rate and deferred interest reflecting a 6.5% per annum rate. The Company will pay the cash interest monthly and will accrue deferred interest on the unpaid principal balance. The deferred interest will be due and payable upon maturity. In addition, the Company agreed to pay PFG a charge of up to $100,000 due and payable upon maturity (the “back-end fee”), $76,000 of which was earned on April 27, 2017, and $24,000 of which is earned at the rate of $1,000 per month on the first day of each month if the loan principal (of any amount) is outstanding during any day of the prior month. If the Company meets or exceeds certain revenue and net income minimums in fiscal 2018, the amount could be reduced by 25 percent. To stay in compliance with the loan terms, the Company must meet certain financial covenants associated with minimum quarterly revenues and monthly minimum shareholders’ equity. The lender can accelerate the maturity of the loan in case of a default. The Company can prepay the loan before maturity at any time without fee or penalty.

 

In connection with its loan to the Company, PFG will receive up to 250,000 shares of common stock, 190,000 of which was earned on April 27, 2017 and 60,000 of which is earned at the rate of 2,500 per month on the first day of each month if the loan principal (of any amount) is outstanding during any day of the prior month.

 

The Company has pledged all its assets as collateral for the loan made by PFG, including all its accounts, inventory, equipment, deposit accounts, intellectual property and all other personal property. The PFG loan is subordinate to the Bridge Bank line of credit (see Note 6, Accounts Receivable Line of Credit).

 

The requirement to issue 60,000 shares of the Company’s common stock over the term of the loan is an embedded derivative (an embedded equity forward). The Company evaluated the embedded derivative in accordance with ASC 815-15-25. The embedded derivative is not clearly and closely related to the debt host instrument and therefore has been separately measured at fair value, with subsequent changes in fair value recognized in the Condensed Consolidated Statements of Operations.

 

 
10 

 

 

The proceeds received upon issuing the loan was allocated to: i) common stock, for the fair value of the 190,000 shares of common stock initially issued to the lender; ii) the fair value of the embedded derivative; and iii) the loan host instrument. Upon issuance of the loan, the Company recognized $1,576,000 of principal payable to PFG, representing the stated principal balance of $1,500,000 plus the initial back-end fee of $76,000. The initial carrying value of the loan was recognized net of debt discount aggregating approximately $326,000, which is comprised of the following:

 

Fees paid to the lender and third parties

  $ 44,000  

Backend fee

    76,000  

Estimated fair value of embedded equity forward

    49,000  

Fair value of 190,000 shares of common stock issued to lender

    157,000  

Aggregate discount amount

  $ 326,000  

 

The bifurcated embedded derivative and the debt discount are presented net with the related loan balance in the Condensed Consolidated Balance Sheets. The debt discount is amortized to interest expense over the loan’s term using the effective interest method.

 

The Company amortized approximately $22,000 to interest expense in the quarter ended June 24, 2017. Additionally, the Company recognized a loss of approximately $500 in the in the quarter ended June 24, 2017 due to the estimated increase in fair value of the embedded equity forward.

  

PFG’s ability to call the debt on default (contingent put) and its ability to assess interest rate at a default rate (contingent interest) are embedded derivatives which the Company evaluated. The fair value of these embedded features were determined to be immaterial and were not bifurcated from the debt host for accounting purposes.

 

As of June 24, 2017, the Company was not in compliance with certain financial covenants associated with the PFG loan. On August 2, 2017, the Company and PFG entered into a short-term forbearance arrangement (through the end of August) with respect to such noncompliance. No assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. There is a 6% default rate associated with the forbearance agreement. The Company will most likely be required to raise additional capital to rectify the noncompliance.  No assurance can be given that the Company will be able to raise sufficient capital on timely basis.

 

On March 13, 2014, the Company entered into a three year, $2.0 million term loan agreement with PFG under which the Company received $1.0 million on March 14, 2014 (“First Draw”). Interest on the initial $1.0 million term loan was fixed at 9.75%. On June 16, 2014, the Company amended its loan agreement with PFG (the “Amendment”). Under the terms of the Amendment, PFG made a revolving credit line available to Giga-tronics in the amount of $500,000, and the Company borrowed the entire amount on June 17, 2014. The revolving line had a thirty-three month term. The Amendment reduced the future amount potentially available for the Company to borrow under the PFG Loan agreement from $1.0 million to $500,000. The interest on the PFG revolving credit line was fixed, calculated on a daily basis at a rate of 12.50% per annum. The Company as of June 24, 2017, and March 25, 2017 had fully repaid both the $1.0 million term loan and the $500,000 revolving credit line.

 

In connection with the March 2014 loan agreement, the Company issued warrants convertible into shares of the Company’s common stock, of which 180,000 were exercisable upon receipt of the initial $1.0 million from the First Draw, and 80,000 became exercisable with the First Amendment. Each warrant issued under the loan agreement has a term of five years and an exercise price of $1.42 which was equal to the average NASDAQ closing price of the Company’s common stock for the ten trading days prior to the First Draw.

 

If the warrants are not exercised before expiration on March 31, 2019, the Company would be required to pay PFG $150,000 and $67,000 as settlement for warrants associated with the First Draw and the Amendment, respectively. The warrants could be settled for cash at an earlier date in the event of any acquisition or other change in control of the Company, future public issuance of Company securities or liquidation (or substantially similar event) of the Company. The Company currently has no definitive plans for any of the aforementioned events, and as a result, the cash payment date is estimated to be the expiration date unless warrants are exercised before then. The warrants have the characteristics of both debt and equity and are accounted for as a derivative liability measured at fair value each reporting period with the change in fair value recorded in earnings.

 

As of June 24, 2017, and March 25, 2017, the estimated fair values of the derivative liabilities associated with the warrants issued in connection with the First Draw and Amendment were $133,000 and $89,000, respectively, for a combined value of $222,000, respectively. There was no change in the fair value of the warrant liability in the first quarter ended June 24, 2017. The change in the fair value of the warrant liability totaled $46,000 for the first quarter ended June 25, 2016 and is reported in the accompanying statement of operations as a gain on adjustment of derivative liability to fair value. There was no accretion recorded in the first quarter ended June 24, 2017 in connection with the March 2014 loan agreement as the loan was paid in full. For the quarter ended June 25, 2016, the Company recorded accretion of discount expense associated with the warrants issued with the PFG Loan of $11,000.  

 

( 8 )         Fair Value

 

Pursuant to the accounting guidance for fair value measurement and its subsequent updates, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. The accounting guidance establishes a hierarchy for inputs used in measuring fair value that minimizes the use of unobservable inputs by requiring the use of observable market data when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on active market data. Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.  

  

The fair value hierarchy is broken down into the three input levels summarized below:

  

     

•  

Level 1  —Valuations are based on quoted prices in active markets for identical assets or liabilities and readily accessible by us at the reporting date. Examples of assets and liabilities utilizing Level 1 inputs are certain money market funds, U.S. Treasuries and trading securities with quoted prices on active markets.

  

   

•  

Level 2  —Valuations based on inputs other than the quoted prices in active markets that are observable either directly or indirectly in active markets. Examples of assets and liabilities utilizing Level 2 inputs are U.S. government agency bonds, corporate bonds, commercial paper, certificates of deposit and over-the- counter derivatives.

  

   

•  

Level 3  —Valuations based on unobservable inputs in which there are little or no market data, which require us to develop our own assumptions.

 

 
11

 

 

Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the three month period ended June 24, 2017. The carrying values of cash and cash equivalents, trade accounts receivable, line of credit, term debt and accounts payable approximate their fair values given their short-term nature. As of June 24, 2017, the carrying value of the outstanding PFG loan approximates the estimated aggregate fair value, since the embedded equity forward is recognized at fair value and classified with the loan host. The fair value estimate of the embedded equity forward is based on the closing price of the Company’s common stock on the measurement date, the risk-free rate, the date of expiration, and any expected cash distributions of the underlying asset before expiration. The estimated fair value of the embedded equity forward represents a Level 2 measurement.

 

Derivatives The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including notes payable, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company accounts for certain of its warrants as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of warrant liability to fair value.

 

Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet.

 

The Company’s derivative warrant liability is measured at fair value on a recurring basis and is categorized as Level 3 in the fair value hierarchy. The derivative warrant liability is valued using a Monte Carlo simulation model, which used the following assumptions as of June 24, 2017: (i) the remaining expected life of 1.7 years, (ii) the Company’s historical volatility rate of 101.1%, (iii) risk-free interest rate of 1.26%, and (iv) a discount rate of thirty percent.

 

The aforementioned derivative warrant liability and equity forward are the Company’s only asset and liability recognized and measured at fair value on a recurring or non-recurring basis and are follows:

 

Fair Value Measurements as of June 24, 2017

(In Thousands):

                       
   

Level 1

   

Level 2

   

Level 3

 

Warrant liability

  $     $     $ 222  

Equity forward

          46        

Total

  $     $ 46     $ 222  

 

Fair Value Measurements as of March 25, 2017

(In Thousands):

                       
   

Level 1

   

Level 2

   

Level 3

 

Warrant liability

  $     $     $ 222  

Total

  $     $     $ 222  

 

There were no transfers between Level 1, Level 2 or Level 3 for the quarter ended June 24, 2017.  

  

The table below summarizes changes in gains and losses recorded in earnings for Level 3 assets and liabilities that are still held at June 24, 2017:

 

   

Quarter Ended

   

Quarter Ended

 

(In thousands)

 

June 24,

2017

   

June 25,

2016

 

Warrant liability at beginning of year

  $ 222     $ 353  

Gains on adjustment of warrant liability to fair value

          (46 )

Losses on adjustment of warrant liability to fair value

           

Warrant liability at end of period

  $ 222     $ 307  

  

There were no assets measured at fair value on a recurring basis and there were no assets or liabilities measured on a non-recurring basis at June 24, 2017 and March 25, 2017.

  

The following table presents quantitative information about recurring Level 3 fair value measurements at June 24, 2017 and March 25, 2017:

  

June 24, 2017

 

Valuation Technique(s)

 

Unobservable Input

       

Warrant liability

 

Monte Carlo

 

Discount rate

    30%

 

  

March 25, 2017

 

Valuation Techniques(s)

 

Unobservable Input

       

Warrant liability

 

Monte Carlo

 

Discount rate

    24%

 

  

The discount rate of thirty percent at June 24, 2017, and twenty four percent at March 25, 2017 is management’s estimate of the cost of capital given the Company’s credit worthiness. A significant increase in the discount rate would significantly decrease the fair value, but the magnitude of this decrease would be less significant in a scenario where the Company’s stock price is significantly higher than the exercise price since the holder’s option to take a cash payment at maturity represents a smaller component of the total fair value when the Company’s stock price is higher. The Monte Carlo simulation model simulated the Company’s stock price through the maturity date of March 31, 2019. At the end of the simulated period, the value of the warrant was determined based on the greater of (1) the net share settlement value, (2) the net exercise value, or (3) the fixed cash put value.   

 

 
12

 

 

( 9 )         Sale of Product Lines  

 

On June 20, 2016, the Company entered into an Asset Purchase Agreement for the sale of its Switch product line to Astronics Test Systems Inc. (Astronics). Upon signing the agreement, Astronics paid $850,000 for the intellectual property of the product line. The Company recognized a net gain of $802,000 in the quarter ended June 25, 2016 after related expenses were subtracted from the sales price. The following table presents the breakdown of the gain recognized in the quarter related to the asset sale:

 

(In thousands)

 

Quarter Ended

June 25,

2016

 

Cash received from Astronics

  $ 850  

Cash paid to buy out future commission obligation

    (170

)

Employee severance

    (97

)

Legal fees

    (13

)

Commissions

    (46

)

Warranty Liability released

    278  

Net gain recognized in the quarter

  $ 802  

   

In calculating the gain included in the accompanying consolidated financial statements, the Company released $278,000 of deferred warranty obligations related to the Switch asset. Pursuant to the terms of the agreement, Astronics assumed all the warranty obligations for the Switch product line, including the products sold prior to the asset being transferred to Astronics. The deferred warranty obligation was previously included in other current liabilities in the consolidated financial statements. The Company also had a previous agreement with a consultant supporting the Switch product line, which included a three percent commission on the sales of the Switch product line for a period of 4 years ending in January 2020. The agreement allowed for a buyout of future commissions associated with the Switch product, which the Company exercised in connection with the Astronics sales in June 2016 which resulted in a payment by the Company during June of $170,000. Astronics also purchased approximately $500,000 of related materials inventory from Giga-tronics between July and August of 2016.

 

The Company had no revenues or gross margin associated with the Switch product line in the first quarter ended June 24, 2017. The Switch product line accounted for $1.1 million in revenue for the fiscal quarter ended June 25, 2016. The Switch product line’s gross margin on revenues was $437,000 for the fiscal quarter ended June 25, 2016. While the Company is able to distinguish revenue and gross margin information related to the sale of the Switch product line, the Company is unable to present meaningful information about results of operation and cash flows from the Switch product line.

 

On December 15, 2015, the Company entered into an Asset Purchase Agreement with Spanawave Corporation, whereby Spanawave agreed to purchase the Giga-tronics’ Division product lines for its Power Meters, Amplifiers, and Legacy Signal Generators for $1.5 million. The agreement provided for the transfer of these product lines to Spanawave sequentially in six phases beginning with certain sensor and amplifier products. The Company had transferred the Power Meters and Amplifiers in phases one through five, the Company still holds the right to phase 6 (Legacy Signal Generators). During the second quarter ended September 24, 2016, the Company and Spanawave became engaged in a dispute, including litigation initiated by Spanawave and an arbitration proceeding initiated by Spanawave’s affiliate Liberty Test Equipment, Inc., as to whether the Company has fulfilled all the requirements to close phases one through five and become entitled to the $375,000 received by the Company during the first quarter of fiscal 2017 (see below).

  

The complaint seeks specific performance of the agreement and damages. Spanawave’s affiliate Liberty Test Equipment also filed an arbitration claim for $440,000 under a distribution agreement between the Company and Liberty. The Company has filed cross-complaints in both the litigation and arbitration asserting breach of the respective agreements by Spanawave and Liberty. The Company had previously asserted that the distribution agreement does not extend to the products with respect to which the claim has been made. Certain customers of the lines of business sold to Spanawave are also customers of the Company’s ongoing Advance Signal Generator business. Continued disruption of the phase 6 signal generator business could have an adverse effect on the ASG business. The parties have negotiated in an effort to settle the dispute notwithstanding the filings. The expenses and potential liability of negotiation, any settlement or continued litigation or arbitration could have a material adverse effect on the Company.

  

During fiscal 2017, the Company received $750,000 from Spanawave under the agreement. Of this amount, the Company returned $375,000 to Spanawave on July 28, 2016 resulting from the dispute regarding the status of phases one through five. The remaining $375,000 is included in deferred liability related to asset sales in the consolidated balance sheet. In addition, in June 2016, the Company received approximately $275,000 in exchange for raw material purchases. The purchase price of the raw materials approximated its carrying value, therefore no gain or loss was recognized. The parties are currently attempting to resolve this dispute. No gain has been recognized in connection with this product line sale because of the aforementioned dispute. These product lines accounted for approximately $95,000 and $275,000 in revenue during the fiscal quarter ended June 24, 2017, and June 25, 2016, respectively. For the fiscal quarter ended June 24, 2017, gross margin was immaterial. There was no margin associated with the revenue derived in the first quarter of fiscal 2017 as the revenues were primarily related to inventory transfer at book value. While the Company is able to distinguish revenue and gross margin information related to the sale of these product lines, the Company is unable to present meaningful information about results of operation and cash flows from these product lines.

 

 
13

 

 

 (10)          Loss Per Share

 

Basic loss per share (EPS) is calculated by dividing net income or loss by the weighted average common shares outstanding during the period. Diluted EPS reflects the net incremental shares that would be issued if unvested restricted shares became vested and dilutive outstanding stock options were exercised, using the treasury stock method. In the case of a net loss, it is assumed that no incremental shares would be issued because they would be antidilutive. In addition, certain options are considered antidilutive because assumed proceeds from exercise price, related tax benefits and average future compensation was greater than the weighted average number of options outstanding multiplied by the average market price during the period. The shares used in per share computations are as follows:  

 

   

Three Months Ended

 

(In thousands except per share data)

 

June 24,

2017

   

June 25,

2016

 

Net loss

  $ (1,258

)

  $ (102

)

                 

Weighted average:

               

Common shares outstanding

    9,715       9,550  

Potential common shares

           

Common shares assuming dilution

    9,715       9,550  
                 

Loss per common share – basic

  $ (0.13

)

  $ (0.01

)

Loss per common share – diluted

  $ (0.13

)

  $ (0.01

)

Stock options not included in computation that could potentially dilute EPS in the future

    1,104       1,529  

Restricted stock awards not included in computation that could potentially dilute EPS in the future

    350        

Issuable shares for interest on loan

    55        

Convertible preferred stock not included in computation that could potentially dilute EPS in the future

    1,853       1,853  

Warrants not included in computation that could potentially dilute EPS in the future

    3,737       3,737  

 

The stock options, restricted stock, convertible preferred stocks and warrants not included in the computation of diluted earnings per share (EPS) for the three month period ended June 24, 2017 and June 25, 2016 is a result of the Company’s net loss and, therefore, the effect of these instruments would be anti-dilutive.

   

(11)          Share Based Compensation

 

The Company has established the 2005 Equity Incentive Plan, which provide for the granting of options and restricted stock for up to 2,850,000 shares of common stock at 100% of fair market value at the date of grant, with each grant requiring approval by the Board of Directors of the Company. The 2005 Plan has been extended to be effective until 2025. Option grants under the 2000 Stock Option Plan are no longer available. Options granted generally vest in one or more installments in a four or five year period and must be exercised while the grantee is employed by the Company or within a certain period after termination of employment. Options granted to employees shall not have terms in excess of 10 years from the grant date. Holders of options may be granted stock appreciation rights (SARs), which entitle them to surrender outstanding awards for a cash distribution under certain changes in ownership of the Company, as defined in the stock option plan. As of June 24, 2017, no SAR’s have been granted under the option plan. As of June 24, 2017, the total number of shares of common stock available for issuance was 934,677. All outstanding options have a ten year life from the date of grant. The Company records compensation cost associated with share-based compensation equivalent to the estimated fair value of the awards over the requisite service period.

 

Stock Options

 

In calculating compensation related to stock option grants, the fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option-pricing model and the following weighted average assumptions: 

 

   

Three Months Ended

 
   

June 24,

2017

   

June 25,

2016

 

Dividend yield

           

Expected volatility

          98.95 %

Risk-free interest rate

          1.38 %

Expected term (years)

          8.36  

 

The computation of expected volatility used in the Black-Scholes-Merton option-pricing model is based on the historical volatility of the Company’s share price. The expected term is estimated based on a review of historical employee exercise behavior with respect to option grants. The risk-free interest rate is based on the U.S. Treasury rates with maturity similar to the expected term of the option on the date of grant.

  

 
14

 

 

 A summary of the changes in stock options outstanding for the three-month period ended June 24, 2017 and the year ended March 25, 2017 is as follows:      

 

           

Weighted

Average

   

Weighted

Average

Remaining

Contractual

   

Aggregate

Intrinsic

 
   

Shares

   

Exercise Price

   

Terms (Years)

   

Value

 

Outstanding at March 26, 2016

    1,592,200     $ 1.52       6.8     $ 69  

Granted

    148,000       0.97                  

Exercised

                           

Forfeited / Expired

    635,700       1.57                  

Outstanding at March 25, 2017

    1,104,500     $ 1.41       6.1     $ 3  

Granted

                           

Exercised

                           

Forfeited / Expired

                           

Outstanding at June 24, 2017

    1,104,500     $ 1.41       6.1     $ 3  
                                 

Exercisable at June 24, 2017

    812,050     $ 1.45       5.2     $  
                                 

At June 24, 2017 expected to vest in the future

    1,006,157     $ 1.42       5.7     $  

  

As of June 24, 2017, there was $156,000 of total unrecognized compensation cost related to non-vested options. That cost is expected to be recognized over a weighted average period of 3.06 years and will be adjusted for subsequent changes in estimated forfeitures. There were 29,500 options that vested during the quarter ended June 24, 2017, and 28,500 options that vested during the quarter ended June 25, 2016. The total fair value of options vested during each of the quarters ended June 24, 2017 and June 25, 2016 was $33,000 and $1,000 respectively. There were no options exercised in the three-month period ended June 24, 2017 and June 25, 2016. Share based compensation cost related to stock options recognized in operating results for the three months ended June 24, 2017 and June 25, 2016 totaled $37,000 and $72,000, respectively.

 

Restricted Stock

 

The Company granted 350,450 restricted awards during the first quarter of fiscal 2018. No restricted awards were granted during the first quarter of fiscal 2017. No restricted awards vested during the first quarter of fiscal 2018 and 2017. The restricted stock awards are considered fixed awards as the number of shares and fair value at the grant date is amortized over the requisite service period net of estimated forfeitures. As of June 24, 2017, there was $204,000 of total unrecognized compensation cost related to non-vested awards. That cost is expected to be recognized over a weighted average period of 1.98 years and will be adjusted for subsequent changes in estimated forfeitures. Compensation cost recognized for the restricted and unrestricted stock awards during the first quarter of 2018 was $9,000. There was no compensation recognized for the restricted and unrestricted stock awards during the first quarter of fiscal 2017.

   

A summary of the changes in non-vested restricted stock awards outstanding for the three-month period ended June 24, 2017 and the fiscal year ended March 25, 2017 is as follows:

 

   

Shares

   

Weighted

Average

Fair Value

 

Non-Vested at March 26, 2016

        $  

Granted

    44,500       0.66  

Vested

    44,500       0.66  

Forfeited or cancelled

           

Non-Vested at March 25, 2017

        $  

Granted

    350,450          

Vested

             

Forfeited or cancelled

           

Non-Vested at June 24, 2017

    350,450     $  

   

 ( 12 )           Significant Customer and Industry Segment Information

 

The Company has two reportable segments: Giga-tronics Division and Microsource.

 

 

The Giga-tronics Division historically produces a broad line of test and measurement equipment used primarily for the design, production, repair and maintenance of products in aerospace, telecommunications, RADAR, and electronic warfare.

 

Microsource primarily develops and manufactures YIG RADAR filters used in fighter jet aircraft for two prime contractors. 

   

 
15

 

 

The tables below present information for the three month periods ended June 24, 2017 and June 25, 2016:

 

   

Three Month Periods Ended

           

Three Month Periods Ended

         

(In thousands)

 

At June 24,

2017

   

June 24,

2017

           

At June 25,

2016

   

June 25,

2016

         
   

Assets

   

Net Sales

   

Net Income

(Loss)

   

Assets

   

Net Sales

   

Net Income

(Loss)

 

Giga-tronics Division

  $ 6,153     $ 297     $ (1,849 )   $ 8,233     $ 2,125     $ (554

)

Microsource

    2,907       1,694       591       3,887       1,317       452  

Total

  $ 9,060     $ 1,991     $ (1,258 )   $ 12,120     $ 3,442     $ (102

)

 

During the first quarter of fiscal 2018, one customer accounted for 43% of the Company’s consolidated revenues and was included in the Microsource segment. A second customer accounted for 37% and was also included in the Microsource segment. During the first quarter of fiscal 2017, one customer accounted for 30% of the Company’s consolidated revenues and was included in the Microsource segment. A second customer accounted for 22% and was included in the Giga-tronics Division. A third customer accounted for 17% of the Company’s consolidated revenue and was also included in the Giga-tronics Division.

 

(13)          Income Taxes

 

The Company accounts for income taxes using the asset and liability method as codified in Topic 740. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards.

 

The Company recorded no tax expense for the three months ended June 24, 2017 and June 25, 2016. The effective tax rate for the three months ended June 24, 2017 and June 25, 2016 was 0% respectively, primarily due to a valuation allowance recorded against the net deferred tax asset balance.

 

As of June 24, 2017, the Company had recorded $120,000 for unrecognized tax benefits related to uncertain tax positions. The unrecognized tax benefit is netted against the non-current deferred tax asset on the Consolidated Balance Sheet. The Company does not expect the liability for unrecognized tax benefits to change materially within the next 12 months. The Company does have a California Franchise Tax Board audit that is currently in process. The Company is working with the California Franchise Tax Board to resolve all audit issues and does not believe any material taxes, penalties and fees are due. However, as a result of the on-going examination, the Company recorded an estimated associated tax liability of $45,000 in the first quarter of fiscal 2015.

 

( 14 )        Warranty Obligations

 

The Company records a liability in cost of sales for estimated warranty obligations at the date products are sold. Adjustments are made as new information becomes available. The following provides a reconciliation of changes in the Company’s warranty reserve. The Company provides no other guarantees.

 

(In thousands)

 

Three Months

Ended

June 24,

2017

   

Three Months

Ended

June 25,

2016

 

Balance at beginning of period

  $ 123     $ 60  

Provision, net

    1       112  

Warranty costs incurred

    (33

)

    (112

)

Balance at end of period

  $ 91     $ 60  

  

(15)       Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants

 

On November 10, 2011, the Company received $2,199,000 in cash proceeds from Alara Capital AVI II, LLC, a Delaware limited liability company (the “Investor”), an investment vehicle sponsored by Active Value Investors, LLC, under a Securities Purchase Agreement entered into on October 31, 2011. Under the terms of the Securities Purchase Agreement, the Company issued 9,997 shares of its Series B Convertible Voting Perpetual Preferred Stock (“Series B Preferred Stock”) to the Investor at a price of $220 per share. The Company has recorded $2.0 million as Series B Preferred Stock on the consolidated balance sheet which is net of stock offering costs of approximately $202,000 and represents the value attributable to both the convertible preferred stock and warrants issued to the Investor. After considering the value of the warrants, the effective conversion price of the preferred stock was greater than the common stock price on date of issue and therefore no beneficial conversion feature was present.

  

 
16

 

 

On February 19, 2013, the Company entered into a Securities Purchase Agreement pursuant to which it agreed to sell 3,424.65 shares of its Series C Convertible Voting Perpetual Preferred Stock (“Series C Preferred Stock”) to the Investor, for aggregate consideration of $500,000, which is approximately $146.00 per share. The Company has recorded $457,000 as Series C Preferred Stock on the consolidated balance sheet, which is net of stock offering costs of approximately $43,000. After considering the reduction in the value of the warrant, the effective conversion price of the preferred stock was greater than the common stock price on the date of issue and therefore no beneficial conversion feature was present.

  

On July 8, 2013 the Company received $817,000 in net cash proceeds from the Investor under a Securities Purchase Agreement. The Company sold to the Investor 5,111.86 shares of its Series D Convertible Voting Perpetual Preferred Stock (Series D Preferred Stock) and a warrant to purchase up to 511,186 additional shares of common stock at the price of $1.43 per share. The allocation of the $858,000 in gross proceeds from issuance of Series D Preferred Stock based on the relative fair values resulted in an allocation of $498,000 (which was recorded net of $41,000 of issuance costs) to Series D Preferred Stock and $360,000 to Common Stock.  In addition, because the effective conversion rate based on the $498,000 allocated to Series D Preferred Stock was $0.97 per common share which was less than the Company’s stock price on the date of issuance, a beneficial conversion feature was present at the issuance date. The beneficial conversion feature totaled $238,000 and was recorded as an increase of common stock and an increase to accumulated deficit. 

 

Each share of Series B, Series C and Series D Preferred Stock is convertible into one hundred shares of the Company’s common stock. In connection with the preferred stock issuance described above, the Company issued to the investor warrants to purchase a total of 1,017,405 common shares at an exercise price of $1.43 per share. These warrants were exercised in February 2015, and May 2015. The Company received funds from Alara in separate closings dated February 16, 2015 and February 23, 2015. Alara exercised a total of 1,002,818 of its existing Series C and Series D warrants to purchase common shares, all of which had an exercise price of $1.43 per share for total cash proceeds of $1,434,000, which was recorded net of $42,000 of stock issuance costs. As part of the consideration for this exercise, the Company sold to Alara two new warrants to purchase an additional 898,634 and 194,437 common shares at an exercise price of $1.78 and $1.76 per share, respectively, for a total purchase price of $137,000 or $0.125 per share. The new warrants have a term of five years and may be paid in cash or through a cashless net share settlement. The Company and Alara amended the remaining 14,587 warrants as part of the February closings. On May 14, 2015, Alara exercised the remaining 14,587 warrants by acquiring 7,216 of shares of the Company’s common stock through a cashless net share settlement.

 

The table below present information for the periods ended June 24, 2017 and March 25, 2017:

 

Preferred Stock                        

As of June 24, 2017 and March 25, 2017  

  

                           

Liquidation

 
   

Designated

Shares

   

Shares

Issued

   

Shares

Outstanding

   

Preference

(in thousands)

 

Series B

    10,000.00       9,997.00       9,997.00     $ 2,309  

Series C

    3,500.00       3,424.65       3,424.65       500  

Series D

    6,000.00       5,111.86       5,111.86       731  

Total

    19,500.00       18,533.51       18,533.51     $ 3,540  

 

(16)        Private Placement Offering

 

On January 19, 2016, the Company entered into a Securities Purchase Agreement for the sale of 2,787,872 Units, each consisting of one share of common stock and a warrant to purchase 0.75 shares of common stock, to approximately 20 private investors. The purchase price for each Unit was $1.24375. Gross proceeds were approximately $3.5 million. Net proceeds to the Company after fees was approximately $3.1 million. The portion of the purchase price attributable to the common shares included in each Unit was $1.15, the consolidated closing bid price for the Company’s common stock on January 15, 2016. The warrant price was $.09375 per Unit (equivalent to $0.125 per whole warrant share), with an exercise price of $1.15 per share. The term of the warrants is five years from the date of completion of the transaction. Emerging Growth Equities, Ltd also received warrants to purchase 292,727 shares of common stock at an exercise price of $1.15 per share as part of its consideration for serving as placement agent in connection with the private placement.

 

 
17

 

 

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The forward-looking statements included in this report including, without limitation, statements containing the words "believes", "anticipates", "estimates", "expects", "intends" and words of similar import, which reflect management’s best judgment based on factors currently known, involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including but not limited to those listed in Giga-tronics’ Annual Report on Form 10-K for the fiscal year ended March 25, 2017 Part I, under the heading “Risk Factors”, and Part II, under the heading “Management’s Discussion and Analysis of Financial Conditions and Results of Operations”.

 

Company Overview

  

We produce an Advanced Signal Generator (ASG) for the electronic warfare market and YIG (Yttrium, Iron, Garnet) RADAR filters used in fighter jet aircraft. We have two reporting segments: Giga-tronics Division and Microsource.

  

  

The Giga-tronics Division over the past thirty-five years has produced a broad line of test and measurement equipment used primarily for the design, production, repair and maintenance of products in aerospace, telecommunications, RADAR, and electronic warfare. Giga-tronics has recently completed a move within the test and measurement market from its legacy products to the newly developed ASG product. As part of this evolution certain legacy product lines were sold to raise additional capital. For example, we sold our SCPM product line to Teradyne in 2013, and in December of 2015, Giga-tronics sold its Power Meters, Amplifiers, and Legacy Signal Generators to Spanawave (see Note 9, Sale of Product Lines). In June of 2016, Giga-tronics sold its Switch product line to Astronics (see Note 9, Sale of Product Lines). With the sales of these legacy product lines, the Giga-tronics Division is solely focused on the ASG product in the test and measurement equipment market.

  

  

Microsource primarily develops and manufactures YIG RADAR filters used in fighter jet aircraft for two prime contractors. The Microsource YIG RADAR filters provide us with long term production and development contracts with strong gross margins.

 

The ASG has the potential to significantly grow product sales and achieve strong gross margins. However, Giga-tronics has experienced significant delays developing, manufacturing and receiving ASG customer orders. The ASG is the most technically complex and advanced product Giga-tronics has developed and manufactured, and we have experienced delays in bringing the product to market and efficiently manufacturing it. It is also priced significantly higher than any other Giga-tronics product, and we have experienced longer than anticipated procurement cycles in the electronic warfare market it services. The delays in the development and manufacturing of the ASG, along with the longer than anticipated procurement cycles, have significantly contributed to the increased operating losses in the first fiscal quarter of 2018 and prior years. Giga-tronics could experience similar losses in the current fiscal year if there are further delays in ASG features currently being developed, manufacturing efficiencies are not achieved, and customer orders are delayed. To bring the ASG to its full potential, Giga-tronics may be required to seek additional working capital, however, there are no assurances that such working capital will be available, or on terms acceptable to the Company.   

 

Significant Orders  

 

Both the Giga-tronics Division and Microsource receive large customer orders each year. The timing of orders, and any associated milestones achievement, causes significant differences in orders received, backlog, sales, deferred revenue, inventory and cash flow when comparing one fiscal period to another. Below is a review of recently received significant orders:

 

In July 2016, Microsource received a $1.9 million non-recurring engineering order associated with redesigning a component of its high performance YIG filter used on an aircraft platform. Of this NRE service order, we delivered approximately $884,000 in services during the first quarter ended June 24, 2017, and we expect to continue such services over the next nine to twelve months.

 

In March 2017, Microsource received a $404,000 YIG RADAR filter order from one of our customers. We expect to fulfil this order starting in the second quarter of fiscal 2018.

 

Also in July 2017, Microsource received an additional $471,000 YIG RADAR filter order from one of our customers. We expect to fulfil this order in fiscal 2018. This order is not reflected in the orders and backlog numbers reported below as it was received after June 24, 2017.

 

In July 2017, the Giga-tronics Division received a follow on $1.7 million order from the United States Navy for our Real-Time Threat Emulation System (TEmS) which is a combination of the ASG hardware platform, along with software developed and licensed to the Company from a major Aerospace and Defense Company. We expect to fulfil this order in the second quarter of fiscal 2018. This order is not reflected in the orders and backlog numbers reported below as it was received after June 24, 2017.

 

In June 2016, the Giga-tronics Division received a $3.3 million order from the United States Navy for our Real-Time Threat Emulation System (TEmS) which is a combination of the ASG hardware platform, along with software developed and licensed to the Company from a major Aerospace and Defense Company. The complete order included ASG blades, along with engineering services to integrate the Real-Time TEmS product with additional third party hardware and software for the customer. We fulfilled the Navy order during the fourth quarter of fiscal 2017. An additional order for $542,000 was received in July 2016 from the United States Navy for our ASG hardware only platform. We also fulfilled the $542,000 order in fiscal 2017.

  

 
18

 

 

In fiscal 2015 Microsource received a $6.5 million order (“NRE Order”) for non-recurring engineering and for delivery of a limited number of flight-qualified prototype hardware from a second prime defense contractor to develop a variant of our high performance fast tuning YIG RADAR filters for an aircraft platform. In fiscal 2016 our Microsource business unit also finalized an associated multiyear $10.0 million YIG production order (“YIG Production Order”). The Company started shipping the YIG Production Order in the second quarter of fiscal 2017, and anticipates shipping it through fiscal 2020.

  

Critical Accounting Policies

 

Please refer to the section of the Company’s Annual Report on Form 10-K for the year ended March 25, 2017 entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations —Critical Accounting Policies” for a discussion of our critical accounting policies. During the three months ended June 24, 2017, there were no material changes to these policies other than as disclosed in Note 1 Organization and Significant Accounting Policies.

 

In preparing the consolidated financial statements, management is required to make estimates based on the information available that affect the reported amounts of assets and liabilities as of the balance sheet dates and revenues and expenses for the reporting periods. While we believe that these accounting policies and estimates are based on sound measurement criteria, actual future events can and often do result in outcomes that can be materially different from these estimates and forecasts.

 

Results of Operations

 

New orders received by segment are as follows:

 

NEW ORDERS

                       
   

Three Month Periods Ended

         

(Dollars in thousands)

 

June 24,

2017

   

June 25,

2016

   

%

change

 

Giga-tronics Division

  $     $ 4,729       (100

)%

Microsource

    17       4,543       (100

)%

Total

  $ 17     $ 9,272       (100

)%

 

New orders received in the first quarter of fiscal 2018 decreased nearly 100% to $17,000 from $9.3 million received in the first quarter of fiscal 2017. Both the Giga-tronics Division and Microsource segment saw decreases in orders in the first quarter of fiscal 2018. The Giga-tronics Division had no new ASG orders in the first quarter of fiscal 2018, the Company fulfilled the $3.3 million order from the US Navy associated with the Company’s ASG in fiscal 2017. The Microsource business unit saw a decrease in the first quarter of fiscal 2018 as we fulfilled the $4.5 million YIG purchase order in fiscal 2017. The timing of receipt of expected large YIG filter contracts varies from period to period.

 

 The following table shows order backlog and related information at the end of the respective periods:

 

BACKLOG

                       

(Dollars in thousands)

 

June 24,

2017

   

June 25,

2016

   

%

change

 

Backlog of unfilled orders at end of period:

                       

Giga-tronics Division

  $ 444     $ 3,861       (89

)%

Microsource

    8,924       14,506       (38

)%

Total

  $ 9,368     $ 18,367       (49

)%

                         

Backlog of unfilled orders shippable within one year:

                       

Giga-tronics Division

  $ 444     $ 3,861       (89

)%

Microsource

    4,058       5,668       (28

)%

Total

  $ 4,502     $ 9,529       (53

)%

 

Backlog at the end of the first quarter of fiscal 2018 decreased 49% compared to the end of the same period last year. The Giga-tronics ASG backlog at June 24, 2017 was $444,000, a $3.4 million decrease; the decrease in the backlog was due to the fulfilment of the Navy ASG order. Microsource saw a 38% decrease in backlog in the first quarter of fiscal 2018. The decrease is primarily due to the fulfilment of the $4.5 million YIG production Order. The minimal level of new orders and the decrease in backlog could have a material adverse effect on the Company’s revenues, financial condition and ability to continue as a going concern.

 

 
19

 

 

The allocation of net sales was as follows for the periods shown:

 

ALLOCATION OF NET SALES

                       
   

Three Month Periods Ended

         

(Dollars in thousands)

 

June 24,

2017

   

June 25,

2016

   

%

Change

 

Giga-tronics Division

  $ 297     $ 2,125       (86

)%

Microsource

    1,694       1,317       29

%

Total

  $ 1,991     $ 3,442       (42

)%

 

Fiscal 2018 first quarter net sales were $2.0 million, a 42% decrease from the $3.4 million in the first quarter of fiscal 2017. Sales at Microsource increased 29% primarily due to an increase in YIG RADAR filter shipments and completion of certain related nonrecurring engineering (NRE) services.  Net sales for the Company’s Giga-tronics business unit were $297,000, an 86% decrease from $2.1 million in the first quarter of fiscal 2017. The decrease was primarily due to lower legacy product sales mainly due to recent product line divestitures as well as a decrease in the ASG product shipments. Sales for the Company’s Advanced Signal Generator (“ASG”) were $200,000 in the first quarter of fiscal 2018 compared to $674,000 in the first quarter of fiscal 2017.

 

Gross margins was as follows for the periods shown:

 

GROSS MARGIN

                       
   

Three Month Periods Ended

         

(Dollars in thousands)

 

June 24,

2017

   

June 25,

2016

   

%

change

 

Total

  $ 466     $ 925       65

%

 

Gross margin decreased in the first quarter of fiscal 2018 to $466,000 from $925,000 for the first quarter of fiscal 2017. The lower gross margin was primarily due to the lower net sales. 

 

Operating expenses were as follows for the periods shown:

 

OPERATING EXPENSES

                       
   

Three Month Periods Ended

         

(Dollars in thousands)

 

June 24,

2017

   

June 25,

2016

   

%

change

 

Engineering

  $ 452     $ 530       (15

)%

Selling, general and administrative

    1,171       1,305       (10

)%

Total

  $ 1,623     $ 1,835       (12

)%

 

Operating expenses decreased 12% or $212,000 in the first quarter of fiscal 2018 over fiscal 2017. Engineering expenses decreased $78,000, primarily due to a decrease in personnel related expenses as a result of the sale of the Switch and Legacy product lines. Selling, general and administrative decreased by $134,000 primarily due to a non-recurring severance charge associated with an officer departure which was included in the first quarter of fiscal 2017.

 

Gain on Sale of Product Line

 

On June 20, 2016, the Company entered into an Asset Purchase agreement for the sale of its Switch product line to Astronics. Upon signing the agreement, Astronics paid $850,000 to the Company for the intellectual property of the product line. The Company recognized a net gain of $802,000 in the first quarter ended June 25, 2016 after related expenses were subtracted from the sales price. The gain is included in the accompanying consolidated financial statements. During the three-month periods ended June 24, 2017, there was no revenue associated with Switch sales. During the three-month period ended June 25, 2016, net Switch sales were $1.1 million (see Note 9, Sale of Product Lines).

 

Derivative Liability

 

There was no gains or losses recorded in the first quarter of fiscal 2018. The Company recorded a gain of $46,000 in the first quarter of fiscal 2017 related to revaluation of the derivative liability associated with warrants issued with the PFG Loan (see Note 7, Term Loans, Revolving Line of Credit and Warrants).

 

 
20

 

 

Net Interest Expense

 

Net interest expense in the first quarter of fiscal 2018 was $102,000, an increase of $62,000 over the first quarter of fiscal 2017. Interest expense increased primarily due to the new loan with PFG, as well as additional interest accrued as a result of the Company’s noncompliance with certain PFG loan covenants. For the first quarter of fiscal 2018, interest expense includes $22,000 of accretion of discounts on the new PFG loan compared to $11,000 recorded in the first quarter of fiscal 2017.

 

Net Loss

 

Net loss was for the first quarter of fiscal 2018 was $1.3 million compared to a net loss of $102,000 recorded in the first quarter of fiscal 2017. The increase in net loss was primarily due to the $802,000 gain recorded associated with the sale of the Switch product line in the first quarter of fiscal 2017 as discussed above and lower sales.

 

Financial Condition and Liquidity

 

As of June 24, 2017, Giga-tronics had $1.1 million in cash and cash equivalents, compared to $1.4 million as of March 25, 2017. The Company had negative working capital at June 24, 2017 compared to $620,000 at March 25, 2017. The current ratio (current assets divided by current liabilities) at June 24, 2017 was 0.95 compared to 1.09 at March 25, 2017. The decrease in working capital is primarily due to declining revenues resulting in net losses in the recent periods.

 

The Company will need additional financing to continue to fund operations; such financing may not be available on terms favorable to the Company if at all, which raises substantial doubt about our ability to continue as a going concern as of the date of this report. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. If adequate funds are not available, the Company may be required to delay, reduce the scope of, or eliminate some of its operations. The Company plans to meet its capital requirements primarily through issuances of equity securities, future partnerships, debt financing or possible product line sales. Failure to generate revenue or raise additional capital would adversely affect our ability to achieve our intended business objectives. No assurance can be given that the Company will be able to meet its capital requirements through these means or otherwise.

 

Cash used in operating activities was $1.1 million for the three-month period ended June 24, 2017. Cash used in operating activities in the first quarter of fiscal 2018 resulted primarily from our net loss of $1.3 million, a decrease of $441,000 in accounts payable, a decrease of $206,000 in accounts receivable and a decrease of $167,000 in deferred revenues. These were partially offset by non-cash charges of $247,000 for depreciation and amortization and an increase of $451,000 in deferred rent.

 

Cash used in operating activities was $589,000 for the three-month period ended June 25, 2016. Cash used in operating activities in the first quarter of fiscal 2017 resulted primarily from our net loss of $102,000, an increase in inventories of $553,000, and partially offset by an increase in deferred revenue of $1.1 million due to advance payment arrangements for raw materials. These uses of cash were partially offset by a decrease to accounts payable of $173,000.

   

Cash used in investing activities for the three-month period ended June 24, 2017 was $620,000, primarily for leasehold improvements in conjunction with the Company’s relocation to Dublin, California.

 

Cash provided by investing activities was $1.2 million for the three-month period ended June 25, 2016. Cash provided by investing activities in the first quarter of fiscal 2017 resulted primarily from a cash payment from Astronics of $850,000 pertaining to the sale of our Switch product line as well as a cash payment from Spanawave of $375,000 pertaining to the sale of our legacy product lines. The cash payments were offset by additions to property and equipment of $30,000 in the first quarter of fiscal 2017. The additions in the first quarter ended fiscal 2017 were associated with equipment required to manufacture the ASG.

 

Cash provided by financing activities for the quarter ended June 24, 2017 was $1.4 million, primarily due to proceeds from the new term loan with PFG.

 

Cash used in financing activities for the quarter ended June 25, 2016 was $141,000, primarily due to the repayment of the Company’s term loan with PFG.

 

The Company incurred net losses of $1.2 million and $102,000 in the first quarter of fiscal 2018 and fiscal 2017, respectively. These losses have contributed to an accumulated deficit of $26.8 million as of June 24, 2017.

 

The Company has experienced delays in the development of features, orders, and shipments for the new Advanced Signal Generator (“ASG”). These delays have contributed, in part to a decrease in working capital. The new ASG product has shipped to several customers, but potential delays in the development of features, longer than anticipated sales cycles, or the uncertainty as to our ability to efficiently manufacture the ASG, could significantly contribute to additional future losses and decreases in working capital.

 

To help fund operations, the Company relies on advances under the line of credit with Bridge Bank. The line of credit expires on May 6, 2019. The agreement includes a subjective acceleration clause, which allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company’s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender’s judgement. As of June 24, 2017, the line of credit had a balance of $582,000.

 

 
21

 

 

These matters raise substantial doubt as to the Company’s ability to continue as a going concern.

  

To address these matters, the Company’s management has taken several actions to provide additional liquidity and reduce costs and expenses going forward. These actions are described in the following paragraphs. 

    

 

On April 27, 2017, the Company entered into a new loan agreement with PFG. Under the terms of the agreement, PFG made a term loan to the Company in the principal amount of $1,500,000, with funding occurring on April 28, 2017. The loan has a two-year term, with interest only payments for the term of the loan. However, as of June 24, 2017, the Company was not in compliance with certain revenue and shareholders’ equity covenants. On August 2, 2017, the Company and PFG entered into a short-term forbearance arrangement (through the end of August) with respect to such noncompliance. No assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. The Company will most likely be required to raise additional capital to rectify the noncompliance. No assurance can be given that the Company will be able to raise sufficient capital on timely basis.

 

 

 

 

In July 2016, Microsource received a $1.9 million non-recurring engineering order associated with redesigning a component of its high performance YIG filter used on an aircraft platform. The Company delivered NRE services for approximately $314,000 during the first quarter of fiscal 2018 and we expect to continue such services over the next nine to twelve months.

 

 

 

 

In March 2017 and July 2017, Microsource received two orders totaling $875,000 associated with its high performance YIG filter used on an aircraft platform; we expect to start shipping the filters in the second quarter of fiscal 2018.

 

 

 

 

In July 2017, the Giga-tronics Division received a $1.7 million order from the United States Navy for the Real-Time Threat Emulation Systems (“TEmS”) which the Company expects to ship in fiscal 2018.

 

 

 

 

With the elimination of Giga-tronics Switch, Power Meter, Amplifier, and Signal Generator legacy product lines resulting from the Asset Purchase Agreements with Spanawave and Astronics, (see Note 9, Sale of Product Lines), the Company has been able to reduce expenses, while providing additional cash for operations from the proceeds of the sales. The Company is also expecting longer term reductions in overhead costs by the relocating of its operations into a smaller facility beginning in the first quarter of fiscal 2018.

 

 

 

  

● 

In the first quarter of fiscal 2016, the Company’s Microsource business unit also finalized a multiyear $10.0 million YIG production order (“YIG Production Order”). The Company started shipping the YIG Production Order in the second quarter of fiscal 2017, and we expect to ship the remainder through fiscal 2020.

     

  

● 

To assist with the upfront purchases of inventory required for future product deliveries, the Company entered into advance payment arrangements with certain customers, whereby the customers reimburse the Company for raw material purchases prior to the shipment of the finished products. In the first quarter of fiscal 2018, the Company entered into advance payment arrangements totaling $160,000. The Company will continue to seek similar terms in future agreements with these customers and other customers.

  

Management will continue to review all aspects of the business in an effort to improve cash flow and reduce costs and expenses, while continuing to invest, to the extent possible, in new product development for future revenue streams.

 

Management will also continue to seek additional working capital through debt, equity financing or possible product line sales, however there are no assurances that such financings or sales will be available at all, or on terms acceptable to the Company.

 

The Company’s historical operating results and forecasting uncertainties indicate that substantial doubt exists related to the Company’s ability to continue as a going concern. Forecasting uncertainties exist with respect to the ASG product line due to the potential longer than anticipated sales cycles as well as with potential delays in the refinement of certain features, and/or the Company’s ability to efficiently manufacture it in a timely manner. The accompanying Consolidated Financial Statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result if the Company were unable to do so.

 

 
22

 

 

ITEM 3 QUANTITATI VE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Pursuant to Item 305 of Regulation S-K, the Company, as a smaller reporting company, is not required to provide the information required by this item.

 

ITEM 4  – CONTROLS AND PROCEDURES

 

The Company carried out an evaluation, under the supervision and with the participation of the Company's management, including the Company's Co-Chief Executive Officers and Principal Accounting & Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures as of June 24, 2017, which is the end of the fiscal quarter covered by this report. Based upon that evaluation, the Co-Chief Executive Officers and Principle Accounting & Financial Officer concluded that the Company's disclosure controls and procedures are effective to provide reasonable assurances that (i) the information the Company is required to disclose in the reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time period required by the Commission’s rules and forms, and (ii) such information is accumulated and communicated to our management, including our Co-Chief Executive Officers and Principal Accounting & Financial Officer, as appropriate to allow timely decisions regarding required disclosures.

 

There were no significant changes in the Company's internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.

 

 

II - OTHER INFORMATION

 

ITEM 1  – LEGAL PROCEEDINGS  

 

As of June 24, 2017, the Company has no material pending legal proceedings. From time to time, the Company is involved in various disputes and litigation matters that arise in the ordinary course of business.

 

The Company is party to an Asset Purchase Agreement dated November 25, 2015 with Spanawave Corporation under which Spanawave agreed to purchase certain product lines and associated business and assets from the Company. The Company and Spanawave have been engaged in a dispute over their respective rights and obligations under the agreement and have negotiated in an effort to resolve the dispute. The agreement provides for an aggregate purchase of $1,500,000 which includes six phases plus the value of inventory. To date, the Company has received $375,000, against a contract price of $750,000, plus certain inventory payment for phases 1 through 5 of the subject businesses. Because of the dispute, the status of phase 6 (legacy signal generators), which has a contract price of another $750,000 plus the value of inventory is uncertain. On August 19, 2016, Spanawave filed an action against the Company in Contra Costa Superior Court for alleged breach of contract and alleged breach of the implied covenant of good faith and fair dealing. The complaint seeks specific performance of the agreement and damages. Spanawave’s affiliate Liberty Test Equipment also filed an arbitration claim for $440,000 under a distribution agreement between the Company and Liberty. The Company has filed cross-complaints in both the litigation and arbitration asserting breach of the respective agreements by Spanawave and Liberty. The Company had previously asserted that the distribution agreement does not extend to the products with respect to which the claim has been made. Certain customers of the lines of business sold to Spanawave are also customers of the Company’s ongoing ASG business. Continued disruption of the phase 6 signal generator business could have an adverse effect on the ASG business. The parties have negotiated in an effort to settle the dispute notwithstanding the filings. The expenses and potential liability of negotiation, any settlement or continued litigation or arbitration could have a material adverse effect on the Company.

 

ITEM 1A   RISK FACTORS

 

There has been no material change in the risk factors disclosed in the registrant’s Annual Report on Form 10-K for the fiscal year ended March 24, 2017, except (i) with respect to the matter reported in Item 3, Defaults Upon Senior Securities, below and (ii) a continuing decrease in the Company’s cash flow and liquidity, which increases the level of doubt as to the Company’s ability to continue as a going concern.

 

ITEM 2  – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.           

 

ITEM 3  – DEFAULTS UPON SENIOR SECURITIES

 

On April 27, 2017, the Company entered into a new loan agreement with PFG. Under the terms of the agreement, PFG made a term loan to the Company in the principal amount of $1,500,000. As of June 24, 2017, the Company was not in compliance with certain revenue and shareholders’ equity covenants. On August 2, 2017, the Company and PFG entered into a short-term forbearance arrangement (through the end of August) with respect to such noncompliance. No assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. The Company will most likely be required to raise additional capital to rectify the noncompliance. No assurance can be given that the Company will be able to raise sufficient capital on timely basis.

 

 
23

 

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.          

 

ITEM 5 – OTHER INFORMATION

 

None.

 

ITEM 6 –   EXHIBITS

 

31.1

Certification of Co-Chief Executive Officers pursuant to Section 302 of Sarbanes-Oxley Act.

31.2

Certification of Principal Accounting & Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act.

32.1

Certification of Co-Chief Executive Officers pursuant to Section 906 of Sarbanes-Oxley Act.

32.2

Certification of Principal Accounting& Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act.

101.INS**

XBRL Instance

101.SCH**

XBRL Taxonomy Extension Schema

101.CAL**

XBRL Taxonomy Extension Calculation

101.DEF**

XBRL Taxonomy Extension Definition

101.LAB**

XBRL Taxonomy Extension Labels

101.PRE**

XBRL Taxonomy Extension Presentation

 

 
24

 

   

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

GIGA-TRONICS INCORPORATED

 

 

 

(Registrant)

 

 

 

 

 

 

 

 

By:

 

 

 

 

 

 

Date:

August 4, 2017

 

/s/ John R. Regazzi

 

 

 

John R. Regazzi

 

 

 

 

Co-Chief Executive Officer

 

 

 

(Principal Executive Officer)

 

 

 

 

 

Date:

August 4, 2017

 

/s/ Suresh Nair

 

 

 

 

Suresh Nair

 

 

 

 

Co-Chief Executive Officer

 

 

 

 

 

 

Date:

August 4, 2017

 

/s/ Temi Oduozor

 

 

 

Temi Oduozor

 

 

 

Corporate Controller &

 

 

 

Principal Accounting & Officer

 

 

 

25

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 giga20170624_10q.htm

EXHIBIT 31.1  

 

 

CERTIFICATIONS UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, John R. Regazzi, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Giga-tronics Incorporated;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ John R. Regazzi

 

 

 

 

John R. Regazzi

 

 

 

 

Co-Chief Executive Officer

 

 

 
 

 

 

EXHIBIT 31.1  

  

CERTIFICATIONS UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Suresh Nair, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Giga-tronics Incorporated;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ Suresh Nair

 

 

 

 

Suresh Nair

 

 

 

 

Co-Chief Executive Officer

 

 

EX-31.2 3 ex31-2.htm EXHIBIT 31.2 giga20170624_10q.htm

EXHIBIT 31.2

 

CERTIFICATIONS UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Temi Oduozor, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Giga-tronics Incorporated;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ Temi Oduozor

 

 

 

 

Temi Oduozor

 

 

 

 

Corporate Controller &

 

 

 

 

Principal Accounting & Financial Officer

 

 

EX-32.1 4 ex32-1.htm EXHIBIT 32.1 giga20170624_10q.htm

 EXHIBIT 32.1 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the quarterly report of Giga-tronics Incorporated (the "Company") on Form 10-Q for the period ending June 24, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John R. Regazzi, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ John R. Regazzi

 

 

 

 

John R. Regazzi

 

 

 

 

Co-Chief Executive Officer

 

 

 

 

 

 

 

 

In connection with the quarterly report of Giga-tronics Incorporated (the "Company") on Form 10-Q for the period ending June 24, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Suresh Nair, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ Suresh Nair

 

 

 

 

Suresh Nair

 

 

 

 

Co-Chief Executive Officer

 

 

 

 

 

 

 

EX-32.2 5 ex32-2.htm EXHIBIT 32.2 giga20170624_10q.htm  EXHIBIT 32.2

 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the quarterly report of Giga-tronics Incorporated (the "Company") on Form 10-Q for the period ending June 24, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Temi Oduozor, Corporate Controller, Principal Accounting & Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date:

August 4, 2017

 

 

 

 

 

 

/s/ Temi Oduozor

 

 

 

 

Temi Oduozor

 

 

 

 

Corporate Controller &

 

 

 

 

Principal Accounting & Financial Officer

 

 

 

EX-101.INS 6 giga-20170624.xml EXHIBIT 101.INS false --03-25 Q1 2018 2017-06-24 10-Q 0000719274 10142153 Yes Smaller Reporting Company GIGA TRONICS INC No No giga P90D 0.8 1.5 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash received from Astronics</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">850</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash paid to buy out future commission obligation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee severance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(97</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Commissions</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warranty Liability released</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">278</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net gain recognized in the quarter</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">802</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 170000 170000 150000 67000 14587 P5Y 46000 0.095 0.06 0.06 0.065 100000 0.25 24000 1000 0.0425 375000 375000 377000 67000 46000 46000 802000 802000 334000 -79000 -29000 1 250000 60000 2500 20 2 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div>)</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Private</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"> Placement Offering</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.75pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 19, 2016, </div>the Company entered into a Securities Purchase Agreement for the sale of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,787,872</div> Units, each consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of common stock and a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div> shares of common stock, to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div> private investors. The purchase price for each Unit was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.24375.</div> Gross proceeds were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.5</div> million. Net proceeds to the Company after fees was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.1</div> million. The portion of the purchase price attributable to the common shares included in each Unit was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.15,</div> the consolidated closing bid price for the Company&#x2019;s common stock on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 15, 2016. </div>The warrant price was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$.09375</div> per Unit (equivalent to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.125</div> per whole warrant share), with an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.15</div> per share. The term of the warrants is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years from the date of completion of the transaction. Emerging Growth Equities, Ltd also received warrants to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">292,727</div> shares of common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.15</div> per share as part of its consideration for serving as placement agent in connection with the private placement.</div></div></div> 160000 500000 275000 1000 112000 375000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue Recognition</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company records revenue when there is persuasive evidence of an arrangement, delivery has occurred, the price is fixed and determinable, and collectability is reasonably assured. This occurs when products are shipped or the customer accepts title transfer. If the arrangement involves acceptance terms, the Company defers revenue until product acceptance is received. The Company limits the amount of revenue recognition for delivered elements to the amount that is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> contingent on the future delivery of products or services, future performance obligations or subject to customer-specified return or refund privileges. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. On certain large development contracts, revenue is recognized upon achievement of substantive milestones. Determining whether a milestone is substantive is a matter of judgment and that assessment is performed only at the inception of the arrangement. The consideration earned from the achievement of a milestone must meet all of the following for the milestone to be considered substantive:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">a. It is commensurate with either of the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> The Company&#x2019;s performance to achieve the milestone.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 72pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> The enhancement of the value of the delivered item or items as a result of a specific outcome resulting&nbsp;from the Company's performance to achieve the milestone.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">b. It relates solely to past performance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0pt 0pt 36pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">c. It is reasonable relative to all of the deliverables and payment terms (including other potential milestone consideration) within the arrangement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Milestones for revenue recognition are agreed upon with the customer prior to the start of the contract and some milestones will be tied to product shipping while others will be tied to design review. In fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> the Company&#x2019;s Microsource business unit received a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.5</div> million order from a major aerospace company for non-recurring engineering services to develop a variant of its high performance fast tuning YIG filters for an aircraft platform and to deliver a limited number of flight-qualified prototype hardware units (the &#x201c;NRE Order&#x201d;) which is being accounted for on a milestone basis. The Company considered factors such as estimated completion dates and product acceptance of the order prior to accounting for the NRE Order as milestone revenue. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> revenue recognized during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>as the Company had delivered all milestones associated with this contract. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016, </div>revenue recognized on a milestone basis were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$145,000.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On certain contracts with several of the Company&#x2019;s significant customers the Company receives payments in advance of manufacturing. Advanced payments are recorded as deferred revenue until the revenue recognition criteria described above have been met.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Accounts receivable are stated at their net realizable value. The Company has estimated an allowance for uncollectable accounts based on analysis of specifically identified accounts, outstanding receivables, consideration of the age of those receivables, the Company&#x2019;s historical collection experience, and adjustments for other factors management believes are necessary based on perceived credit risk.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company provides for estimated costs that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be incurred for product warranties at the time of shipment. The Company&#x2019;s warranty policy generally provides <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eighteen</div> months depending on the customer. The estimated cost of warranty coverage is based on the Company&#x2019;s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Adjustments are made as new information becomes available.</div></div></div> 0.07 0.03 P4Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fees paid to the lender and third parties</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Backend fee</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Estimated fair value of embedded equity forward</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">49,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of 190,000 shares of common stock issued to lender</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate discount amount</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> </table></div> 3500000 3100000 0.125 1.24375 1.15 0.09375 2787872 7216 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Software Development Costs</div> Development costs included in the research and development of new software products and enhancements to existing software products are expensed as incurred, until technological feasibility in the form of a working model has been established. Capitalized development costs are amortized over the expected life of the product and evaluated each reporting period for impairment.</div></div></div></div></div></div></div></div> 137000 0.125 P5Y P5Y P1Y P1Y180D 666000 1107000 748000 954000 202000 43000 37000 72000 9000 0 45000 45000 22000 0 11000 22000 11000 1104000 1529000 350000 55000 1853000 1853000 3737000 3737000 9060000 9074000 6153000 8233000 2907000 3887000 12120000 7251000 7638000 0 0 0 0 51000 50000 100000 114000 0 151000 0 582000 733000 582000 733000 1137000 1421000 1331000 1796000 -284000 465000 1.42 1.43 1.43 1.43 1.78 1.76 1.15 1.15 0.75 511186 1017405 1002818 898634 194437 1017405 292727 180000 80000 14587 0 0 40000000 40000000 10139653 9594203 10139653 9594203 24596000 24390000 0.43 0.37 0.3 0.22 0.17 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Principles of Consolidation</div> The consolidated financial statements include the accounts of Giga-tronics and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</div></div></div></div></div></div></div></div> 100 1525000 2517000 156000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable Line of Credit</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 1, 2015 </div>the Company entered into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million Revolving Accounts Receivable Line of Credit agreement with Bridge Bank. The agreement provides for a maximum borrowing capacity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million is subject to a borrowing base calculation and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div> is non-formula based. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 23, 2017, </div>the Company renewed this credit line (which expired on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 7, 2017) </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 6, 2019.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loan agreement is secured by all assets of the Company including intellectual property and general intangibles and provides for a borrowing capacity equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80%</div> of eligible accounts receivable. The loan matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 6, 2019 </div>and bears an interest rate, equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.5%</div> over the bank&#x2019;s prime rate of interest (which was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.25%</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>resulting in an interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.75%</div>). Interest is payable monthly with principal due upon maturity. The Company paid an annual commitment fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,500</div> in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017. </div>The loan agreement contains financial and non-financial covenants that are customary for this type of lending and includes a covenant to maintain an asset coverage ratio of at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150%</div> (defined as unrestricted cash and cash equivalents maintained with Bridge Bank, plus eligible accounts receivable aged less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90</div> days from the invoice date, divided by the total amount of outstanding principal of all obligations under the loan agreement). While the Company maintained the asset coverage ratio, the Company was in a cross default at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>as a result of the PFG noncompliance described in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> below.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The line of credit requires a lockbox arrangement, which provides for receipts to be swept daily to reduce borrowings outstanding at the discretion of Bridge Bank. This arrangement, combined with the existence of the subjective acceleration clause in the line of credit agreement, necessitates the line of credit be classified as a current liability on the balance sheet. The acceleration clause allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company&#x2019;s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender's&nbsp;judgment. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the Company&#x2019;s total outstanding borrowings&nbsp;under the Bridge Bank line of credit were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$582,000.</div>&nbsp;</div></div></div> 0.015 238000 0.97 1500000 2000000 76000 0.0575 0.16 0.0975 0.125 P2Y P3Y P2Y270D 326000 44000 76000 49000 157000 451000 3447000 3614000 247000 91000 133000 89000 222000 500 222000 46000 222000 46000 0 222000 222000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Derivatives</div> The Company accounts for certain of its warrants and embedded debt features as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of these instruments to fair value.&nbsp;</div></div></div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Share Based Compensation</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has established the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Equity Incentive Plan, which provide for the granting of options and restricted stock for up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,850,000</div> shares of common stock at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of fair market value at the date of grant, with each grant requiring approval by the Board of Directors of the Company. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005</div> Plan has been extended to be effective until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2025.</div> Option grants under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2000</div> Stock Option Plan are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer available. Options granted generally vest in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more installments in a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> year period and must be exercised while the grantee is employed by the Company or within a certain period after termination of employment. Options granted to employees shall <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> years from the grant date. Holders of options <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be granted stock appreciation rights (SARs), which entitle them to surrender outstanding awards for a cash distribution under certain changes in ownership of the Company, as defined in the stock option plan. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> SAR&#x2019;s have been granted under the option plan. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the total number of shares of common stock available for issuance was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">934,677.</div> All outstanding options have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> year life from the date of grant. The Company records compensation cost associated with share-based compensation equivalent to the estimated fair value of the awards over the requisite service period.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Stock</div> <div style="display: inline; text-decoration: underline;">Options</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In calculating compensation related to stock option grants, the fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option-pricing model and the following weighted average assumptions:&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-TOP: 0px" colspan="6"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 2</div><div style="display: inline; font-weight: bold;">4</div><div style="display: inline; font-weight: bold;">,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">7</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">98.95</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.38</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.36</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The computation of expected volatility used in the Black-Scholes-Merton option-pricing model is based on the historical volatility of the Company&#x2019;s share price. The expected term is estimated based on a review of historical employee exercise behavior with respect to option grants. The risk-free interest rate is based on the U.S. Treasury rates with maturity similar to the expected term of the option on the date of grant.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;A summary of the changes in stock options outstanding for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017 </div>is as follows: &nbsp; &nbsp; &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Terms (Years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at March 26, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,592,200</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.8</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">148,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.97</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited / Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">635,700</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.57</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at March 25, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.41</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited / Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.41</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">812,050</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.45</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.2</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At June 24, 2017 expected to vest in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,006,157</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.42</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.7</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$156,000</div> of total unrecognized compensation cost related to non-vested options. That cost is expected to be recognized over a weighted average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.06</div> years and will be adjusted for subsequent changes in estimated forfeitures. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,500</div> options that vested during the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,500</div> options that vested during the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016. </div>The total fair value of options vested during each of the quarters ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$33,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,000</div> respectively. There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> options exercised in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016. </div>Share based compensation cost related to stock options recognized in operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$37,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$72,000,</div> respectively.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Restricted Stock</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,450</div> restricted awards during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> restricted awards were granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> </div>restricted awards vested during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The restricted stock awards are considered fixed awards as the number of shares and fair value at the grant date is amortized over the requisite service period net of estimated forfeitures. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>there was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$204,000</div> of total unrecognized compensation cost related to non-vested awards. That cost is expected to be recognized over a weighted average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.98</div> years and will be adjusted for subsequent changes in estimated forfeitures. Compensation cost recognized for the restricted and unrestricted stock awards during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9,000.</div> There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> compensation recognized for the restricted and unrestricted stock awards during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> </div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp; <div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">A summary of the changes in non-vested restricted stock awards outstanding for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017 </div>is as follows:</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at March 26, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.66</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.66</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited or cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at March 25, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,450</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited or cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,450</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Discontinued Operations</div> The Company reviews its reporting and presentation requirements for discontinued operations in accordance with the guidance provided by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">205</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div> as it moves to newer technology within the test and measurement market from legacy products to the newly developed Advanced Signal Generator. The disposal of these product line sales represent an evolution of the Company&#x2019;s Giga-tronics Division to a more sophisticated product offered to the same customer base. The Company has evaluated the sales of product lines (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> Sale of Product Lines) concluding that each product line does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet the definition of a &#x201c;component of an entity&#x201d; as defined by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">205</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.The</div> Company is able to distinguish revenue and gross margin information as disclosed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> Sale of Product Lines to the accompanying financial statements however, operations and cash flow information is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> clearly distinguishable and the Company is unable to present meaningful information about results of operations and cash flows from those product lines.</div></div></div></div></div></div></div></div> -0.13 -0.01 -0.13 -0.01 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;<div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Loss Per Share</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Basic loss per share (EPS) is calculated by dividing net income or loss by the weighted average common shares outstanding during the period. Diluted EPS reflects the net incremental shares that would be issued if unvested restricted shares became vested and dilutive outstanding stock options were exercised, using the treasury stock method. In the case of a net loss, it is assumed that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> incremental shares would be issued because they would be antidilutive. In addition, certain options are considered antidilutive because assumed proceeds from exercise price, related tax benefits and average future compensation was greater than the weighted average number of options outstanding multiplied by the average market price during the period. The shares used in per share computations are as follows: &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-TOP: 0px" colspan="6"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands except per share data)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net loss</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,258</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common shares outstanding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,715</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,550</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Potential common shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common shares assuming dilution</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,715</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,550</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Loss per common share &#x2013; basic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Loss per common share &#x2013; diluted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock options not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,529</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted stock awards not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuable shares for interest on loan</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,853</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,853</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,737</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,737</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The stock options, restricted stock, convertible preferred stocks and warrants <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the computation of diluted earnings per share (EPS) for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>is a result of the Company&#x2019;s net loss and, therefore, the effect of these instruments would be anti-dilutive.</div></div></div> 0 0 427000 583000 156000 P3Y21D P1Y357D 204000 0 46000 -46000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter</div> <div style="display: inline; font-weight: bold;">Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter</div> <div style="display: inline; font-weight: bold;">Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability at beginning of year</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">353</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Gains on adjustment of warrant liability to fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Losses on adjustment of warrant liability to fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability at end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">307</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> P1Y255D 1.011 0.0126 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Fair Value</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Pursuant to the accounting guidance for fair value measurement and its subsequent updates, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the &#x201c;exit price&#x201d;) in an orderly transaction between market participants at the measurement date. The accounting guidance establishes a hierarchy for inputs used in measuring fair value that minimizes the use of unobservable inputs by requiring the use of observable market data when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on active market data. Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances. &nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The fair value hierarchy is broken down into the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> input levels summarized below:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 27pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4.9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 3.3%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x2022;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 91.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Level&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></div>&nbsp;&nbsp;&#x2014;Valuations are based on quoted prices in active markets for identical assets or liabilities and readily accessible by us at the reporting date. Examples of assets and liabilities utilizing Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> inputs are certain money market funds, U.S. Treasuries and trading securities with quoted prices on active markets.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4.9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 3.3%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x2022;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 91.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Level&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div></div>&nbsp;&nbsp;&#x2014;Valuations based on inputs other than the quoted prices in active markets that are observable either directly or indirectly in active markets. Examples of assets and liabilities utilizing Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> inputs are U.S. government agency bonds, corporate bonds,&nbsp;commercial paper, certificates of deposit and over-the- counter derivatives.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 4.9%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 3.3%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x2022;&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 91.7%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Level&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></div>&nbsp;&nbsp;&#x2014;Valuations based on unobservable inputs in which there are little or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> market data, which require us to develop our own assumptions.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017. </div>The carrying values of cash and cash equivalents, trade accounts receivable, line of credit, term debt and accounts payable approximate their fair values given their short-term nature. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the carrying value of the outstanding PFG loan approximates the estimated aggregate fair value, since the embedded equity forward is recognized at fair value and classified with the loan host. The fair value estimate of the embedded equity forward is based on the closing price of the Company&#x2019;s common stock on the measurement date, the risk-free rate, the date of expiration, and any expected cash distributions of the underlying asset before expiration. The estimated fair value of the embedded equity forward represents a Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> measurement.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Derivatives</div> The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including notes payable, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company accounts for certain of its warrants as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of warrant liability to fair value.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company&#x2019;s balance sheet.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s derivative warrant liability is measured at fair value on a recurring basis and is categorized as Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> in the fair value hierarchy. The derivative warrant liability is valued using a Monte Carlo simulation model, which used the following assumptions as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017: (</div>i) the remaining expected life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.7</div> years, (ii) the Company&#x2019;s historical volatility rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101.1%,</div> (iii) risk-free interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.26%,</div> and (iv) a discount rate of&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> percent.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The aforementioned derivative warrant liability and equity forward are the Company&#x2019;s only asset and liability recognized and measured at fair value on a recurring or non-recurring basis and are follows:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements as of</div> <div style="display: inline; font-weight: bold;">June 24, 2017</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Thousands):</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 1</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 2</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 3</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Equity forward</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements as of March 25, 2017</div> </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Thousands):</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 1</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 2</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 3</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> transfers between Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> or Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> for the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017. </div><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below summarizes changes in gains and losses recorded in earnings for Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> assets and liabilities that are still held at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017:</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter</div> <div style="display: inline; font-weight: bold;">Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter</div> <div style="display: inline; font-weight: bold;">Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 5.4pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability at beginning of year</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">353</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Gains on adjustment of warrant liability to fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">)</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Losses on adjustment of warrant liability to fair value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability at end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">307</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">There were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assets measured at fair value on a recurring basis and there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assets or liabilities measured on a non-recurring basis at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017.</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The following table presents quantitative information about recurring Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> fair value measurements at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017:</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June</div> <div style="display: inline; font-weight: bold;">24, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Technique(s)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Unobservable Input</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Monte Carlo</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Discount rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March 25, 2017</div> </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Techniques(s)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Unobservable Input</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Monte Carlo</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Discount rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The discount rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty</div> percent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017,&nbsp;</div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twenty four</div> percent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017&nbsp;</div>is management&#x2019;s estimate of the cost of capital given the Company&#x2019;s credit worthiness. A significant increase in the discount rate would significantly decrease the fair value, but the magnitude of this decrease would be less significant in a scenario where the Company&#x2019;s stock price is significantly higher than the exercise price since the holder&#x2019;s option to take a cash payment at maturity represents a smaller component of the total fair value when the Company&#x2019;s stock price is higher. The Monte Carlo simulation model simulated the Company&#x2019;s stock price through the maturity date of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019. </div>At the end of the simulated period, the value of the warrant was determined based on the greater of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) the net share settlement value, (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) the net exercise value, or (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) the fixed cash put value. &nbsp;&nbsp;</div></div></div> 0.3 0.3 0.24 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June</div> <div style="display: inline; font-weight: bold;">24, 2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Technique(s)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Unobservable Input</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Monte Carlo</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Discount rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div></td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March 25, 2017</div> </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Valuation Techniques(s)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Unobservable Input</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: medium none; PADDING-BOTTOM: 0px; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Monte Carlo</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 2%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 27%; VERTICAL-ALIGN: top; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.55pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Discount rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div>&nbsp;</div></td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; font-weight: bold;"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements as of</div> <div style="display: inline; font-weight: bold;">June 24, 2017</div></div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Thousands):</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 1</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 2</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 3</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Equity forward</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 52%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Fair Value Measurements as of March 25, 2017</div> </div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In Thousands):</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 1</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 2</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Level 3</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrant liability</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">222</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> 222000 353000 222000 307000 437000 0 466000 925000 -1258000 -102000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.15pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.15pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company accounts for income taxes using the asset and liability method as codified in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740.</div> Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div></div>tax expense for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016. </div>The effective tax rate for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0%</div></div> respectively, primarily due to a valuation allowance recorded against the net deferred tax asset balance.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the Company had recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$120,000</div> for unrecognized tax benefits related to uncertain tax positions. The unrecognized tax benefit is netted against the non-current deferred tax asset on the Consolidated Balance Sheet. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the liability for unrecognized tax benefits to change materially within the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. The Company does have a California Franchise Tax Board audit that is currently in process. The Company is working with the California Franchise Tax Board to resolve all audit issues and does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any material taxes, penalties and fees are due. However, as a result of the on-going examination, the Company recorded an estimated associated tax liability of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$45,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div></div> 0 0 -441000 -173000 -206000 -304000 -167000 1101000 -156000 81000 178000 553000 -270000 451000 -32000 -75000 -63000 -101000 -40000 39000 23000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;Inventories</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Inventories net of inventory reserves totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.4</div></div> million at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017, </div>respectively consisted of the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Raw materials</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,411</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,775</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Work-in-progress</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,931</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,155</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Finished goods</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">239</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">473</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Demonstration inventory</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">408</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">408</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,989</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,811</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 239000 473000 4989000 4811000 1411000 1775000 3400000 3400000 2931000 2155000 13000 8392000 7354000 9060000 9074000 7619000 7018000 0 0 46000 222000 222000 2500000 12500 2500000 2000000 500000 500000 500000 1000000 582000 582000 1576000 1315000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term Loan</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">s</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">, Revolving Line of Credit and Warrants</div></div><div style="display: inline; text-decoration: underline;"> &nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 27, 2017, </div>the Company entered into a new loan agreement with PFG (Partners For Growth V, L.P.). Under the terms of the agreement, PFG made a term loan to Giga-tronics in the principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,500,000,</div> with funding occurring on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 28, 2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The loan has a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>-year term, with interest only payments for the term of the loan. The principal amount of the loan plus any accrued interest will be due upon maturity. The loan bears interest at an aggregate per annum rate equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16%</div> per annum, fixed, which is comprised of cash interest reflecting a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.5%</div> per annum rate and deferred interest reflecting a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.5%</div> per annum rate. The Company will pay the cash interest monthly and will accrue deferred interest on the unpaid principal balance. The deferred interest will be due and payable upon maturity. In addition, the Company agreed to pay PFG a charge of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> due and payable upon maturity (the &#x201c;back-end fee&#x201d;), <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$76,000</div> of which was earned on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 27, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$24,000</div> of which is earned at the rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,000</div> per month on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of each month if the loan principal (of any amount) is outstanding during any day of the prior month. If the Company meets or exceeds certain revenue and net income minimums in fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the amount could be reduced by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25</div> percent. To stay in compliance with the loan terms, the Company must meet certain financial covenants associated with minimum quarterly revenues and monthly minimum shareholders&#x2019; equity. The lender can accelerate the maturity of the loan in case of a default. The Company can prepay the loan before maturity at any time without fee or penalty</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">.</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with its loan to the Company, PFG will receive up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,000</div> shares of common stock, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">190,000</div> of which was earned on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 27, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div> of which is earned at the rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div> per month on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> day of each month if the loan principal (of any amount) is outstanding during any day of the prior month.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has pledged all its assets as collateral for the loan made by PFG, including all its accounts, inventory, equipment, deposit accounts, intellectual property and all other personal property. The PFG loan is subordinate to the Bridge Bank line of credit (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> Accounts Receivable Line of Credit).</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The requirement to issue <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60,000</div> shares of the Company&#x2019;s common stock over the term of the loan is an embedded derivative (an embedded equity forward). The Company evaluated the embedded derivative in accordance with ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">815</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25.</div> The embedded derivative is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> clearly and closely related to the debt host instrument and therefore has been separately measured at fair value, with subsequent changes in fair value recognized in the Condensed Consolidated Statements of Operations. </div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The proceeds received upon issuing the loan was allocated to: i) common stock, for the fair value of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">190,000</div> shares of common stock initially issued to the lender; ii) the fair value of the embedded derivative; and iii) the loan host instrument. Upon issuance of the loan, the Company recognized <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,576,000</div> of principal payable to PFG, representing the stated principal balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,500,000</div> plus the initial back-end fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$76,000.</div> The initial carrying value of the loan was recognized net of debt discount aggregating approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$326,000,</div> which is comprised of the following:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fees paid to the lender and third parties</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Backend fee</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Estimated fair value of embedded equity forward</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">49,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair value of 190,000 shares of common stock issued to lender</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: top; PADDING-LEFT: 18pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate discount amount</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">326,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; BACKGROUND-COLOR: #ffffff"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The bifurcated embedded derivative and the debt discount are presented net with the related loan balance in the Condensed Consolidated Balance Sheets. The debt discount is amortized to interest expense over the loan&#x2019;s term using the effective interest method.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company amortized approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22,000</div> to interest expense in the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017. </div>Additionally, the Company recognized a loss of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500</div> in the in the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>due to the estimated increase in fair value of the embedded equity forward.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">PFG&#x2019;s ability to call the debt on default (contingent put) and its ability to assess interest rate at a default rate (contingent interest) are embedded derivatives which the Company evaluated. The fair value of these embedded features were determined to be immaterial and were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> bifurcated from the debt host for accounting purposes.</div></div> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the Company was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> in compliance with certain financial covenants associated with the PFG loan. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2, 2017, </div>the Company and PFG entered into a short-term forbearance arrangement (through the end of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August) </div>with respect to such noncompliance. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. There is a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> default rate associated with the forbearance agreement.&nbsp;The Company will most likely be required to raise additional capital to rectify the noncompliance.&nbsp; <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> assurance can be given that the Company will be able to raise sufficient capital on timely basis.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 13, 2014, </div>the Company entered into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> year, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million term loan agreement with PFG under which the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 14, 2014 (</div>&#x201c;First Draw&#x201d;). Interest on the initial <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million term loan was fixed at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.75%.</div> On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 16, 2014, </div>the Company amended its loan agreement with PFG (the &#x201c;Amendment&#x201d;). Under the terms of the Amendment, PFG made a revolving credit line available to Giga-tronics in the amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000,</div> and the Company borrowed the entire amount on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 17, 2014. </div>The revolving line had a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirty-three</div> month term. The Amendment reduced the future amount potentially available for the Company to borrow under the PFG Loan agreement from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000.</div> The interest on the PFG revolving credit line was fixed, calculated on a daily basis at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.50%</div> per annum. The Company as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017 </div>had fully repaid both the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million term loan and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div> revolving credit line.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2014 </div>loan agreement, the Company issued warrants convertible into shares of the Company&#x2019;s common stock, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">180,000</div> were exercisable upon receipt of the initial <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million from the First Draw, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,000</div> became exercisable with the First Amendment. Each warrant issued under the loan agreement has a term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years and an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.42</div> which was equal to the average NASDAQ closing price of the Company&#x2019;s common stock for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> trading days prior to the First Draw.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">If the warrants are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exercised before expiration on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019, </div>the Company would be required to pay PFG <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$150,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$67,000</div> as settlement for warrants associated with the First Draw and the Amendment, respectively. The warrants could be settled for cash at an earlier date in the event of any acquisition or other change in control of the Company, future public issuance of Company securities or liquidation (or substantially similar event) of the Company. The Company currently has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> definitive plans for any of the aforementioned events, and as a result, the cash payment date is estimated to be the expiration date unless warrants are exercised before then. The warrants have the characteristics of both debt and equity and are accounted for as a derivative liability measured at fair value each reporting period with the change in fair value recorded in earnings.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017, </div>the estimated fair values of the derivative liabilities associated with the warrants issued in connection with the First Draw and Amendment were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$133,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$89,000,</div> respectively, for a combined value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$222,000,</div> respectively. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> change in the fair value of the warrant liability in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017. </div>The change in the fair value of the warrant liability totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$46,000</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>and is reported in the accompanying statement of operations as a gain on adjustment of derivative liability to fair value. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> accretion recorded in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2014 </div>loan agreement as the loan was paid in full. For the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016, </div>the Company recorded accretion of discount expense associated with the warrants issued with the PFG Loan of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,000.</div> &nbsp;</div></div></div> 440000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Sale of Product Lines</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 20, 2016, </div>the Company entered into an Asset Purchase Agreement for the sale of its Switch product line to Astronics Test Systems Inc. (Astronics). Upon signing the agreement, Astronics paid <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$850,000</div> for the intellectual property of the product line. The Company recognized a net gain of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$802,000</div> in the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016 </div>after related expenses were subtracted from the sales price. The following table presents the breakdown of the gain recognized in the quarter related to the asset sale:</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 83%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Quarter Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 1.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash received from Astronics</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">850</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash paid to buy out future commission obligation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(170</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Employee severance</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(97</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Legal fees</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Commissions</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(46</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warranty Liability released</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">278</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net gain recognized in the quarter</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">802</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp; &nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In calculating the gain included in the accompanying consolidated financial statements, the Company released <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$278,000</div> of deferred warranty obligations related to the Switch asset. Pursuant to the terms of the agreement, Astronics assumed all the warranty obligations for the Switch product line, including the products sold prior to the asset being transferred to Astronics. The deferred warranty obligation was previously included in other current liabilities in the consolidated financial statements. The Company also had a previous agreement with a consultant supporting the Switch product line, which included a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> percent commission on the sales of the Switch product line for a period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> years ending in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2020. </div>The agreement allowed for&nbsp;a buyout of future commissions associated with the Switch product, which the Company exercised in connection with the Astronics sales in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2016 </div>which resulted in a payment by the Company during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$170,000.</div> Astronics also purchased approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div> of related materials inventory from Giga-tronics between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August </div>of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> revenues or gross margin associated with the Switch product line in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017. </div>The Switch product line accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div> million in revenue for the fiscal quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016. </div>The Switch product line&#x2019;s gross margin on revenues was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$437,000</div> for the fiscal quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016. </div>While the Company is able to distinguish revenue and gross margin information related to the sale of the Switch product line, the Company is unable to present meaningful information about results of operation and cash flows from the Switch product line.</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2015, </div>the Company entered into an Asset Purchase Agreement with Spanawave Corporation, whereby Spanawave agreed to purchase the Giga-tronics&#x2019; Division product lines for its Power Meters, Amplifiers, and Legacy Signal Generators for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.5</div> million. The agreement provided for the transfer of these product lines to Spanawave sequentially in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> phases beginning with certain sensor and amplifier products.&nbsp;The Company had transferred the Power Meters and Amplifiers in phases <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> through five, the Company still holds the right to phase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> (Legacy Signal Generators). During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 24, 2016, </div>the Company and Spanawave became engaged in a dispute, including litigation initiated by Spanawave and an arbitration proceeding initiated by Spanawave&#x2019;s affiliate Liberty Test Equipment, Inc., as to whether the Company has fulfilled all the requirements to close phases <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> and become entitled to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$375,000</div> received by the Company during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> (see below).</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The complaint seeks specific performance of the agreement and damages. Spanawave&#x2019;s affiliate Liberty Test Equipment also filed an arbitration claim for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$440,000</div> under a distribution agreement between the Company and Liberty. The Company has filed cross-complaints in both the litigation and arbitration asserting breach of the respective agreements by Spanawave and Liberty. The Company had previously asserted that the distribution agreement does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> extend to the products with respect to which the claim has been made. Certain customers of the lines of business sold to Spanawave are also customers of the Company&#x2019;s ongoing Advance Signal Generator business. Continued disruption of the phase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> signal generator business could have an adverse effect on the ASG business. The parties have negotiated in an effort to settle the dispute notwithstanding the filings. The expenses and potential liability of negotiation, any settlement or continued litigation or arbitration could have a material adverse effect on the Company.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.65pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$750,000</div> from Spanawave under the agreement. Of this amount, the Company returned <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$375,000</div> to Spanawave on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 28, 2016 </div>resulting from the dispute regarding the status of phases <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> through five. The remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$375,000</div> is included in deferred liability related to asset sales in the consolidated balance sheet. In addition, in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2016, </div>the Company received approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$275,000</div> in exchange for raw material purchases. The purchase price of the raw materials approximated its carrying value, therefore <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> gain or loss was recognized. The parties are currently attempting to resolve this dispute. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> gain has been recognized in connection with this product line sale because of the aforementioned dispute. These product lines accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$95,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$275,000</div> in revenue during the fiscal quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016, </div>respectively. For the fiscal quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>gross margin was immaterial. There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> margin associated with the revenue derived in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> as the revenues were primarily related to inventory transfer at book value. While the Company is able to distinguish revenue and gross margin information related to the sale of these product lines,&nbsp;the Company is unable to present meaningful information about results of operation and cash flows from these product lines.</div></div></div> 1443000 -141000 -620000 1195000 -1107000 -589000 -1258000 -102000 -1849000 -554000 591000 452000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">New Accounting Standards </div>In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> &#x2013; <div style="display: inline; font-style: italic;">Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div>): &#x201c;Balance Sheet Classification of Deferred Taxes&#x201d;.</div> Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> is effective for public business entities for financial statements issued for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods within those annual periods. For all other entities, the amendments are effective for financial statements issued for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>The amendments <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be applied prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>), <div style="display: inline; font-style: italic;">Compensation - Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Improvements to Employee Share-Based Payment Accounting. </div>ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> simplifies several aspects of the accounting for employee share-based payments, including accounting for income taxes, forfeitures, statutory tax withholding requirements, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>with early adoption permitted. The Company adopted this standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June, 24, 2017, </div>the adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>),&nbsp;<div style="display: inline; font-style: italic;">Compensation&#x2014;Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Scope of Modification Accounting</div>. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in this ASU are effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect that the standard will have a material effect on its consolidated financial statements and will apply this guidance to applicable transactions after the adoption date.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02&#x201d;</div>), Leases. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> requires that lessees recognize assets and liabilities for the rights and obligations for leases with a lease term of more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. The amendments in this ASU are effective for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> on its consolidated financial statements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>), Revenue from Contracts with Customers. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> establishes a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this principle, an entity identifies the contract with a customer, identifies the separate performance obligations in the contract, determines the transaction price, allocates the transaction price to the separate performance obligations and recognizes revenue when each separate performance obligation is satisfied. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> was further updated in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>to provide clarification on a number of specific issues as well as requiring additional disclosures. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be applied either retrospectively or through the use of a modified-retrospective method. The full retrospective method requires companies to recast each prior reporting period presented as if the new guidance had always existed. Under the modified retrospective method, companies would recognize the cumulative effect of initially applying the standard as an adjustment to opening retained earnings at the date of initial application. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 9, 2015, </div>the FASB approved a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year deferral of the effective date of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet completed its evaluation of the impact of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its past and future revenue recognition and related disclosure.</div></div></div></div></div></div></div></div></div></div></div> 2 1623000 1835000 -1157000 -910000 175000 175000 408000 408000 710000 707000 41000 42000 620000 30000 3540000 3540000 2309000 500000 731000 0 0 250000 250000 1000000 1000000 19500 19500 10000 3500 6000 0 0 18533.51 18533.51 9997 3424.65 5111.86 9997 3424.65 5111.86 0 0 18533.51 18533.51 9997 3424.65 5111.86 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 10, 2011, </div>the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,199,000</div> in cash proceeds from Alara Capital AVI II, LLC, a Delaware limited liability company (the &#x201c;Investor&#x201d;), an investment vehicle sponsored by Active Value Investors, LLC, under a Securities Purchase Agreement entered into on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 31, 2011. </div>Under the terms of the Securities Purchase Agreement, the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,997</div> shares of its Series&nbsp;B Convertible Voting Perpetual Preferred Stock (&#x201c;Series B Preferred Stock&#x201d;) to the Investor at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$220</div> per share. The Company has recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.0</div> million as Series B Preferred Stock on the consolidated balance sheet which is net of stock offering costs of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$202,000</div> and represents the value attributable to both the convertible preferred stock and warrants issued to the Investor. After considering the value of the warrants, the effective conversion price of the preferred stock was greater than the common stock price on date of issue and therefore <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> beneficial conversion feature was present.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 19, 2013, </div>the Company entered into a Securities Purchase Agreement pursuant to which it agreed to sell <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,424.65</div> shares of its Series&nbsp;C Convertible Voting Perpetual Preferred Stock (&#x201c;Series C Preferred Stock&#x201d;) to the Investor, for aggregate consideration of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000,</div> which is approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$146.00</div> per share. The Company has recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$457,000</div> as Series C Preferred Stock on the consolidated balance sheet, which is net of stock offering costs of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$43,000.</div> After considering the reduction in the value of the warrant, the effective conversion price of the preferred stock was greater than the common stock price on the date of issue and therefore <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> beneficial conversion feature was present.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 8, 2013 </div>the Company received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$817,000</div> in net cash proceeds from the Investor under a Securities Purchase Agreement. The Company sold to the Investor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,111.86</div> shares of its Series&nbsp;D Convertible Voting Perpetual Preferred Stock (Series D Preferred Stock) and a warrant to purchase up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">511,186</div> additional shares of common stock at the price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.43</div> per share. The allocation of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$858,000</div> in gross proceeds from issuance of Series D Preferred Stock based on the relative fair values resulted in an allocation of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$498,000</div> (which was recorded net of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$41,000</div> of issuance costs) to Series D Preferred Stock and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$360,000</div> to Common Stock.&nbsp; In addition, because the effective conversion rate based on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$498,000</div> allocated to Series D Preferred Stock was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.97</div> per common share which was less than the Company&#x2019;s stock price on the date of issuance, a beneficial conversion feature was present at the issuance date. The beneficial conversion feature totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$238,000</div> and was recorded as an increase of common stock and an increase to accumulated deficit.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Each share of Series B, Series C and Series D Preferred Stock is convertible into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one hundred</div> shares of the Company&#x2019;s common stock. In connection with the preferred stock issuance described above, the Company issued to the investor warrants to purchase a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,017,405</div></div> common shares at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.43</div></div> per share. These warrants were exercised in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2015, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2015. </div>The Company received funds from Alara in separate closings dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 16, 2015 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 23, 2015. </div>Alara exercised a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,002,818</div> of its existing Series C and Series D warrants to purchase common shares, all of which had an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.43</div> per share for total cash proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,434,000,</div> which was recorded net of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$42,000</div> of stock issuance costs. As part of the consideration for this exercise, the Company sold to Alara <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> new warrants to purchase an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">898,634</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">194,437</div> common shares at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.78</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.76</div> per share, respectively, for a total purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$137,000</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.125</div> per share. The new warrants have a term of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be paid in cash or through a cashless net share settlement. The Company and Alara amended the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,587</div> warrants as part of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February </div>closings. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 14, 2015, </div>Alara exercised the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,587</div> warrants by acquiring <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,216</div> of shares of the Company&#x2019;s common stock through a cashless net share settlement.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The table below present information for the periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017:</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Preferred Stock</div> <div style="display: inline; font-weight: bold;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">As of</div></div> <div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017</div></div></div> <div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017</div></div></div> <div style="display: inline; text-decoration: underline;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Liquidation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Designated</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preference</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 44%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series B</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,000.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,997.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,997.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,309</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series C</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,500.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,424.65</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,424.65</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series D</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,000.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,111.86</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,111.86</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">731</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,500.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,533.51</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,533.51</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 2000000 457000 2911000 2911000 377000 452000 360000 817000 858000 498000 1000000 1000000 500000 1456000 500000 2199000 314000 850000 1500000 375000 750000 375000 850000 1225000 0 0 1434000 123000 60000 91000 60000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Warranty Obligations</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company records a liability in cost of sales for estimated warranty obligations at the date products are sold. Adjustments are made as new information becomes available. The following provides a reconciliation of changes in the Company&#x2019;s warranty reserve. The Company provides <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other guarantees.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">123</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Provision, net</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">112</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warranty costs incurred</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(112</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 33000 112000 1052000 528000 13000 11000 130000 452000 530000 1200000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Software Development Costs</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 3, 2015, </div>the Company entered a software development agreement with a major aerospace and defense company whereby the aerospace company developed and licensed its simulation software to the Company. The simulation software (also called Open Loop Simulator or OLS technology) is currently the aerospace company&#x2019;s intellectual property. The OLS technology generates threat simulations and enables various hardware to generate signals for performing threat analysis on systems under test. The Company licenses the OLS software as a bundled or integrated solution with its Advanced Signal Generator system.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company paid the aerospace company software development costs and fees&nbsp;for OLS of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.2</div> million in the aggregate (this includes an amendment to the software development agreement for additional features and functionality), which was paid in monthly installments as the work was performed by the aerospace company through the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> The OLS technology is a perpetual license agreement that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be terminated by the Company at any time as long as the Company provides a notice to the aerospace company and pays for the development costs incurred through the notice termination date. The Company is also obligated to pay royalties to the aerospace company on net sales of its Advanced Signal Generator product sold with the OLS software equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">seven</div> percent of net sales price of each ASG system sold and subject to certain minimums.&nbsp;The Company expenses research and development costs as they are incurred. Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product&#x2019;s technological feasibility has been established and ending when a product is available for general release to customers.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017, </div>capitalized software costs were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$582,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$733,000,</div> respectively. The Company began amortizing the costs of capitalized software to cost of sales in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> using the straight-line methodology over an estimated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-year amortization period. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company changed its estimated amortization period from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> years to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> years due to the longer than anticipated procurement cycle associated with the ASG TEmS product line. The Company also amortized capitalized software costs using the estimated percentage of revenue approach (which was greater than straight-line amortization) in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> revenues associated with its ASG TEmS product line and therefore amortized capitalized software costs on a straight-line basis. Amortization of capitalized software costs recorded during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$151,000.</div> There was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> </div>amortization recorded in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> as the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet released its ASG TEmS units.</div></div></div> -26800000 -26839000 -25581000 0 145000 95000 275000 220 146 0 1100000 1991000 3442000 297000 2125000 1694000 1317000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-TOP: 0px" colspan="6"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands except per share data)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Net loss</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,258</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted average:</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common shares outstanding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,715</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,550</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Potential common shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Common shares assuming dilution</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,715</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,550</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Loss per common share &#x2013; basic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Loss per common share &#x2013; diluted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.13</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Stock options not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,529</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Restricted stock awards not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issuable shares for interest on loan</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Convertible preferred stock not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,853</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,853</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warrants not included in computation that could potentially dilute EPS in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,737</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,737</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">March 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Raw materials</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,411</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,775</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Work-in-progress</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,931</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,155</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Finished goods</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">239</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">473</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Demonstration inventory</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">408</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">408</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,989</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,811</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 70%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Ended</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at beginning of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">123</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Provision, net</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">112</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Warranty costs incurred</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(33</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(112</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Balance at end of period</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 12%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 5.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Month Periods Ended</div> </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 5.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Month Periods Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 28%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">At June 24,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">At June 25,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Assets</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Sales</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Income</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Loss)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Assets</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Sales</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Income</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Loss)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Giga-tronics Division</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,153</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">297</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,849</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,233</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,125</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(554</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Microsource</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,907</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">591</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,887</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,317</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">452</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,060</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,991</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,258</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,120</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,442</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 95%; MARGIN-LEFT: 2.5%; MARGIN-RIGHT: 2.5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Fair Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 68%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at March 26, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.66</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.66</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited or cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at March 25, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,450</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Vested</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited or cancelled</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Non-Vested at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,450</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 13%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 98%; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 2%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Weighted</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Average</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Remaining</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Contractual</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Aggregate</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Intrinsic</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercise Price</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Terms (Years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Value</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 48%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at March 26, 2016</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,592,200</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.52</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.8</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">148,000</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.97</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited / Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">635,700</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.57</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at March 25, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.41</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Granted</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercised</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-LEFT: 9pt; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Forfeited / Expired</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,104,500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.41</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.1</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Exercisable at June 24, 2017</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">812,050</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.45</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.2</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="BACKGROUND-COLOR: #ffffff">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">At June 24, 2017 expected to vest in the future</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,006,157</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.42</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.7</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 10%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-LEFT: 5%; MARGIN-RIGHT: 5%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="MARGIN-BOTTOM: 0px; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; MARGIN-TOP: 0px" colspan="6"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: center; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 2</div><div style="display: inline; font-weight: bold;">4</div><div style="display: inline; font-weight: bold;">,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-weight: bold;">7</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 66%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Dividend yield</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected volatility</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">98.95</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Risk-free interest rate</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.38</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">%</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Expected term (years)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&#x2014;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 14%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.36</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 90%; MARGIN-RIGHT: 10%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Liquidation</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Designated</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Issued</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Shares</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Outstanding</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Preference</div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">(in thousands)</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 44%; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series B</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,000.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,997.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,997.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,309</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series C</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,500.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,424.65</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,424.65</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Series D</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,000.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,111.86</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,111.86</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">731</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: middle; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,500.00</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,533.51</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,533.51</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 0px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 11%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,540</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; PADDING-BOTTOM: 1px; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div></div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div></div><div style="display: inline; text-decoration: underline;"> </div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Significant</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"> Customer and</div></div> <div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">Industry Segment Information</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> reportable segments: Giga-tronics Division and Microsource.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Giga-tronics Division historically produces a broad line of test and measurement equipment used primarily for the design, production, repair and maintenance of products in aerospace, telecommunications, RADAR, and electronic warfare.</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Microsource primarily develops and manufactures&nbsp;YIG RADAR filters used in fighter jet aircraft for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> prime contractors.&nbsp;</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The tables below present information for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> month periods ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 25, 2016:</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 5.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Month Periods Ended</div> </div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="6"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 5.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Three Month Periods Ended</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 28%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(In thousands)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">At June 24,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 24,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2017</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">At June 25,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">June 25,</div></div></div> <div style=" TEXT-ALIGN: center; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">2016</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Assets</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Sales</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Income</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Loss)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Assets</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Sales</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt" colspan="2"> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Net Income</div></div></div> <div style=" TEXT-ALIGN: right; MARGIN: 0pt 3.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">(Loss)</div></div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Giga-tronics Division</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,153</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">297</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,849</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,233</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,125</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(554</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> <tr style="BACKGROUND-COLOR: #ffffff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Microsource</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,907</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">591</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,887</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,317</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; BACKGROUND-COLOR: #ffffff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">452</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #ffffff" nowrap="nowrap">&nbsp;</td> </tr> <tr style="BACKGROUND-COLOR: #cceeff"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff"> <div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Total</div></div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,060</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,991</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,258</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">)</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,120</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,442</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; BACKGROUND-COLOR: #cceeff">&nbsp;</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff">$</td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 9%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102</div></td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 3px double; MARGIN-LEFT: 0pt; BACKGROUND-COLOR: #cceeff" nowrap="nowrap"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 1.6pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">)</div></div></td> </tr> </table> </div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">43%</div> of the Company&#x2019;s consolidated revenues and was included in the Microsource segment. A <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37%</div> and was also included in the Microsource segment. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30%</div> of the Company&#x2019;s consolidated revenues and was included in the Microsource segment. A <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> and was included in the Giga-tronics Division. A <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> of the Company&#x2019;s consolidated revenue and was also included in the Giga-tronics Division.</div></div></div> 1171000 1305000 97000 46000 72000 P4Y P5Y 0 350450 0 44500 0.66 350450 0 0 44500 0.66 0.9895 0.0138 2850000 934677 812050 1.45 635700 148000 69000 3000 1592200 1104500 1104500 1.52 1.41 1.41 1006157 1.42 1.57 0.97 P10Y P8Y131D P5Y73D P6Y292D P6Y36D P5Y255D 33000 1000 29500 28500 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Organization and Significant Accounting Policies</div></div></div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The condensed consolidated financial statements included herein have been prepared by Giga-tronics Incorporated (the &#x201c;Company&#x201d;), pursuant to the rules and regulations of the Securities and Exchange Commission. The consolidated results of operations for the interim periods shown in this report are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments (consisting of normal recurring entries) necessary to make the consolidated results of operations for the interim periods a fair statement of such operations. For further information, refer to the consolidated financial statements and footnotes thereto, included in the Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K, filed with the Securities and Exchange Commission for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 25, 2017.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Principles of Consolidation</div> The consolidated financial statements include the accounts of Giga-tronics and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Derivatives</div> The Company accounts for certain of its warrants and embedded debt features as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of these instruments to fair value.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Software Development Costs</div> Development costs included in the research and development of new software products and enhancements to existing software products are expensed as incurred, until technological feasibility in the form of a working model has been established. Capitalized development costs are amortized over the expected life of the product and evaluated each reporting period for impairment.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 5.7pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Discontinued Operations</div> The Company reviews its reporting and presentation requirements for discontinued operations in accordance with the guidance provided by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">205</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20</div> as it moves to newer technology within the test and measurement market from legacy products to the newly developed Advanced Signal Generator. The disposal of these product line sales represent an evolution of the Company&#x2019;s Giga-tronics Division to a more sophisticated product offered to the same customer base. The Company has evaluated the sales of product lines (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> Sale of Product Lines) concluding that each product line does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet the definition of a &#x201c;component of an entity&#x201d; as defined by ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">205</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20.The</div> Company is able to distinguish revenue and gross margin information as disclosed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> Sale of Product Lines to the accompanying financial statements however, operations and cash flow information is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> clearly distinguishable and the Company is unable to present meaningful information about results of operations and cash flows from those product lines.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">New Accounting Standards </div>In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> &#x2013; <div style="display: inline; font-style: italic;">Income Taxes (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div>): &#x201c;Balance Sheet Classification of Deferred Taxes&#x201d;.</div> Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> is effective for public business entities for financial statements issued for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>and interim periods within those annual periods. For all other entities, the amendments are effective for financial statements issued for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and interim periods within annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>The amendments <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be applied prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17</div> eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>), <div style="display: inline; font-style: italic;">Compensation - Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Improvements to Employee Share-Based Payment Accounting. </div>ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> simplifies several aspects of the accounting for employee share-based payments, including accounting for income taxes, forfeitures, statutory tax withholding requirements, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>with early adoption permitted. The Company adopted this standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June, 24, 2017, </div>the adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25">&nbsp;</div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>),&nbsp;<div style="display: inline; font-style: italic;">Compensation&#x2014;Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>): Scope of Modification Accounting</div>. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in this ASU are effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect that the standard will have a material effect on its consolidated financial statements and will apply this guidance to applicable transactions after the adoption date.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02&#x201d;</div>), Leases. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> requires that lessees recognize assets and liabilities for the rights and obligations for leases with a lease term of more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. The amendments in this ASU are effective for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018. </div>Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> on its consolidated financial statements.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> (&#x201c;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09&#x201d;</div>), Revenue from Contracts with Customers. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> establishes a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this principle, an entity identifies the contract with a customer, identifies the separate performance obligations in the contract, determines the transaction price, allocates the transaction price to the separate performance obligations and recognizes revenue when each separate performance obligation is satisfied. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> was further updated in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May, </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>to provide clarification on a number of specific issues as well as requiring additional disclosures. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be applied either retrospectively or through the use of a modified-retrospective method. The full retrospective method requires companies to recast each prior reporting period presented as if the new guidance had always existed. Under the modified retrospective method, companies would recognize the cumulative effect of initially applying the standard as an adjustment to opening retained earnings at the date of initial application. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 9, 2015, </div>the FASB approved a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year deferral of the effective date of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> to annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet completed its evaluation of the impact of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its past and future revenue recognition and related disclosure.</div></div></div> -278000 190000 668000 1720000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt 2.35pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Going Concern and Management&#x2019;s Plan</div></div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company incurred net losses of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.3</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$102,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. These losses have contributed to an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$26.8</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017.</div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company used cash flow in operations totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$589,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. </div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company has experienced delays in the development of features, receipt of orders, and shipments for the new Advanced Signal Generator (&#x201c;ASG&#x201d;). These delays have contributed, in part to a decrease in working capital. The new ASG product has shipped to several customers, but potential delays in the development of features, longer than anticipated sales cycles, or uncertainty as to the Company&#x2019;s ability to efficiently manufacture the ASG, could significantly contribute to additional future losses and decreases in working capital.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To help fund operations, the Company relies on advances under the line of credit with Bridge Bank which expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 6, 2019. </div>The agreement includes a subjective acceleration clause, which allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company&#x2019;s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender&#x2019;s judgement. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the line of credit had a balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$582,000.</div></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">These matters raise substantial doubt as to the Company&#x2019;s ability to continue as a going concern.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div> <div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To address these matters, the Company&#x2019;s management has taken several actions to provide additional liquidity and reduce costs and expenses going forward. These actions are described in the following paragraphs.&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp; &nbsp;&nbsp;&nbsp;</div></div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 27, 2017, </div>the Company entered into a new loan agreement with PFG. Under the terms of the agreement, PFG made a term loan to the Company in the principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,500,000,</div> with funding occurring on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 28, 2017. </div>The loan has a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div></div>-year term, with interest only payments for the term of the loan. However, as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 24, 2017, </div>the Company was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> in compliance with certain revenue and shareholders&#x2019; equity covenants. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2, 2017, </div>the Company and PFG entered into a short-term forbearance arrangement (through the end of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August) </div>with respect to such noncompliance. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. The default interest rate associated with the forbearance agreement is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%.</div>&nbsp;The Company will most likely be required to raise additional capital to rectify the noncompliance. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> assurance can be given that the Company will be able to raise sufficient capital on timely basis.</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"></div></div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016, </div>Microsource received a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.9</div> million non-recurring engineering order associated with redesigning a component of its high performance YIG filter used on an aircraft platform. The Company delivered NRE services for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$314,000</div>&nbsp;during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of&nbsp;fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and we expect to continue such services over the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months.</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle">&nbsp; </td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top">&nbsp; </td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2017, </div>Microsource received <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> orders totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$875,000</div> associated with its high performance YIG filter used on an aircraft platform; we expect to start shipping the filters in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> </div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle">&nbsp; </td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top">&nbsp; </td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top">&nbsp; </td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2017, </div>the Giga-tronics Division received a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.7</div> million order from the United States Navy for the Real-Time Threat Emulation Systems (&#x201c;TEmS&#x201d;) which the Company expects to ship in fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div>&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">With the elimination of Giga-tronics Switch, Power Meter, Amplifier, and Signal Generator legacy product lines resulting from the Asset Purchase Agreements with Spanawave and Astronics, (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> Sale of Product Lines), the Company has been able to reduce expenses, while&nbsp;providing additional cash for operations from the proceeds of the sales. The Company is also expecting longer term reductions in overhead costs by the relocating of its operations into a smaller facility beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;</div></div></td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>&nbsp;quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company&#x2019;s Microsource business unit also finalized a multiyear <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10.0</div> million YIG production order (&#x201c;YIG Production Order&#x201d;). The Company started shipping the YIG Production Order in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div>&nbsp;and we expect to ship the remainder through fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div></div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: left; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> <td style="WIDTH: 96%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div></td> </tr> <tr> <td style="WIDTH: 2%; VERTICAL-ALIGN: middle"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;&nbsp;</div></div></td> <td style="WIDTH: 2%; VERTICAL-ALIGN: top"> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt 0.8pt 0pt 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&#x25cf;&nbsp;</div></div></td> <td style="MARGIN-BOTTOM: 0px; WIDTH: 96%; VERTICAL-ALIGN: top; MARGIN-TOP: 0px"> <div style=" MARGIN-BOTTOM: 0px; TEXT-ALIGN: justify; MARGIN-TOP: 0px; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">To assist with the upfront purchases of inventory required for future product deliveries, the Company entered into advance payment arrangements with&nbsp;certain customers, whereby the customers reimburse the Company for raw material purchases prior to the shipment of the finished products. In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> the Company entered into advance payment arrangements totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$160,000.</div> The Company will continue to seek similar terms in future agreements with these customers and other customers.</div></div></td> </tr> </table> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management will continue to review all aspects of the business in an effort to improve cash flow and reduce costs and expenses, while continuing to invest, to the extent possible, in new product development for future revenue streams.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Management will also continue to seek additional working capital through debt, equity financing or possible product line sales, however there are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurances that such financings or sales will be available at all, or on terms acceptable to the Company.</div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div> <div style=" MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></div></div> <div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s historical operating results and forecasting uncertainties indicate that substantial doubt exists related to the Company&#x2019;s ability to continue as a going concern. Forecasting uncertainties exist with respect to the ASG product line due to the potential longer than anticipated sales cycles as well as with potential delays in the refinement of certain features, and/or the Company&#x2019;s ability to efficiently manufacture it in a timely manner. The accompanying Consolidated Financial Statements have been prepared assuming that the Company will continue as a going concern and do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include any adjustments that might result if the Company were unable to do so.</div></div></div> 875000 1700000 10000000 6500000 1900000 120000 45000 9715000 9550000 9715000 9550000 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000719274 us-gaap:SeriesBPreferredStockMember 2011-11-10 2011-11-10 0000719274 us-gaap:SeriesCPreferredStockMember 2013-02-19 2013-02-19 0000719274 us-gaap:SeriesDPreferredStockMember giga:SpaMember 2013-07-01 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember 2013-07-08 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember giga:AllocatedMember giga:SpaMember 2013-07-08 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember giga:UnallocatedMember giga:SpaMember 2013-07-08 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember giga:SpaMember 2013-07-08 2013-07-08 0000719274 giga:PFGLoanMember 2014-03-01 2014-03-14 0000719274 giga:PFGLoanMember 2014-03-13 2014-03-13 0000719274 giga:PFGLoanMember 2014-03-14 2014-03-14 0000719274 giga:PFGLoanMember us-gaap:CommonStockMember 2014-03-14 2014-03-14 0000719274 us-gaap:RevolvingCreditFacilityMember giga:PFGLoanMember giga:PartnersForGrowthIVLPMember 2014-06-16 2014-06-16 0000719274 giga:PFGLoanMember 2014-06-16 2014-06-16 0000719274 giga:AlaraCapitalAVIIILLCMember giga:NewWarrantMember 2015-02-23 2015-02-23 0000719274 giga:AlaraCapitalAVIIILLCMember giga:SeriesCAndDWarrantsMember 2015-02-23 2015-02-23 0000719274 2015-03-28 2016-03-26 0000719274 giga:AlaraCapitalAVIIILLCMember 2015-05-14 2015-05-14 0000719274 giga:NewAmendedCreditFacility2Member 2015-06-01 2015-06-01 0000719274 giga:NewAmendedCreditFacility2Member us-gaap:PrimeRateMember 2015-06-01 2015-06-01 0000719274 giga:AerospaceCompanyMember giga:OLSTechnologyMember 2015-09-03 2015-09-03 0000719274 giga:OLSTechnologyMember 2015-09-03 2015-09-03 0000719274 giga:SpanawaveMember 2015-12-15 2015-12-15 0000719274 2016-01-19 2016-01-19 0000719274 2016-03-27 2016-06-25 0000719274 giga:CommonSharesIssuableForDebtInterestMember 2016-03-27 2016-06-25 0000719274 us-gaap:ConvertibleDebtSecuritiesMember 2016-03-27 2016-06-25 0000719274 giga:EquityOptionMember 2016-03-27 2016-06-25 0000719274 us-gaap:RestrictedStockMember 2016-03-27 2016-06-25 0000719274 us-gaap:WarrantMember 2016-03-27 2016-06-25 0000719274 us-gaap:RestrictedStockMember 2016-03-27 2016-06-25 0000719274 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember giga:FirstCustomerMember giga:MicrosourceMember 2016-03-27 2016-06-25 0000719274 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember giga:SecondCustomerMember giga:GigatronicsDivisionMember 2016-03-27 2016-06-25 0000719274 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember giga:ThirdCustomerMember giga:GigatronicsDivisionMember 2016-03-27 2016-06-25 0000719274 us-gaap:OperatingSegmentsMember giga:PowerMetersAmplifiersAndLegacySignalGeneratorsMember giga:GigatronicsDivisionMember 2016-03-27 2016-06-25 0000719274 giga:AstronicsTestSystemsIncMember giga:SwitchProductLineMember 2016-03-27 2016-06-25 0000719274 giga:WarrantDebtMember 2016-03-27 2016-06-25 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-03-27 2016-06-25 0000719274 giga:StockOptionPlanAnd2005EquityIncentivePlanMember 2016-03-27 2016-06-25 0000719274 giga:SoftwareDevelopmentCostsAmortizationMethodMember 2016-03-27 2016-06-25 0000719274 giga:SwitchProductLineMember 2016-03-27 2016-06-25 0000719274 giga:GigatronicsDivisionMember 2016-03-27 2016-06-25 0000719274 giga:MicrosourceMember 2016-03-27 2016-06-25 0000719274 2016-03-27 2017-03-25 0000719274 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2016-03-27 2017-03-25 0000719274 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2016-03-27 2017-03-25 0000719274 us-gaap:RestrictedStockMember 2016-03-27 2017-03-25 0000719274 us-gaap:StockAppreciationRightsSARSMember 2016-03-27 2017-03-25 0000719274 giga:SpanawaveMember 2016-03-27 2017-03-25 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember giga:MonteCarloMember 2016-03-27 2017-03-25 0000719274 giga:StockOptionPlanAnd2005EquityIncentivePlanMember 2016-03-27 2017-03-25 0000719274 giga:PowerMetersAmplifiersAndLegacySignalGeneratorsMember 2016-03-27 2017-03-25 0000719274 us-gaap:SeriesBPreferredStockMember 2016-03-27 2017-03-25 0000719274 giga:AstronicsTestSystemsIncMember giga:SwitchProductLineMember 2016-06-01 2016-06-30 0000719274 giga:SpanawaveMember 2016-06-01 2016-06-30 0000719274 giga:AstronicsTestSystemsIncMember giga:SwitchProductLineMember 2016-06-20 2016-06-20 0000719274 giga:AstronicsTestSystemsIncMember giga:SwitchProductLineMember 2016-07-01 2016-08-31 0000719274 giga:SpanawaveMember 2016-07-28 2016-07-28 0000719274 2017-03-26 2017-06-24 0000719274 giga:CommonSharesIssuableForDebtInterestMember 2017-03-26 2017-06-24 0000719274 us-gaap:ConvertibleDebtSecuritiesMember 2017-03-26 2017-06-24 0000719274 giga:EquityOptionMember 2017-03-26 2017-06-24 0000719274 us-gaap:RestrictedStockMember 2017-03-26 2017-06-24 0000719274 us-gaap:WarrantMember 2017-03-26 2017-06-24 0000719274 us-gaap:RestrictedStockMember 2017-03-26 2017-06-24 0000719274 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember giga:FirstCustomerMember giga:MicrosourceMember 2017-03-26 2017-06-24 0000719274 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember giga:SecondCustomerMember giga:MicrosourceMember 2017-03-26 2017-06-24 0000719274 us-gaap:OperatingSegmentsMember giga:PowerMetersAmplifiersAndLegacySignalGeneratorsMember giga:GigatronicsDivisionMember 2017-03-26 2017-06-24 0000719274 giga:SpanawaveMember 2017-03-26 2017-06-24 0000719274 giga:PFGLoanMember 2017-03-26 2017-06-24 0000719274 giga:WarrantDebtMember 2017-03-26 2017-06-24 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-26 2017-06-24 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember giga:MonteCarloMember 2017-03-26 2017-06-24 0000719274 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-03-26 2017-06-24 0000719274 us-gaap:LongTermDebtMember us-gaap:FairValueMeasurementsRecurringMember 2017-03-26 2017-06-24 0000719274 giga:StockOptionPlanAnd2005EquityIncentivePlanMember 2017-03-26 2017-06-24 0000719274 giga:RealTimeTEmSMember giga:GigatronicsDivisionMember 2017-03-26 2017-06-24 0000719274 giga:SoftwareDevelopmentCostsAmortizationMethodMember 2017-03-26 2017-06-24 0000719274 giga:SwitchProductLineMember 2017-03-26 2017-06-24 0000719274 us-gaap:MaximumMember 2017-03-26 2017-06-24 0000719274 us-gaap:MinimumMember 2017-03-26 2017-06-24 0000719274 giga:GigatronicsDivisionMember 2017-03-26 2017-06-24 0000719274 giga:MicrosourceMember 2017-03-26 2017-06-24 0000719274 giga:PFGLoanMember 2017-04-27 2017-04-27 0000719274 us-gaap:SeriesBPreferredStockMember 2011-11-10 0000719274 us-gaap:SeriesCPreferredStockMember 2013-02-19 0000719274 giga:NewWarrantMember 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember 2013-07-08 0000719274 us-gaap:SeriesDPreferredStockMember giga:AllocatedMember giga:SpaMember 2013-07-08 0000719274 giga:PFGLoanMember 2014-03-13 0000719274 giga:PFGLoanMember 2014-03-14 0000719274 giga:PFGLoanMember us-gaap:CommonStockMember 2014-03-14 0000719274 giga:PFGLoanMember us-gaap:CommonStockMember giga:AmendmentMember 2014-03-14 0000719274 giga:PFGLoanMember us-gaap:CommonStockMember giga:UnderFirstDrawMember 2014-03-14 0000719274 giga:PFGLoanMember giga:AchievementOfPerformanceMilestonesFirstHalfOfFiscal2015Member 2014-03-14 0000719274 us-gaap:RevolvingCreditFacilityMember giga:PFGLoanMember giga:PartnersForGrowthIVLPMember 2014-06-16 0000719274 us-gaap:RevolvingCreditFacilityMember giga:PartnersForGrowthIVLPMember 2014-06-16 0000719274 giga:PFGLoanMember giga:PartnersForGrowthIVLPMember 2014-06-16 0000719274 giga:PFGLoanMember us-gaap:CommonStockMember giga:AmendmentMember 2014-06-16 0000719274 giga:AlaraCapitalAVIIILLCMember giga:NewWarrantMember 2015-02-16 0000719274 giga:AlaraCapitalAVIIILLCMember giga:AdditionalWarrantMember 2015-02-23 0000719274 giga:AlaraCapitalAVIIILLCMember giga:NewWarrantMember 2015-02-23 0000719274 giga:AlaraCapitalAVIIILLCMember giga:SeriesCAndDWarrantsMember 2015-02-23 0000719274 giga:AlaraCapitalAVIIILLCMember 2015-02-28 0000719274 2015-03-28 0000719274 giga:AlaraCapitalAVIIILLCMember 2015-05-14 0000719274 giga:AlaraCapitalAVIIILLCMember 2015-05-31 0000719274 giga:NewAmendedCreditFacility2Member 2015-06-01 0000719274 giga:NewAmendedCreditFacility2Member giga:BorrowingBaseForInternationalServicesSublimitMember 2015-06-01 0000719274 giga:NewAmendedCreditFacility2Member giga:FormulabasisSublimitMember 2015-06-01 0000719274 giga:NewAmendedCreditFacility2Member giga:NonformulaBasisSublimitMember 2015-06-01 0000719274 giga:YIGProductionOrderMember giga:MicrosourceMember 2015-06-27 0000719274 2016-01-15 0000719274 2016-01-19 0000719274 giga:EmergingGrowthEquitiesLtdMember 2016-01-19 0000719274 us-gaap:CommonStockMember 2016-01-19 0000719274 us-gaap:WarrantMember 2016-01-19 0000719274 2016-03-26 0000719274 us-gaap:RestrictedStockMember 2016-03-26 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-03-26 0000719274 2016-06-24 0000719274 2016-06-25 0000719274 giga:AstronicsTestSystemsIncMember giga:SwitchProductLineMember 2016-06-25 0000719274 giga:SpanawaveMember 2016-06-25 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-25 0000719274 giga:GigatronicsDivisionMember 2016-06-25 0000719274 giga:MicrosourceMember 2016-06-25 0000719274 giga:RealTimeTEmSMember giga:GigatronicsDivisionMember 2016-07-30 0000719274 2017-03-25 0000719274 us-gaap:RestrictedStockMember 2017-03-25 0000719274 giga:PFGLoanMember 2017-03-25 0000719274 giga:WarrantDebtMember giga:AmendmentMember 2017-03-25 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-25 0000719274 us-gaap:FairValueInputsLevel1Member 2017-03-25 0000719274 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-03-25 0000719274 us-gaap:FairValueInputsLevel2Member 2017-03-25 0000719274 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-03-25 0000719274 us-gaap:FairValueInputsLevel3Member 2017-03-25 0000719274 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-03-25 0000719274 giga:StockOptionPlanAnd2005EquityIncentivePlanMember 2017-03-25 0000719274 us-gaap:SeriesAPreferredStockMember 2017-03-25 0000719274 giga:SeriesBCAndDPreferredStockMember 2017-03-25 0000719274 us-gaap:SeriesBPreferredStockMember 2017-03-25 0000719274 giga:PFGLoanMember 2017-04-27 0000719274 giga:PFGLoanMember giga:BackendFeesMember 2017-04-27 0000719274 giga:PFGLoanMember giga:EquityIssuedToLendersMember 2017-04-27 0000719274 giga:PFGLoanMember giga:EstimatedFairValueOfDerivativesMember 2017-04-27 0000719274 giga:PFGLoanMember giga:FeesPaidToLendersAndThirdPartiesMember 2017-04-27 0000719274 2017-06-24 0000719274 us-gaap:RestrictedStockMember 2017-06-24 0000719274 giga:NewAmendedCreditFacility2Member 2017-06-24 0000719274 giga:WarrantDebtMember giga:UnderFirstDrawMember 2017-06-24 0000719274 us-gaap:WarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquityContractMember 2017-06-24 0000719274 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:WarrantMember 2017-06-24 0000719274 giga:StockOptionPlanAnd2005EquityIncentivePlanMember 2017-06-24 0000719274 giga:GigatronicsDivisionMember 2017-06-24 0000719274 giga:MicrosourceMember 2017-06-24 0000719274 us-gaap:SeriesAPreferredStockMember 2017-06-24 0000719274 giga:SeriesBCAndDPreferredStockMember 2017-06-24 0000719274 us-gaap:SeriesBPreferredStockMember 2017-06-24 0000719274 us-gaap:SeriesCPreferredStockMember 2017-06-24 0000719274 us-gaap:SeriesDPreferredStockMember 2017-06-24 0000719274 giga:RealTimeTEmSMember giga:GigatronicsDivisionMember us-gaap:SubsequentEventMember 2017-07-31 0000719274 giga:YIGProductionOrderMember giga:MicrosourceMember us-gaap:SubsequentEventMember 2017-07-31 0000719274 2017-08-01 EX-101.SCH 7 giga-20170624.xsd EXHIBIT 101.SCH 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Organization and Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Going Concern and Management's Plan link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 3 - Revenue Recognition link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Inventories link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Software Development Costs link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6 - Accounts Receivable Line of Credit link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 8 - Fair Value link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 9 - Sale of Product Lines link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 10 - Loss Per Common Share link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 12 - Significant Customer and Industry Segment Information link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 13 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 018 - Document - Note 14 - Warranty Obligations link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 16 - Private Placement Offering link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 4 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 8 - Fair Value (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 9 - Sale of Product Lines (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 10 - Loss Per Common Share (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 12 - Significant Customer and Industry Segment Information (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 14 - Warranty Obligations (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Going Concern and Management's Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Revenue Recognition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 4 - Inventories (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Inventories - Inventories, Net of Reserves (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 5 - Software Development Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 6 - Accounts Receivable Line of Credit (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 8 - Fair Value (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 8 - Fair Value - Fair Value Measurements (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 8 - Fair Value - Summary of Changes in Gains and Losses (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 8 - Fair Value - Quantitative Information (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 9 - Sale of Product Lines (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 9 - Sale of Product Lines - Asset Purchase Agreement (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 10 - Loss Per Common Share - Net Income (Loss) and Common Shares Used in Per Share Computations (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Weighted Average Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Stock Options Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Nonvested Restricted Stock Awards Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 12 - Significant Customer and Industry Segment Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 12 - Significant Customer and Industry Segment Information - Breakdown of Customer and Segment Information (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 13 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 14 - Warranty Obligations - Reconciliation of Company's Estimated Warranty Obligations (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants - Preferred Stock Information (Details) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 16 - Private Placement Offering (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 giga-20170624_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 giga-20170624_def.xml EXHIBIT 101.DEF EX-101.LAB 10 giga-20170624_lab.xml EXHIBIT 101.LAB Document And Entity Information Note To Financial Statement Details Textual statementsignificantaccountingpoliciespolicies statementnote4inventoriestables statementnote7termloanrevolvinglineofcreditandwarrantstables Interest expense: statementnote8fairvaluetables statementnote9saleofproductlinestables statementnote10losspercommonsharetables Variable Rate [Domain] Under First Draw [Member] statementnote11sharebasedcompensationandemployeebenefitplanstables Variable Rate [Axis] Partners For Growth IV, L.P. [Member] Represents transactions with Partners For Growth IV, L.P. statementnote12significantcustomerandindustrysegmentinformationtables Prime Rate [Member] Amendment [Member] The Amendment. statementnote14warrantyobligationstables New Warrant [Member] New warrant. statementnote15seriesbcdconvertiblevotingperpetualpreferredstockandwarrantstables statementnote4inventoriesinventoriesnetofreservesdetails statementnote7termloanrevolvinglineofcreditandwarrantsdebtdiscontdetails us-gaap_Revenues Revenues statementnote7termloanrevolvinglineofcreditandwarrantsdebtdiscontdetailsparentheticals statementnote8fairvaluefairvaluemeasurementsdetails statementnote8fairvaluesummaryofchangesingainsandlossesdetails statementnote8fairvaluequantitativeinformationdetails statementnote9saleofproductlinesassetpurchaseagreementdetails statementnote10losspercommonsharenetincomelossandcommonsharesusedinpersharecomputationsdetails statementnote11sharebasedcompensationandemployeebenefitplansweightedaverageassumptionsdetails Series B, C, and D Preferred Stock [Member] Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer. statementnote11sharebasedcompensationandemployeebenefitplanschangesinstockoptionsoutstandingdetails statementnote11sharebasedcompensationandemployeebenefitplanschangesinnonvestedrestrictedstockawardsoutstandingdetails statementnote12significantcustomerandindustrysegmentinformationbreakdownofcustomerandsegmentinformationdetails statementnote14warrantyobligationsreconciliationofcompanysestimatedwarrantyobligationsdetails statementnote15seriesbcdconvertiblevotingperpetualpreferredstockandwarrantspreferredstockinformationdetails Notes To Financial Statements Notes To Financial Statements [Abstract] Cash flows from investing activities: us-gaap_CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers Capitalized Software Development Costs for Software Sold to Customers Interim Period, Costs Not Allocable [Domain] Nature of Expense [Axis] Long-term Debt [Text Block] us-gaap_IncreaseDecreaseInDeferredRevenue Deferred revenue us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities Accrued payroll and benefits us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity Preferred stock, outstanding (in shares) Shares outstanding (in shares) Common stock, outstanding (in shares) us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity New Accounting Pronouncements, Policy [Policy Text Block] us-gaap_LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Substantial Doubt about Going Concern [Text Block] Consolidation, Policy [Policy Text Block] Subsequent Event [Member] Line of Credit Facility, Lender [Domain] Lender Name [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Net sales Revenue, Net Cash and cash-equivalents Beginning cash and cash-equivalents Ending cash and cash-equivalents us-gaap_IncreaseDecreaseInOtherCurrentLiabilities Other current liabilities Common stock issued in connection with debt issuance Change in deferred rent Debt Disclosure [Text Block] us-gaap_FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate us-gaap_FairValueInputsDiscountRate Fair Value Inputs, Discount Rate us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Customer Concentration Risk [Member] Valuation Technique [Domain] Concentration Risk Type [Domain] Valuation Technique [Axis] Concentration Risk Type [Axis] us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets Sales Revenue, Net [Member] Fair Value by Liability Class [Domain] Liability Class [Axis] Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block] us-gaap_AllocatedShareBasedCompensationExpense Allocated Share-based Compensation Expense Concentration Risk Benchmark [Domain] Aerospace Company [Member] Represents a major aerospace company. Concentration Risk Benchmark [Axis] YIG Production Order [Member] Represents the multiyear $10.0 million YIG production order. Exercised (in shares) giga_NumberOfWarrantsSold Number of Warrants Sold Represents the number of warrants sold during the period. Supplementary disclosure of noncash investing and financing activities: giga_WarrantPurchasePrice Warrant Purchase Price The item represents the purchase price for the new warrants. giga_WarrantTerm Warrant Term The item represents the term of the new warrant. giga_WarrantPurchasePricePerShare Warrant Purchase Price Per Share The item represents warrant purchase price per share. giga_SharesIssuedUponCashlessWarrantExercise Shares Issued Upon Cashless Warrant Exercise Represents the share issued upon cashless warrant exercise. giga_ClassOfWarrantOrRightExercisedInPeriod Class of Warrant Or Right Exercised in Period The item represents class of warrant or right exercised during the period. Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block] us-gaap_IncreaseDecreaseInAccountsReceivable Trade accounts receivable Additional Warrant [Member] The additional security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Forfeited / Expired (in shares) Granted (in shares) Power Meters, Amplifiers, and Legacy Signal Generators [Member] Product lines part of the Giga-tronics Division segment. Fully depreciated equipment disposal The noncash transaction relating to the disposal of equipment that has been fully depreciated. giga_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainIncludedInEarnings Gains on adjustment of warrant liability to fair value Amount of gain recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Common stock issued to lender (in shares) Stock Issued During Period, Shares, New Issues us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and shareholders' equity Accumulated deficit Retained Earnings (Accumulated Deficit) SPA [Member] SPA. giga_DebtInstrumentMaximumFeeAmountToBePaidUponMaturity Debt Instrument, Maximum Fee Amount to be Paid upon Maturity Maximum amount of the fee to be paid upon maturity under the debt instrument. giga_DebtInstrumentRemainingFeeAmountPerMonth Debt Instrument, Remaining Fee Amount, Per Month Amount of the remaining fee per month that accompanies borrowing money under the debt instrument. us-gaap_IncreaseDecreaseInInventories Inventories giga_DebtInstrumentCashInterestRate Debt Instrument, Cash Interest Rate Contractual cash interest rate for funds borrowed, under the debt agreement. giga_DebtInstrumentDeferredInterestRate Debt Instrument, Deferred Interest Rate Contractual deferred interest rate for funds borrowed, under the debt agreement. us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Warrant liability at beginning of year Warrant liability at end of period giga_DebtInstrumentReductionInFeeAmountContingentOnMeetingOrExceedingMinimums Debt Instrument, Reduction in Fee Amount Contingent on Meeting or Exceeding Minimums Represents the percentage of reduction in the amount of fees that accompanies borrowing money under the debt instrument contingent on meeting or exceeding revenue and net income minimums. giga_DebtInstrumentRemainingFeeAmount Debt Instrument, Remaining Fee Amount Amount of the remaining fee that accompanies borrowing money under the debt instrument. giga_NumberOfNewSharesToBeIssuedRemaining Number of New Shares to be Issued, Remaining Represents the remaining number of new shares to be issued. giga_NumberOfNewSharesToBeIssuedRemainingPerMonth Number of New Shares to be Issued, Remaining, Per Month Represents the remaining number of new shares to be issued per month. giga_NumberOfNewSharesToBeIssuedMaximum Number of New Shares to be Issued, Maximum Represents the maximum number of new shares to be issued. Schedule of Segment Reporting Information, by Segment [Table Text Block] us-gaap_NumberOfReportableSegments Number of Reportable Segments us-gaap_InterestIncomeExpenseNet Total interest expense, net Segment Reporting Disclosure [Text Block] us-gaap_LiabilitiesFairValueDisclosureNonrecurring Liabilities, Fair Value Disclosure, Nonrecurring us-gaap_LiabilitiesFairValueDisclosureRecurring Total Prepaid expenses and other current assets Gigatronics Division [Member] Represents the reportable segment, Gigatronics Division. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements us-gaap_FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate us-gaap_FairValueAssumptionsExpectedTerm Fair Value Assumptions, Expected Term Demonstration inventory Raw materials Finished goods Formula-Basis Sub-Limit [Member] Represents the part of the debt that is subject to a borrowing base calculation. Fair Value, Measurements, Recurring [Member] Work-in-progress Fair Value, Measurement Frequency [Domain] Measurement Frequency [Axis] Changes in operating assets and liabilities: Discontinued Operations, Policy [Policy Text Block] Monte Carlo [Member] Monte Carlo valuation technique used to measure fair value. us-gaap_OperatingIncomeLoss Operating loss Schedule of Inventory, Current [Table Text Block] us-gaap_CostOfRevenue Cost of sales Inventory Disclosure [Text Block] us-gaap_GrossProfit Gross Profit Gross margin Amendment Flag Common stock of no par value; Authorized - 40,000,000 shares; 10,139,653 shares at June 24, 2017 and 9,594,203 shares at March 25, 2017 issued and outstanding Adjustment of warrant liability to fair value Fair Value Adjustment of Warrants Gain/(loss) on adjustment of warrant liability to fair value Common stock, authorized (in shares) Common stock, issued (in shares) Other long term assets Common stock, par value (in dollars per share) Share based compensation Current Fiscal Year End Date us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease Standard Product Warranty Accrual, Period Increase (Decrease) Warranty Liability released Document Fiscal Period Focus Accretion of discounts on debt Amortization of Debt Discount (Premium) Interest expense from accretion of loan discount Document Fiscal Year Focus Preferred stock, liquidation preference Liquidation preference Document Period End Date Convertible preferred stock of no par value Authorized - 1,000,000 shares; Series A - designated 250,000 shares; no shares at June 24, 2017 and March 25, 2017 issued and outstanding Preferred Stock, Value, Issued Preferred stock, issued (in shares) Preferred Stock, Shares Issued us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized Document Type Product Warranty Disclosure [Text Block] Preferred stock, par valaue (in dollars per share) Preferred stock, authorized (in shares) Designated shares (in shares) Schedule of Product Warranty Liability [Table Text Block] Document Information [Line Items] Document Information [Table] us-gaap_AssetsCurrent Total current assets Entity Filer Category Entity Current Reporting Status Entity Voluntary Filers us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion Entity Well-known Seasoned Issuer Real-Time TEmS [Member] Information pertaining to the Real-Time Threat Emulation System (Real-Time TEmS). Adjustments to reconcile net loss to net cash used in operating activities: giga_RoyaltiesPercentage Royalties Percentage Percent of net sales price obligated to pay royalties on each Advanced Signal Generator product sold. Entity Central Index Key Entity Registrant Name Entity [Domain] Legal Entity [Axis] Class of Warrant or Right [Domain] Schedule of Stock by Class [Table Text Block] us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding Class of Warrant or Right [Axis] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Entity Common Stock, Shares Outstanding (in shares) Cash paid for income taxes Cash paid for interest us-gaap_AssetsFairValueDisclosureNonrecurring Assets, Fair Value Disclosure, Nonrecurring Inventories, net Total OLS Technology [Member] Represents the Open Loop Simulator software, or OLS Technology. Shareholders' equity: us-gaap_AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring Trading Symbol us-gaap_InventoryValuationReserves Inventory Valuation Reserves Commitments and contingencies us-gaap_Liabilities Total liabilities Cash flows from operating activities: Trade accounts receivable, allowance Trade accounts receivable, net of allowance of $45, respectively Statement [Line Items] Operating expenses: us-gaap_DerivativeLiabilities Derivative liabilities us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Fair Value Disclosures [Text Block] Long-term Debt [Member] Assets: us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by (used in) financing activities us-gaap_SaleOfStockPricePerShare Sale of Stock, Price Per Share us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash (used in) provided by investing activities us-gaap_NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (Decrease)/Increase in cash and cash-equivalents Total shareholders' equity us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs Equity Contract [Member] us-gaap_LongTermDebt Long-term Debt Financial Instruments [Domain] Weighted average common shares used in per share calculation: Weighted average common shares used in per share calculation [abstract] Financial Instrument [Axis] Derivatives, Policy [Policy Text Block] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 1 [Member] us-gaap_ProceedsFromWarrantExercises Proceeds from Warrant Exercises Fair Value, Inputs, Level 3 [Member] us-gaap_LineOfCredit Long-term Line of Credit us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock us-gaap_ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised Fair Value Hierarchy [Domain] Fair Value, Hierarchy [Axis] us-gaap_ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock Equity Component [Domain] Common Stock [Member] us-gaap_ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants Equity Components [Axis] Aggregate discount amount Debt Instrument, Unamortized Discount Preferred Stock [Text Block] Derivative Financial Instruments, Liabilities [Member] Transaction [Domain] Diluted (in shares) Common shares assuming dilution (in shares) Transaction Type [Axis] Anti-dilutive securities excluded from computation of earning per share (in shares) us-gaap_DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net Mergers, Acquisitions and Dispositions Disclosures [Text Block] Loss per common share - diluted (in dollars per share) us-gaap_UnbilledReceivablesNotBillableAmountExpectedToBeCollectedInRemainderOfFiscalYear Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Principal payments on capital leases us-gaap_RepaymentsOfLongTermDebt Repayments of debt us-gaap_UnbilledReceivablesNotBillableAtBalanceSheetDateAmountExpectedToBeCollectedWithinOneYear Unbilled Receivables, Not Billable, Amount Expected to be Collected in Next Twelve Months Basic (in shares) Loss per common share - basic (in dollars per share) Scenario, Unspecified [Domain] Scenario [Axis] Software Development Costs, Policy [Policy Text Block] Disclosure of the accounting policy for software development costs. Proceeds from borrowings, net of issuance costs Consolidation Items [Domain] Consolidation Items [Axis] Operating Segments [Member] Maximum [Member] Range [Domain] Minimum [Member] Customer [Axis] Significant Accounting Policies [Text Block] Range [Axis] Customer [Domain] us-gaap_UnrecognizedTaxBenefits Unrecognized Tax Benefits Accounting Policies [Abstract] Statement of Financial Position [Abstract] Statement of Cash Flows [Abstract] Research, Development, and Computer Software Disclosure [Text Block] giga_PercentOfFairMarketValueOfCommonStockAtDateOfGrant Percent Of Fair Market Value Of Common Stock At Date Of Grant Percentage of fair market value of common stock at date of grant. Equity Option [Member] Represents the stock options. Products and Services [Domain] Products and Services [Axis] Legal Entity Type of Counterparty [Domain] Legal Entity of Counterparty, Type [Axis] Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] us-gaap_ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt Private Placement Offering [Text Block] The entire disclosure of private placement offering. us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss before income taxes us-gaap_EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent Provision for income taxes Income Tax Expense (Benefit) Emerging Growth Equities, Ltd [Member] Represents Emerging Growth Equities, Ltd. Warrant liability, at estimated fair value Segments [Axis] Segments [Domain] us-gaap_PolicyTextBlockAbstract Accounting Policies Series C Preferred Stock [Member] Series B Preferred Stock [Member] Series D Preferred Stock [Member] Credit Facility [Domain] Long term deferred rent Series A Preferred Stock [Member] Statement [Table] Revolving Credit Facility [Member] Credit Facility [Axis] Cash flows from financing activities: Income Statement [Abstract] Long term obligations - capital lease Class of Stock [Domain] Class of Stock [Axis] Award Type [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Equity Award [Domain] Deferred liability related to asset sale Current amount of deferred liability related to asset sale. giga_ProceedsFromSaleOfInventory Proceeds from sale of Inventory Cash inflow for the sale of inventory. Astronics Test Systems Inc [Member] The entity Astronics Test Systems Inc. giga_ProceedsFromAdvancePaymentArrangements Proceeds from Advance Payment Arrangements The cash inflow from advance payment arrangements. Microsource [Member] Represents the reportable segment, Microsource. us-gaap_LiabilitiesCurrent Total current liabilities Software Development Costs, Amortization Method [Member] A revision in the amortization method in related to software development. Switch Product Line [Member] Represents the switch product line. giga_SalesCommissionTerm Sales Commission, Term Duration of an agreement to provide a sales commission related to a product line. giga_SalesCommision Sales Commision Percentage of sales commission related to a product line. us-gaap_LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss us-gaap_OtherLiabilitiesCurrent Other current liabilities giga_CashPaidToBuyOutFutureCommissionObligation Cash Paid to Buy Out Future Commission Obligation Cash paid to buy out future commission obligation Amount of cash paid to buy out future commission obligation. giga_ReturnOfPayment Return of Payment Amount of cash outflow for the return of a payment in a disputed transaction. Asset Purchase Agreement [Table Text Block] Tabular disclosure of an asset purchase agreement. us-gaap_OperatingExpenses Total operating expenses Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Unallocated [Member] Unallocated [member] Allocated [Member] Allocated [member] Share-based Compensation, Stock Options, Activity [Table Text Block] giga_Commissions Commissions Amount of comissions related to an asset purchase agreement. Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Interest expense, net Includes interest income or expense excluding the accretion of loan and warrant discounts. Alara Capital AVI II, LLC [Member] Represents a company related to the reporting entity. Dividend yield Equity forward, at estimated fair value us-gaap_DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability Series C and D Warrants [Member] Represents series C and D warrants. Risk-free interest rate us-gaap_ProceedsFromSaleAndCollectionOfReceivables Proceeds from Sale and Collection of Receivables Expected volatility Deferred revenue Expected term (years) (Year) Capital lease obligations us-gaap_LegalFees Legal fees Derivative Contract [Domain] Derivative Instrument [Axis] Revenue Recognition Disclosure [Text Block] The entire disclosure for revenue recognition. us-gaap_LongTermDebtCurrent Loan payable, net of discounts and issuance costs giga_WarrantyTerm Warranty Term Represents term of warranty. Vested (in dollars per share) Spanawave [Member] Represents Spanawave Corporation. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Non-vested (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Non-vested (in shares) Non-vested (in shares) Income Tax Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Granted (in dollars per share) Granted (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Line of credit Line of Credit, Current Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period giga_SecuritiesPurchaseAgreementUnitsIssued Securities Purchase Agreement, Units Issued Number of units issued as a part of the Securities Purchase Agreement. giga_NumberOfCommonStockPerUnit Number of Common Stock Per Unit Number of common stock included in each unit issued. giga_SecuritiesPurchaseAgreementPurchasePrice Securities Purchase Agreement, Purchase Price The purchase price for each unit. giga_SecuritiesPurchaseAgreementGrossProceeds Securities Purchase Agreement, Gross Proceeds The gross amount received from the Securities Purchase Agreement. Expected to vest in the future (in dollars per share) 2000 Stock Option Plan and 2005 Equity Incentive Plan [Member] Expected to vest in the future (in shares) Expected to vest in the future (Year) giga_SecuritiesPurchaseAgreementNetProceeds Securities Purchase Agreement, Net Proceeds The net amount received from the Securities Purchase Agreement. Expected to vest in the future Exercisable Exercisable (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Exercisable (in dollars per share) Exercisable (in shares) Outstanding Outstanding (Year) us-gaap_SeveranceCosts1 Employee severance Losses on adjustment of warrant liability to fair value Amount of loss recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Accounts payable us-gaap_EmployeeRelatedLiabilitiesCurrent Accrued payroll and benefits First Customer [Member] Represents one major customer. Counterparty Name [Domain] Third Customer [Member] Third customer accounting for a certain percentage of the company's consolidated revenue. Counterparty Name [Axis] Second Customer [Member] Second customer accounting for a certain percentage of the company's consolidated revenue. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding (in dollars per share) Outstanding (in dollars per share) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Forfeited / Expired (in dollars per share) us-gaap_ProductWarrantyAccrualClassifiedCurrent Balance at beginning of period Balance at end of period us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Granted (in dollars per share) Depreciation and amortization Exercised (in dollars per share) Net gain recognized in the quarter Gain (Loss) on Sale of Business, Affiliated and Productive Assets Gain on sale of product line The gain (loss) recognized on a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities. giga_ProductWarrantyAccuralProvisionNet Provision, net Represents the aggregate increase in the liability, net of expirations. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding (in shares) Outstanding (in shares) Warrant Debt [Member] The amount of Warrant Debt included in Other Long-term Debt. giga_NumberOfPrivateInvestors Number of Private Investors The number of private investors in a securities purchase agreement. giga_SecuritiesPurchaseAgreementPriceOfOneCommonShare Securities Purchase Agreement, Price of One Common Share In a securities purchase agreement, the price allocated to one common share converted from warrant. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Liabilities and shareholders' equity us-gaap_Assets Total assets Assets us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period giga_IncreaseDecreaseInCapitalizedSoftwareDevelopmentCosts Capitalized software development costs Amount of increase (decrease) during the period in capitalized software development costs. Net loss Net Income (Loss) Attributable to Parent Net loss Cash received from Astronics Proceeds from Sales of Business, Affiliate and Productive Assets Plan Name [Axis] Selling, general and administrative us-gaap_DebtInstrumentTerm Debt Instrument, Term Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options us-gaap_ProductWarrantyExpense Warranty costs incurred us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Stock Appreciation Rights (SARs) [Member] Restricted Stock [Member] Warrant [Member] Antidilutive Securities, Name [Domain] Employee Stock Option [Member] Convertible Debt Securities [Member] us-gaap_DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price Antidilutive Securities [Axis] Engineering Disclosure of Compensation Related Costs, Share-based Payments [Text Block] us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature giga_AdvanceRate Advance Rate Advance rate. us-gaap_ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost Research and Development Expense, Software (Excluding Acquired in Process Cost) Supplementary disclosure of cash flow information: Property and equipment, net Debt Instrument [Axis] giga_DebtInstrumentVariableInterestRate Debt Instrument, Variable Interest Rate Represents the variable interest rate for the debt instrument. Debt Instrument, Name [Domain] giga_AccountsReceivableAgingFromInvoiceDate Accounts Receivable, Aging from Invoice Date Represents the aging for the accounts receivable from the invoice date. giga_AssetCoverageRatio Asset Coverage Ratio Represents the asset coverage ratio. us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Estimated equity forward Amount of expense (income) related to adjustment to fair value of warrant liability. Non-Formula Basis Sub-Limit [Member] Represents a sub-limit on the borrowing capacity for a line of credit on a non-formula basis. Fees Paid to Lenders and Third Parties [Member] Fees paid to lenders and third parties as part of a debt agreement. New Amended Credit Facility 2 [Member] Represents the credit facility amended in May 2015. us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage Backend Fees [Member] Fees back on the backend of a debt agreement. Capitalized software development costs giga_DebtInstrumentDebtDefaultRate Debt Instrument, Debt Default, Rate Default rate of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured. us-gaap_CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization us-gaap_DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage Borrowing Base for International Services Sub-Limit [Member] Represents a sub-limit on the borrowing capacity for a line of credit under the borrowing base for international services. Schedule of Debt Discount [Table Text Block] Tabular disclosure of amount, after accumulated amortization, of debt discount. Common Shares Issuable for Debt Interest [Member] Common shares issuable for interest on debt that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented. us-gaap_TableTextBlock Notes Tables Estimated Fair Value of Derivatives [Member] Expenses incurred that are related to the estimated fair value of derivatives. Equity Issued to Lenders [Member] The expense recognized from issuing equity to lenders of a debt agreement. us-gaap_DebtInstrumentFeeAmount Debt Instrument, Fee Amount giga_ClassOfWarrantOrRightTerm Class of Warrant or Right, Term Term of the warrant, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount giga_ClassOfWarrantOrRightExchangedForCashAmount Class of Warrant or Right, Exchanged for Cash, Amount The amount for which warrants can be exchanged in the event of any acquisition or other change in control of the Company, future public issuance of Company securities, liquidation (or substantially similar event) of the Company, or expiration of the warrants. Achievement of Performance Milestones First Half of Fiscal 2015 [Member] Additional borrowing capacity if the Company meets certain performance milestones in first half of fiscal 2015. PFG Loan [Member] This item represents characteristics associated with the PFG loan. Earnings Per Share [Text Block] EX-101.PRE 11 giga-20170624_pre.xml EXHIBIT 101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - shares
3 Months Ended
Jun. 24, 2017
Aug. 01, 2017
Document Information [Line Items]    
Entity Registrant Name GIGA TRONICS INC  
Entity Central Index Key 0000719274  
Trading Symbol giga  
Current Fiscal Year End Date --03-25  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   10,142,153
Document Type 10-Q  
Document Period End Date Jun. 24, 2017  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 24, 2017
Mar. 25, 2017
Assets:    
Cash and cash-equivalents $ 1,137,000 $ 1,421,000
Trade accounts receivable, net of allowance of $45, respectively 748,000 954,000
Inventories, net 4,989,000 4,811,000
Prepaid expenses and other current assets 377,000 452,000
Total current assets 7,251,000 7,638,000
Property and equipment, net 1,052,000 528,000
Other long term assets 175,000 175,000
Capitalized software development costs 582,000 733,000
Total assets 9,060,000 9,074,000
Liabilities and shareholders' equity    
Line of credit 582,000 582,000
Accounts payable 666,000 1,107,000
Loan payable, net of discounts and issuance costs 1,315,000
Equity forward, at estimated fair value 46,000 0
Accrued payroll and benefits 427,000 583,000
Deferred revenue 3,447,000 3,614,000
Capital lease obligations 51,000 50,000
Deferred liability related to asset sale 375,000 375,000
Other current liabilities 710,000 707,000
Total current liabilities 7,619,000 7,018,000
Warrant liability, at estimated fair value 222,000 222,000
Long term deferred rent 451,000
Long term obligations - capital lease 100,000 114,000
Total liabilities 8,392,000 7,354,000
Commitments and contingencies
Shareholders' equity:    
Common stock of no par value; Authorized - 40,000,000 shares; 10,139,653 shares at June 24, 2017 and 9,594,203 shares at March 25, 2017 issued and outstanding 24,596,000 24,390,000
Accumulated deficit (26,839,000) (25,581,000)
Total shareholders' equity 668,000 1,720,000
Total liabilities and shareholders' equity 9,060,000 9,074,000
Series A Preferred Stock [Member]    
Shareholders' equity:    
Convertible preferred stock of no par value Authorized - 1,000,000 shares; Series A - designated 250,000 shares; no shares at June 24, 2017 and March 25, 2017 issued and outstanding
Series B, C, and D Preferred Stock [Member]    
Shareholders' equity:    
Convertible preferred stock of no par value Authorized - 1,000,000 shares; Series A - designated 250,000 shares; no shares at June 24, 2017 and March 25, 2017 issued and outstanding $ 2,911,000 $ 2,911,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)
$ / shares in Thousands, $ in Thousands
Jun. 24, 2017
Mar. 25, 2017
Trade accounts receivable, allowance $ 45 $ 45
Preferred stock, par valaue (in dollars per share) $ 0 $ 0
Preferred stock, authorized (in shares) 1,000,000 1,000,000
Common stock, par value (in dollars per share) $ 0 $ 0
Common stock, authorized (in shares) 40,000,000 40,000,000
Common stock, issued (in shares) 10,139,653 9,594,203
Common stock, outstanding (in shares) 10,139,653 9,594,203
Series A Preferred Stock [Member]    
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Preferred stock, authorized (in shares) 250,000 250,000
Series B, C, and D Preferred Stock [Member]    
Preferred stock, issued (in shares) 18,533.51 18,533.51
Preferred stock, outstanding (in shares) 18,533.51 18,533.51
Preferred stock, authorized (in shares) 19,500 19,500
Preferred stock, liquidation preference $ 3,540 $ 3,540
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Net sales $ 1,991,000 $ 3,442,000
Cost of sales 1,525,000 2,517,000
Gross margin 466,000 925,000
Operating expenses:    
Engineering 452,000 530,000
Selling, general and administrative 1,171,000 1,305,000
Total operating expenses 1,623,000 1,835,000
Operating loss (1,157,000) (910,000)
Net gain recognized in the quarter 802,000
Gain/(loss) on adjustment of warrant liability to fair value 46,000
Interest expense:    
Interest expense, net (79,000) (29,000)
Interest expense from accretion of loan discount (22,000) (11,000)
Total interest expense, net (101,000) (40,000)
Loss before income taxes (1,258,000) (102,000)
Provision for income taxes 0 0
Net loss $ (1,258,000) $ (102,000)
Loss per common share - basic (in dollars per share) $ (0.13) $ (0.01)
Loss per common share - diluted (in dollars per share) $ (0.13) $ (0.01)
Weighted average common shares used in per share calculation:    
Basic (in shares) 9,715 9,550
Diluted (in shares) 9,715 9,550
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Cash flows from operating activities:    
Net loss $ (1,258,000) $ (102,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 247,000 91,000
Share based compensation 46,000 72,000
Adjustment of warrant liability to fair value (46,000)
Capitalized software development costs (334,000)
Estimated equity forward 46,000
Accretion of discounts on debt 22,000 11,000
Change in deferred rent 451,000 (32,000)
Gain on sale of product line (802,000)
Changes in operating assets and liabilities:    
Trade accounts receivable 206,000 304,000
Inventories (178,000) (553,000)
Prepaid expenses and other assets 75,000 63,000
Accounts payable (441,000) (173,000)
Accrued payroll and benefits (156,000) 81,000
Deferred revenue (167,000) 1,101,000
Other current liabilities (270,000)
Net cash used in operating activities (1,107,000) (589,000)
Cash flows from investing activities:    
Cash received from Astronics 1,225,000
Purchases of property and equipment (620,000) (30,000)
Net cash (used in) provided by investing activities (620,000) 1,195,000
Cash flows from financing activities:    
Principal payments on capital leases (13,000) (11,000)
Proceeds from borrowings, net of issuance costs 1,456,000
Repayments of debt (130,000)
Net cash provided by (used in) financing activities 1,443,000 (141,000)
(Decrease)/Increase in cash and cash-equivalents (284,000) 465,000
Beginning cash and cash-equivalents 1,421,000 1,331,000
Ending cash and cash-equivalents 1,137,000 1,796,000
Supplementary disclosure of cash flow information:    
Cash paid for income taxes
Cash paid for interest 39,000 23,000
Supplementary disclosure of noncash investing and financing activities:    
Common stock issued in connection with debt issuance 156,000
Fully depreciated equipment disposal $ 377,000 $ 67,000
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Organization and Significant Accounting Policies
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
(
1
)          Organization and Significant Accounting Policies
 
The condensed consolidated financial statements included herein have been prepared by Giga-tronics Incorporated (the “Company”), pursuant to the rules and regulations of the Securities and Exchange Commission. The consolidated results of operations for the interim periods shown in this report are
not
necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments (consisting of normal recurring entries) necessary to make the consolidated results of operations for the interim periods a fair statement of such operations. For further information, refer to the consolidated financial statements and footnotes thereto, included in the Annual Report on Form
10
-K, filed with the Securities and Exchange Commission for the year ended
March 25, 2017.
   
Principles of Consolidation
The consolidated financial statements include the accounts of Giga-tronics and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
  
Derivatives
The Company accounts for certain of its warrants and embedded debt features as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of these instruments to fair value. 
 
Software Development Costs
Development costs included in the research and development of new software products and enhancements to existing software products are expensed as incurred, until technological feasibility in the form of a working model has been established. Capitalized development costs are amortized over the expected life of the product and evaluated each reporting period for impairment.
 
Discontinued Operations
The Company reviews its reporting and presentation requirements for discontinued operations in accordance with the guidance provided by ASC
205
-
20
as it moves to newer technology within the test and measurement market from legacy products to the newly developed Advanced Signal Generator. The disposal of these product line sales represent an evolution of the Company’s Giga-tronics Division to a more sophisticated product offered to the same customer base. The Company has evaluated the sales of product lines (see Note
9,
Sale of Product Lines) concluding that each product line does
not
meet the definition of a “component of an entity” as defined by ASC
205
-
20.The
Company is able to distinguish revenue and gross margin information as disclosed in Note
9,
Sale of Product Lines to the accompanying financial statements however, operations and cash flow information is
not
clearly distinguishable and the Company is unable to present meaningful information about results of operations and cash flows from those product lines.
 
New Accounting Standards
In
November 2015,
the FASB issued ASU
2015
-
17
Income Taxes (Topic
740
): “Balance Sheet Classification of Deferred Taxes”.
Topic
740
is effective for public business entities for financial statements issued for annual periods beginning after
December 15, 2016,
and interim periods within those annual periods. For all other entities, the amendments are effective for financial statements issued for annual periods beginning after
December 15, 2017,
and interim periods within annual periods beginning after
December 15, 2018.
The amendments
may
be applied prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The amendments in ASU
2015
-
17
eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The adoption of this guidance did
not
have a material impact on the Company’s consolidated financial statements.
 
In
March 2016,
the FASB issued ASU
2016
-
09
(“ASU
2016
-
09”
),
Compensation - Stock Compensation (Topic
718
): Improvements to Employee Share-Based Payment Accounting.
ASU
2016
-
09
simplifies several aspects of the accounting for employee share-based payments, including accounting for income taxes, forfeitures, statutory tax withholding requirements, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after
December 15, 2016,
with early adoption permitted. The Company adopted this standard in the
first
quarter ended
June, 24, 2017,
the adoption of this guidance did
not
have a material impact on the Company’s consolidated financial statements.
 
In
May 2017,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2017
-
09
(“ASU
2017
-
09”
), 
Compensation—Stock Compensation (Topic
718
): Scope of Modification Accounting
. ASU
2017
-
09
was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in this ASU are effective for annual periods beginning after
December 15, 2017.
The Company does
not
expect that the standard will have a material effect on its consolidated financial statements and will apply this guidance to applicable transactions after the adoption date.
 
In
February 2016,
the FASB issued ASU
2016
-
02
(“ASU
2016
-
02”
), Leases. ASU
2016
-
02
requires that lessees recognize assets and liabilities for the rights and obligations for leases with a lease term of more than
one
year. The amendments in this ASU are effective for annual periods ending after
December 15, 2018.
Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU
2016
-
02
on its consolidated financial statements.
 
In
May 2014,
the FASB issued ASU
2014
-
09
(“ASU
2014
-
09”
), Revenue from Contracts with Customers. ASU
2014
-
09
establishes a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this principle, an entity identifies the contract with a customer, identifies the separate performance obligations in the contract, determines the transaction price, allocates the transaction price to the separate performance obligations and recognizes revenue when each separate performance obligation is satisfied. ASU
2014
-
09
was further updated in
March,
April,
May,
and
December 2016
to provide clarification on a number of specific issues as well as requiring additional disclosures. ASU
2014
-
09
may
be applied either retrospectively or through the use of a modified-retrospective method. The full retrospective method requires companies to recast each prior reporting period presented as if the new guidance had always existed. Under the modified retrospective method, companies would recognize the cumulative effect of initially applying the standard as an adjustment to opening retained earnings at the date of initial application. On
July 9, 2015,
the FASB approved a
one
year deferral of the effective date of ASU
2014
-
09
to annual reporting periods beginning after
December 15, 2017.
The Company has
not
yet completed its evaluation of the impact of ASU
2014
-
09
on its past and future revenue recognition and related disclosure.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Going Concern and Management's Plan
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
(
2
)          Going Concern and Management’s Plan
 
The Company incurred net losses of
$1.3
million and
$102,000
in the
first
quarter of fiscal
2018
and fiscal
2017,
respectively. These losses have contributed to an accumulated deficit of
$26.8
million as of
June 24, 2017.
The Company used cash flow in operations totaling
$1.1
million and
$589,000
in the
first
quarter of fiscal
2018
and
2017,
respectively.
 
The Company has experienced delays in the development of features, receipt of orders, and shipments for the new Advanced Signal Generator (“ASG”). These delays have contributed, in part to a decrease in working capital. The new ASG product has shipped to several customers, but potential delays in the development of features, longer than anticipated sales cycles, or uncertainty as to the Company’s ability to efficiently manufacture the ASG, could significantly contribute to additional future losses and decreases in working capital.
 
To help fund operations, the Company relies on advances under the line of credit with Bridge Bank which expires on
May 6, 2019.
The agreement includes a subjective acceleration clause, which allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company’s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender’s judgement. As of
June 24, 2017,
the line of credit had a balance of
$582,000.
 
These matters raise substantial doubt as to the Company’s ability to continue as a going concern.
  
To address these matters, the Company’s management has taken several actions to provide additional liquidity and reduce costs and expenses going forward. These actions are described in the following paragraphs. 
     
 
On
April 27, 2017,
the Company entered into a new loan agreement with PFG. Under the terms of the agreement, PFG made a term loan to the Company in the principal amount of
$1,500,000,
with funding occurring on
April 28, 2017.
The loan has a
two
-year term, with interest only payments for the term of the loan. However, as of
June 24, 2017,
the Company was
not
in compliance with certain revenue and shareholders’ equity covenants. On
August 2, 2017,
the Company and PFG entered into a short-term forbearance arrangement (through the end of
August)
with respect to such noncompliance.
No
assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. The default interest rate associated with the forbearance agreement is
6%.
 The Company will most likely be required to raise additional capital to rectify the noncompliance.
No
assurance can be given that the Company will be able to raise sufficient capital on timely basis.
 
 
 
 
In
July 2016,
Microsource received a
$1.9
million non-recurring engineering order associated with redesigning a component of its high performance YIG filter used on an aircraft platform. The Company delivered NRE services for approximately
$314,000
 during the
first
quarter of fiscal
2018
and we expect to continue such services over the next
nine
to
twelve
months.
 
 
 
   
In
March 2017
and
July 2017,
Microsource received
two
orders totaling
$875,000
associated with its high performance YIG filter used on an aircraft platform; we expect to start shipping the filters in the
second
quarter of fiscal
2018.
     
 
In
July 2017,
the Giga-tronics Division received a
$1.7
million order from the United States Navy for the Real-Time Threat Emulation Systems (“TEmS”) which the Company expects to ship in fiscal
2018.
 
 
 
 
 
With the elimination of Giga-tronics Switch, Power Meter, Amplifier, and Signal Generator legacy product lines resulting from the Asset Purchase Agreements with Spanawave and Astronics, (see Note
9,
Sale of Product Lines), the Company has been able to reduce expenses, while providing additional cash for operations from the proceeds of the sales. The Company is also expecting longer term reductions in overhead costs by the relocating of its operations into a smaller facility beginning in the
first
quarter of fiscal
2018.
 
 
 
 
In the
first
 quarter of fiscal
2016,
the Company’s Microsource business unit also finalized a multiyear
$10.0
million YIG production order (“YIG Production Order”). The Company started shipping the YIG Production Order in the
second
quarter of fiscal
2017,
 and we expect to ship the remainder through fiscal
2020.
 
 
 
  
● 
To assist with the upfront purchases of inventory required for future product deliveries, the Company entered into advance payment arrangements with certain customers, whereby the customers reimburse the Company for raw material purchases prior to the shipment of the finished products. In the
first
quarter of fiscal
2018,
the Company entered into advance payment arrangements totaling
$160,000.
The Company will continue to seek similar terms in future agreements with these customers and other customers.
 
Management will continue to review all aspects of the business in an effort to improve cash flow and reduce costs and expenses, while continuing to invest, to the extent possible, in new product development for future revenue streams.
 
Management will also continue to seek additional working capital through debt, equity financing or possible product line sales, however there are
no
assurances that such financings or sales will be available at all, or on terms acceptable to the Company.
 
The Company’s historical operating results and forecasting uncertainties indicate that substantial doubt exists related to the Company’s ability to continue as a going concern. Forecasting uncertainties exist with respect to the ASG product line due to the potential longer than anticipated sales cycles as well as with potential delays in the refinement of certain features, and/or the Company’s ability to efficiently manufacture it in a timely manner. The accompanying Consolidated Financial Statements have been prepared assuming that the Company will continue as a going concern and do
not
include any adjustments that might result if the Company were unable to do so.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Revenue Recognition
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Revenue Recognition Disclosure [Text Block]
(
3
)         Revenue Recognition
 
The Company records revenue when there is persuasive evidence of an arrangement, delivery has occurred, the price is fixed and determinable, and collectability is reasonably assured. This occurs when products are shipped or the customer accepts title transfer. If the arrangement involves acceptance terms, the Company defers revenue until product acceptance is received. The Company limits the amount of revenue recognition for delivered elements to the amount that is
not
contingent on the future delivery of products or services, future performance obligations or subject to customer-specified return or refund privileges. The Company evaluates each deliverable in an arrangement to determine whether they represent separate units of accounting. On certain large development contracts, revenue is recognized upon achievement of substantive milestones. Determining whether a milestone is substantive is a matter of judgment and that assessment is performed only at the inception of the arrangement. The consideration earned from the achievement of a milestone must meet all of the following for the milestone to be considered substantive:
 
a. It is commensurate with either of the following:
1.
The Company’s performance to achieve the milestone.
2.
The enhancement of the value of the delivered item or items as a result of a specific outcome resulting from the Company's performance to achieve the milestone.
b. It relates solely to past performance.
c. It is reasonable relative to all of the deliverables and payment terms (including other potential milestone consideration) within the arrangement.
 
Milestones for revenue recognition are agreed upon with the customer prior to the start of the contract and some milestones will be tied to product shipping while others will be tied to design review. In fiscal
2015
the Company’s Microsource business unit received a
$6.5
million order from a major aerospace company for non-recurring engineering services to develop a variant of its high performance fast tuning YIG filters for an aircraft platform and to deliver a limited number of flight-qualified prototype hardware units (the “NRE Order”) which is being accounted for on a milestone basis. The Company considered factors such as estimated completion dates and product acceptance of the order prior to accounting for the NRE Order as milestone revenue. There was
no
revenue recognized during the
three
-month period ended
June 24, 2017
as the Company had delivered all milestones associated with this contract. During the
three
-month period ended
June 25, 2016,
revenue recognized on a milestone basis were
$145,000.
  
On certain contracts with several of the Company’s significant customers the Company receives payments in advance of manufacturing. Advanced payments are recorded as deferred revenue until the revenue recognition criteria described above have been met.
 
Accounts receivable are stated at their net realizable value. The Company has estimated an allowance for uncollectable accounts based on analysis of specifically identified accounts, outstanding receivables, consideration of the age of those receivables, the Company’s historical collection experience, and adjustments for other factors management believes are necessary based on perceived credit risk.
 
The Company provides for estimated costs that
may
be incurred for product warranties at the time of shipment. The Company’s warranty policy generally provides
twelve
to
eighteen
months depending on the customer. The estimated cost of warranty coverage is based on the Company’s actual historical experience with its current products or similar products. For new products, the required reserve is based on historical experience of similar products until such time as sufficient historical data has been collected on the new product. Adjustments are made as new information becomes available.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventories
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Inventory Disclosure [Text Block]
(
4
)         
 Inventories
 
Inventories net of inventory reserves totaling
$3.4
million at
June 24, 2017
and
March 25, 2017,
respectively consisted of the following:
 
(In thousands)
 
June 24,
2017
 
 
March 25,
2017
 
Raw materials
  $
1,411
    $
1,775
 
Work-in-progress
   
2,931
     
2,155
 
Finished goods
   
239
     
473
 
Demonstration inventory
   
408
     
408
 
Total
  $
4,989
    $
4,811
 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Software Development Costs
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Research, Development, and Computer Software Disclosure [Text Block]
(
5
)         
Software Development Costs
 
On
September 3, 2015,
the Company entered a software development agreement with a major aerospace and defense company whereby the aerospace company developed and licensed its simulation software to the Company. The simulation software (also called Open Loop Simulator or OLS technology) is currently the aerospace company’s intellectual property. The OLS technology generates threat simulations and enables various hardware to generate signals for performing threat analysis on systems under test. The Company licenses the OLS software as a bundled or integrated solution with its Advanced Signal Generator system.
 
The Company paid the aerospace company software development costs and fees for OLS of
$1.2
million in the aggregate (this includes an amendment to the software development agreement for additional features and functionality), which was paid in monthly installments as the work was performed by the aerospace company through the
third
quarter of fiscal
2017.
The OLS technology is a perpetual license agreement that
may
be terminated by the Company at any time as long as the Company provides a notice to the aerospace company and pays for the development costs incurred through the notice termination date. The Company is also obligated to pay royalties to the aerospace company on net sales of its Advanced Signal Generator product sold with the OLS software equal to
seven
percent of net sales price of each ASG system sold and subject to certain minimums. The Company expenses research and development costs as they are incurred. Development costs of computer software to be sold, leased, or otherwise marketed are subject to capitalization beginning when a product’s technological feasibility has been established and ending when a product is available for general release to customers.
 
As of
June 24, 2017
and
March 25, 2017,
capitalized software costs were
$582,000
and
$733,000,
respectively. The Company began amortizing the costs of capitalized software to cost of sales in
third
quarter of fiscal
2017
using the straight-line methodology over an estimated
three
-year amortization period. During the
fourth
quarter of fiscal
2017,
the Company changed its estimated amortization period from
three
years to
two
years due to the longer than anticipated procurement cycle associated with the ASG TEmS product line. The Company also amortized capitalized software costs using the estimated percentage of revenue approach (which was greater than straight-line amortization) in the
fourth
quarter of fiscal
2017.
During the
first
quarter of fiscal
2018,
the Company had
no
revenues associated with its ASG TEmS product line and therefore amortized capitalized software costs on a straight-line basis. Amortization of capitalized software costs recorded during the
first
quarter of fiscal
2018
were
$151,000.
There was
no
amortization recorded in the
first
quarter of fiscal
2017
as the Company had
not
yet released its ASG TEmS units.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Accounts Receivable Line of Credit
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Debt Disclosure [Text Block]
(
6
)      Accounts Receivable Line of Credit
 
On
June 1, 2015
the Company entered into a
$2.5
million Revolving Accounts Receivable Line of Credit agreement with Bridge Bank. The agreement provides for a maximum borrowing capacity of
$2.5
million of which
$2.0
million is subject to a borrowing base calculation and
$500,000
is non-formula based. On
May 23, 2017,
the Company renewed this credit line (which expired on
May 7, 2017)
through
May 6, 2019.
  
The loan agreement is secured by all assets of the Company including intellectual property and general intangibles and provides for a borrowing capacity equal to
80%
of eligible accounts receivable. The loan matures on
May 6, 2019
and bears an interest rate, equal to
1.5%
over the bank’s prime rate of interest (which was
4.25%
at
June 24, 2017
resulting in an interest rate of
5.75%
). Interest is payable monthly with principal due upon maturity. The Company paid an annual commitment fee of
$12,500
in
May 2017.
The loan agreement contains financial and non-financial covenants that are customary for this type of lending and includes a covenant to maintain an asset coverage ratio of at least
150%
(defined as unrestricted cash and cash equivalents maintained with Bridge Bank, plus eligible accounts receivable aged less than
90
days from the invoice date, divided by the total amount of outstanding principal of all obligations under the loan agreement). While the Company maintained the asset coverage ratio, the Company was in a cross default at
June 24, 2017,
as a result of the PFG noncompliance described in Note
7
below.
 
The line of credit requires a lockbox arrangement, which provides for receipts to be swept daily to reduce borrowings outstanding at the discretion of Bridge Bank. This arrangement, combined with the existence of the subjective acceleration clause in the line of credit agreement, necessitates the line of credit be classified as a current liability on the balance sheet. The acceleration clause allows for amounts due under the facility to become immediately due in the event of a material adverse change in the Company’s business condition (financial or otherwise), operations, properties or prospects, or ability to repay the credit based on the lender's judgment. As of
June 24, 2017,
the Company’s total outstanding borrowings under the Bridge Bank line of credit were
$582,000.
 
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Term Loan, Revolving Line of Credit and Warrants
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Long-term Debt [Text Block]
(
7
)
       Term Loan
s
, Revolving Line of Credit and Warrants
 
 
On
April 27, 2017,
the Company entered into a new loan agreement with PFG (Partners For Growth V, L.P.). Under the terms of the agreement, PFG made a term loan to Giga-tronics in the principal amount of
$1,500,000,
with funding occurring on
April 28, 2017.
  
The loan has a
two
-year term, with interest only payments for the term of the loan. The principal amount of the loan plus any accrued interest will be due upon maturity. The loan bears interest at an aggregate per annum rate equal to
16%
per annum, fixed, which is comprised of cash interest reflecting a
9.5%
per annum rate and deferred interest reflecting a
6.5%
per annum rate. The Company will pay the cash interest monthly and will accrue deferred interest on the unpaid principal balance. The deferred interest will be due and payable upon maturity. In addition, the Company agreed to pay PFG a charge of up to
$100,000
due and payable upon maturity (the “back-end fee”),
$76,000
of which was earned on
April 27, 2017,
and
$24,000
of which is earned at the rate of
$1,000
per month on the
first
day of each month if the loan principal (of any amount) is outstanding during any day of the prior month. If the Company meets or exceeds certain revenue and net income minimums in fiscal
2018,
the amount could be reduced by
25
percent. To stay in compliance with the loan terms, the Company must meet certain financial covenants associated with minimum quarterly revenues and monthly minimum shareholders’ equity. The lender can accelerate the maturity of the loan in case of a default. The Company can prepay the loan before maturity at any time without fee or penalty
.
 
In connection with its loan to the Company, PFG will receive up to
250,000
shares of common stock,
190,000
of which was earned on
April 27, 2017
and
60,000
of which is earned at the rate of
2,500
per month on the
first
day of each month if the loan principal (of any amount) is outstanding during any day of the prior month.
 
The Company has pledged all its assets as collateral for the loan made by PFG, including all its accounts, inventory, equipment, deposit accounts, intellectual property and all other personal property. The PFG loan is subordinate to the Bridge Bank line of credit (see Note
6,
Accounts Receivable Line of Credit).
 
The requirement to issue
60,000
shares of the Company’s common stock over the term of the loan is an embedded derivative (an embedded equity forward). The Company evaluated the embedded derivative in accordance with ASC
815
-
15
-
25.
The embedded derivative is
not
clearly and closely related to the debt host instrument and therefore has been separately measured at fair value, with subsequent changes in fair value recognized in the Condensed Consolidated Statements of Operations.
 
The proceeds received upon issuing the loan was allocated to: i) common stock, for the fair value of the
190,000
shares of common stock initially issued to the lender; ii) the fair value of the embedded derivative; and iii) the loan host instrument. Upon issuance of the loan, the Company recognized
$1,576,000
of principal payable to PFG, representing the stated principal balance of
$1,500,000
plus the initial back-end fee of
$76,000.
The initial carrying value of the loan was recognized net of debt discount aggregating approximately
$326,000,
which is comprised of the following:
 
Fees paid to the lender and third parties
  $
44,000
 
Backend fee
   
76,000
 
Estimated fair value of embedded equity forward
   
49,000
 
Fair value of 190,000 shares of common stock issued to lender
   
157,000
 
Aggregate discount amount
  $
326,000
 
 
The bifurcated embedded derivative and the debt discount are presented net with the related loan balance in the Condensed Consolidated Balance Sheets. The debt discount is amortized to interest expense over the loan’s term using the effective interest method.
 
The Company amortized approximately
$22,000
to interest expense in the quarter ended
June 24, 2017.
Additionally, the Company recognized a loss of approximately
$500
in the in the quarter ended
June 24, 2017
due to the estimated increase in fair value of the embedded equity forward.
 
 
PFG’s ability to call the debt on default (contingent put) and its ability to assess interest rate at a default rate (contingent interest) are embedded derivatives which the Company evaluated. The fair value of these embedded features were determined to be immaterial and were
not
bifurcated from the debt host for accounting purposes.
 
As of
June 24, 2017,
the Company was
not
in compliance with certain financial covenants associated with the PFG loan. On
August 2, 2017,
the Company and PFG entered into a short-term forbearance arrangement (through the end of
August)
with respect to such noncompliance.
No
assurance can be given that the Company will be able to comply with the terms of the forbearance agreement that the parties agreed on, or that PFG will agree to a further extension of forbearance at the end of the initial forbearance period. There is a
6%
default rate associated with the forbearance agreement. The Company will most likely be required to raise additional capital to rectify the noncompliance. 
No
assurance can be given that the Company will be able to raise sufficient capital on timely basis.
 
On
March 13, 2014,
the Company entered into a
three
year,
$2.0
million term loan agreement with PFG under which the Company received
$1.0
million on
March 14, 2014 (
“First Draw”). Interest on the initial
$1.0
million term loan was fixed at
9.75%.
On
June 16, 2014,
the Company amended its loan agreement with PFG (the “Amendment”). Under the terms of the Amendment, PFG made a revolving credit line available to Giga-tronics in the amount of
$500,000,
and the Company borrowed the entire amount on
June 17, 2014.
The revolving line had a
thirty-three
month term. The Amendment reduced the future amount potentially available for the Company to borrow under the PFG Loan agreement from
$1.0
million to
$500,000.
The interest on the PFG revolving credit line was fixed, calculated on a daily basis at a rate of
12.50%
per annum. The Company as of
June 24, 2017,
and
March 25, 2017
had fully repaid both the
$1.0
million term loan and the
$500,000
revolving credit line.
 
In connection with the
March 2014
loan agreement, the Company issued warrants convertible into shares of the Company’s common stock, of which
180,000
were exercisable upon receipt of the initial
$1.0
million from the First Draw, and
80,000
became exercisable with the First Amendment. Each warrant issued under the loan agreement has a term of
five
years and an exercise price of
$1.42
which was equal to the average NASDAQ closing price of the Company’s common stock for the
ten
trading days prior to the First Draw.
 
If the warrants are
not
exercised before expiration on
March 31, 2019,
the Company would be required to pay PFG
$150,000
and
$67,000
as settlement for warrants associated with the First Draw and the Amendment, respectively. The warrants could be settled for cash at an earlier date in the event of any acquisition or other change in control of the Company, future public issuance of Company securities or liquidation (or substantially similar event) of the Company. The Company currently has
no
definitive plans for any of the aforementioned events, and as a result, the cash payment date is estimated to be the expiration date unless warrants are exercised before then. The warrants have the characteristics of both debt and equity and are accounted for as a derivative liability measured at fair value each reporting period with the change in fair value recorded in earnings.
 
As of
June 24, 2017,
and
March 25, 2017,
the estimated fair values of the derivative liabilities associated with the warrants issued in connection with the First Draw and Amendment were
$133,000
and
$89,000,
respectively, for a combined value of
$222,000,
respectively. There was
no
change in the fair value of the warrant liability in the
first
quarter ended
June 24, 2017.
The change in the fair value of the warrant liability totaled
$46,000
for the
first
quarter ended
June 25, 2016
and is reported in the accompanying statement of operations as a gain on adjustment of derivative liability to fair value. There was
no
accretion recorded in the
first
quarter ended
June 24, 2017
in connection with the
March 2014
loan agreement as the loan was paid in full. For the quarter ended
June 25, 2016,
the Company recorded accretion of discount expense associated with the warrants issued with the PFG Loan of
$11,000.
 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
(
8
)
       
Fair Value
 
Pursuant to the accounting guidance for fair value measurement and its subsequent updates, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date. The accounting guidance establishes a hierarchy for inputs used in measuring fair value that minimizes the use of unobservable inputs by requiring the use of observable market data when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on active market data. Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability based on the best information available in the circumstances.  
  
The fair value hierarchy is broken down into the
three
input levels summarized below:
  
     
•  
Level 
1
  —Valuations are based on quoted prices in active markets for identical assets or liabilities and readily accessible by us at the reporting date. Examples of assets and liabilities utilizing Level
1
inputs are certain money market funds, U.S. Treasuries and trading securities with quoted prices on active markets.
  
   
•  
Level 
2
  —Valuations based on inputs other than the quoted prices in active markets that are observable either directly or indirectly in active markets. Examples of assets and liabilities utilizing Level
2
inputs are U.S. government agency bonds, corporate bonds, commercial paper, certificates of deposit and over-the- counter derivatives.
  
   
•  
Level 
3
  —Valuations based on unobservable inputs in which there are little or
no
market data, which require us to develop our own assumptions.
 
Fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management as of and during the
three
month period ended
June 24, 2017.
The carrying values of cash and cash equivalents, trade accounts receivable, line of credit, term debt and accounts payable approximate their fair values given their short-term nature. As of
June 24, 2017,
the carrying value of the outstanding PFG loan approximates the estimated aggregate fair value, since the embedded equity forward is recognized at fair value and classified with the loan host. The fair value estimate of the embedded equity forward is based on the closing price of the Company’s common stock on the measurement date, the risk-free rate, the date of expiration, and any expected cash distributions of the underlying asset before expiration. The estimated fair value of the embedded equity forward represents a Level
2
measurement.
 
Derivatives
The Company does
not
use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including notes payable, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company accounts for certain of its warrants as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of warrant liability to fair value.
 
Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated embedded derivatives are classified with the related host contract in the Company’s balance sheet.
 
The Company’s derivative warrant liability is measured at fair value on a recurring basis and is categorized as Level
3
in the fair value hierarchy. The derivative warrant liability is valued using a Monte Carlo simulation model, which used the following assumptions as of
June 24, 2017: (
i) the remaining expected life of
1.7
years, (ii) the Company’s historical volatility rate of
101.1%,
(iii) risk-free interest rate of
1.26%,
and (iv) a discount rate of 
thirty
percent.
 
The aforementioned derivative warrant liability and equity forward are the Company’s only asset and liability recognized and measured at fair value on a recurring or non-recurring basis and are follows:
 
Fair Value Measurements as of
June 24, 2017
(In Thousands):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Warrant liability
  $
    $
    $
222
 
Equity forward
   
     
46
     
 
Total
  $
    $
46
    $
222
 
 
Fair Value Measurements as of March 25, 2017
(In Thousands):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Warrant liability
  $
    $
    $
222
 
Total
  $
    $
    $
222
 
 
There were
no
transfers between Level
1,
Level
2
or Level
3
for the quarter ended
June 24, 2017.
 
  
The table below summarizes changes in gains and losses recorded in earnings for Level
3
assets and liabilities that are still held at
June 24, 2017:
 
 
 
Quarter
Ended
 
 
Quarter
Ended
 
(In thousands)
 
June 24,
2017
 
 
June 25,
2016
 
Warrant liability at beginning of year
  $
222
    $
353
 
Gains on adjustment of warrant liability to fair value
   
     
(46
)
Losses on adjustment of warrant liability to fair value
   
     
 
Warrant liability at end of period
  $
222
    $
307
 
  
There were
no
assets measured at fair value on a recurring basis and there were
no
assets or liabilities measured on a non-recurring basis at
June 24, 2017
and
March 25, 2017.
  
The following table presents quantitative information about recurring Level
3
fair value measurements at
June 24, 2017
and
March 25, 2017:
  
June
24, 2017
 
Valuation Technique(s)
 
Unobservable Input
 
 
 
 
Warrant liability
 
Monte Carlo
 
Discount rate
   
30%
 
  
March 25, 2017
 
Valuation Techniques(s)
 
Unobservable Input
 
 
 
 
Warrant liability
 
Monte Carlo
 
Discount rate
   
24%
 
  
The discount rate of
thirty
percent at
June 24, 2017, 
and
twenty four
percent at
March 25, 2017 
is management’s estimate of the cost of capital given the Company’s credit worthiness. A significant increase in the discount rate would significantly decrease the fair value, but the magnitude of this decrease would be less significant in a scenario where the Company’s stock price is significantly higher than the exercise price since the holder’s option to take a cash payment at maturity represents a smaller component of the total fair value when the Company’s stock price is higher. The Monte Carlo simulation model simulated the Company’s stock price through the maturity date of
March 31, 2019.
At the end of the simulated period, the value of the warrant was determined based on the greater of (
1
) the net share settlement value, (
2
) the net exercise value, or (
3
) the fixed cash put value.   
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Sale of Product Lines
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
(
9
)
       
Sale of Product Lines
 
 
On
June 20, 2016,
the Company entered into an Asset Purchase Agreement for the sale of its Switch product line to Astronics Test Systems Inc. (Astronics). Upon signing the agreement, Astronics paid
$850,000
for the intellectual property of the product line. The Company recognized a net gain of
$802,000
in the quarter ended
June 25, 2016
after related expenses were subtracted from the sales price. The following table presents the breakdown of the gain recognized in the quarter related to the asset sale:
 
(In thousands)
 
Quarter Ended
June 25,
2016
 
Cash received from Astronics
  $
850
 
Cash paid to buy out future commission obligation
   
(170
)
Employee severance
   
(97
)
Legal fees
   
(13
)
Commissions
   
(46
)
Warranty Liability released
   
278
 
Net gain recognized in the quarter
  $
802
 
   
In calculating the gain included in the accompanying consolidated financial statements, the Company released
$278,000
of deferred warranty obligations related to the Switch asset. Pursuant to the terms of the agreement, Astronics assumed all the warranty obligations for the Switch product line, including the products sold prior to the asset being transferred to Astronics. The deferred warranty obligation was previously included in other current liabilities in the consolidated financial statements. The Company also had a previous agreement with a consultant supporting the Switch product line, which included a
three
percent commission on the sales of the Switch product line for a period of
4
years ending in
January 2020.
The agreement allowed for a buyout of future commissions associated with the Switch product, which the Company exercised in connection with the Astronics sales in
June 2016
which resulted in a payment by the Company during
June
of
$170,000.
Astronics also purchased approximately
$500,000
of related materials inventory from Giga-tronics between
July
and
August
of
2016.
 
The Company had
no
revenues or gross margin associated with the Switch product line in the
first
quarter ended
June 24, 2017.
The Switch product line accounted for
$1.1
million in revenue for the fiscal quarter ended
June 25, 2016.
The Switch product line’s gross margin on revenues was
$437,000
for the fiscal quarter ended
June 25, 2016.
While the Company is able to distinguish revenue and gross margin information related to the sale of the Switch product line, the Company is unable to present meaningful information about results of operation and cash flows from the Switch product line.
 
On
December 15, 2015,
the Company entered into an Asset Purchase Agreement with Spanawave Corporation, whereby Spanawave agreed to purchase the Giga-tronics’ Division product lines for its Power Meters, Amplifiers, and Legacy Signal Generators for
$1.5
million. The agreement provided for the transfer of these product lines to Spanawave sequentially in
six
phases beginning with certain sensor and amplifier products. The Company had transferred the Power Meters and Amplifiers in phases
one
through five, the Company still holds the right to phase
6
(Legacy Signal Generators). During the
second
quarter ended
September 24, 2016,
the Company and Spanawave became engaged in a dispute, including litigation initiated by Spanawave and an arbitration proceeding initiated by Spanawave’s affiliate Liberty Test Equipment, Inc., as to whether the Company has fulfilled all the requirements to close phases
one
through
five
and become entitled to the
$375,000
received by the Company during the
first
quarter of fiscal
2017
(see below).
  
The complaint seeks specific performance of the agreement and damages. Spanawave’s affiliate Liberty Test Equipment also filed an arbitration claim for
$440,000
under a distribution agreement between the Company and Liberty. The Company has filed cross-complaints in both the litigation and arbitration asserting breach of the respective agreements by Spanawave and Liberty. The Company had previously asserted that the distribution agreement does
not
extend to the products with respect to which the claim has been made. Certain customers of the lines of business sold to Spanawave are also customers of the Company’s ongoing Advance Signal Generator business. Continued disruption of the phase
6
signal generator business could have an adverse effect on the ASG business. The parties have negotiated in an effort to settle the dispute notwithstanding the filings. The expenses and potential liability of negotiation, any settlement or continued litigation or arbitration could have a material adverse effect on the Company.
  
During fiscal
2017,
the Company received
$750,000
from Spanawave under the agreement. Of this amount, the Company returned
$375,000
to Spanawave on
July 28, 2016
resulting from the dispute regarding the status of phases
one
through five. The remaining
$375,000
is included in deferred liability related to asset sales in the consolidated balance sheet. In addition, in
June 2016,
the Company received approximately
$275,000
in exchange for raw material purchases. The purchase price of the raw materials approximated its carrying value, therefore
no
gain or loss was recognized. The parties are currently attempting to resolve this dispute.
No
gain has been recognized in connection with this product line sale because of the aforementioned dispute. These product lines accounted for approximately
$95,000
and
$275,000
in revenue during the fiscal quarter ended
June 24, 2017,
and
June 25, 2016,
respectively. For the fiscal quarter ended
June 24, 2017,
gross margin was immaterial. There was
no
margin associated with the revenue derived in the
first
quarter of fiscal
2017
as the revenues were primarily related to inventory transfer at book value. While the Company is able to distinguish revenue and gross margin information related to the sale of these product lines, the Company is unable to present meaningful information about results of operation and cash flows from these product lines.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Loss Per Common Share
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Earnings Per Share [Text Block]
 
(
10
)         
Loss Per Share
 
Basic loss per share (EPS) is calculated by dividing net income or loss by the weighted average common shares outstanding during the period. Diluted EPS reflects the net incremental shares that would be issued if unvested restricted shares became vested and dilutive outstanding stock options were exercised, using the treasury stock method. In the case of a net loss, it is assumed that
no
incremental shares would be issued because they would be antidilutive. In addition, certain options are considered antidilutive because assumed proceeds from exercise price, related tax benefits and average future compensation was greater than the weighted average number of options outstanding multiplied by the average market price during the period. The shares used in per share computations are as follows:  
 
 
 
Three Months Ended
 
(In thousands except per share data)
 
June 24,
2017
 
 
June 25,
2016
 
Net loss
  $
(1,258
)
  $
(102
)
                 
Weighted average:
               
Common shares outstanding
   
9,715
     
9,550
 
Potential common shares
   
     
 
Common shares assuming dilution
   
9,715
     
9,550
 
                 
Loss per common share – basic
  $
(0.13
)
  $
(0.01
)
Loss per common share – diluted
  $
(0.13
)
  $
(0.01
)
Stock options not included in computation that could potentially dilute EPS in the future
   
1,104
     
1,529
 
Restricted stock awards not included in computation that could potentially dilute EPS in the future
   
350
     
 
Issuable shares for interest on loan
   
55
     
 
Convertible preferred stock not included in computation that could potentially dilute EPS in the future
   
1,853
     
1,853
 
Warrants not included in computation that could potentially dilute EPS in the future
   
3,737
     
3,737
 
 
The stock options, restricted stock, convertible preferred stocks and warrants
not
included in the computation of diluted earnings per share (EPS) for the
three
month period ended
June 24, 2017
and
June 25, 2016
is a result of the Company’s net loss and, therefore, the effect of these instruments would be anti-dilutive.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
11
)          Share Based Compensation
 
The Company has established the
2005
Equity Incentive Plan, which provide for the granting of options and restricted stock for up to
2,850,000
shares of common stock at
100%
of fair market value at the date of grant, with each grant requiring approval by the Board of Directors of the Company. The
2005
Plan has been extended to be effective until
2025.
Option grants under the
2000
Stock Option Plan are
no
longer available. Options granted generally vest in
one
or more installments in a
four
or
five
year period and must be exercised while the grantee is employed by the Company or within a certain period after termination of employment. Options granted to employees shall
not
have terms in excess of
10
years from the grant date. Holders of options
may
be granted stock appreciation rights (SARs), which entitle them to surrender outstanding awards for a cash distribution under certain changes in ownership of the Company, as defined in the stock option plan. As of
June 24, 2017,
no
SAR’s have been granted under the option plan. As of
June 24, 2017,
the total number of shares of common stock available for issuance was
934,677.
All outstanding options have a
ten
year life from the date of grant. The Company records compensation cost associated with share-based compensation equivalent to the estimated fair value of the awards over the requisite service period.
 
Stock
Options
 
In calculating compensation related to stock option grants, the fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option-pricing model and the following weighted average assumptions: 
 
 
 
Three Months Ended
 
 
 
June 2
4
,
201
7
 
 
June 25,
2016
 
Dividend yield
   
     
 
Expected volatility
   
     
98.95
%
Risk-free interest rate
   
     
1.38
%
Expected term (years)
   
     
8.36
 
 
The computation of expected volatility used in the Black-Scholes-Merton option-pricing model is based on the historical volatility of the Company’s share price. The expected term is estimated based on a review of historical employee exercise behavior with respect to option grants. The risk-free interest rate is based on the U.S. Treasury rates with maturity similar to the expected term of the option on the date of grant.
  
 A summary of the changes in stock options outstanding for the
three
-month period ended
June 24, 2017
and the year ended
March 25, 2017
is as follows:      
 
           
Weighted
Average
   
Weighted
Average
Remaining
Contractual
   
Aggregate
Intrinsic
 
   
Shares
   
Exercise Price
   
Terms (Years)
   
Value
 
Outstanding at March 26, 2016
   
1,592,200
    $
1.52
     
6.8
    $
69
 
Granted
   
148,000
     
0.97
     
 
     
 
 
Exercised
   
     
     
 
     
 
 
Forfeited / Expired
   
635,700
     
1.57
     
 
     
 
 
Outstanding at March 25, 2017
   
1,104,500
    $
1.41
     
6.1
    $
3
 
Granted
   
     
     
 
     
 
 
Exercised
   
     
     
 
     
 
 
Forfeited / Expired
   
     
     
 
     
 
 
Outstanding at June 24, 2017
   
1,104,500
    $
1.41
     
6.1
    $
3
 
                                 
Exercisable at June 24, 2017
   
812,050
    $
1.45
     
5.2
    $
 
                                 
At June 24, 2017 expected to vest in the future
   
1,006,157
    $
1.42
     
5.7
    $
 
  
As of
June 24, 2017,
there was
$156,000
of total unrecognized compensation cost related to non-vested options. That cost is expected to be recognized over a weighted average period of
3.06
years and will be adjusted for subsequent changes in estimated forfeitures. There were
29,500
options that vested during the quarter ended
June 24, 2017,
and
28,500
options that vested during the quarter ended
June 25, 2016.
The total fair value of options vested during each of the quarters ended
June 24, 2017
and
June 25, 2016
was
$33,000
and
$1,000
respectively. There were
no
options exercised in the
three
-month period ended
June 24, 2017
and
June 25, 2016.
Share based compensation cost related to stock options recognized in operating results for the
three
months ended
June 24, 2017
and
June 25, 2016
totaled
$37,000
and
$72,000,
respectively.
 
Restricted Stock
 
The Company granted
350,450
restricted awards during the
first
quarter of fiscal
2018.
No
restricted awards were granted during the
first
quarter of fiscal
2017.
No
restricted awards vested during the
first
quarter of fiscal
2018
and
2017.
The restricted stock awards are considered fixed awards as the number of shares and fair value at the grant date is amortized over the requisite service period net of estimated forfeitures. As of
June 24, 2017,
there was
$204,000
of total unrecognized compensation cost related to non-vested awards. That cost is expected to be recognized over a weighted average period of
1.98
years and will be adjusted for subsequent changes in estimated forfeitures. Compensation cost recognized for the restricted and unrestricted stock awards during the
first
quarter of
2018
was
$9,000.
There was
no
compensation recognized for the restricted and unrestricted stock awards during the
first
quarter of fiscal
2017.
 
 
A summary of the changes in non-vested restricted stock awards outstanding for the
three
-month period ended
June 24, 2017
and the fiscal year ended
March 25, 2017
is as follows:
 
   
Shares
   
Weighted
Average
Fair Value
 
Non-Vested at March 26, 2016
   
    $
 
Granted
   
44,500
     
0.66
 
Vested
   
44,500
     
0.66
 
Forfeited or cancelled
   
     
 
Non-Vested at March 25, 2017
   
    $
 
Granted
   
350,450
     
 
 
Vested
   
     
 
 
Forfeited or cancelled
   
     
 
Non-Vested at June 24, 2017
   
350,450
    $
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Significant Customer and Industry Segment Information
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
(
12
)          
Significant
Customer and
Industry Segment Information
 
The Company has
two
reportable segments: Giga-tronics Division and Microsource.
 
 
The Giga-tronics Division historically produces a broad line of test and measurement equipment used primarily for the design, production, repair and maintenance of products in aerospace, telecommunications, RADAR, and electronic warfare.
 
Microsource primarily develops and manufactures YIG RADAR filters used in fighter jet aircraft for
two
prime contractors. 
   
The tables below present information for the
three
month periods ended
June 24, 2017
and
June 25, 2016:
 
 
 
Three Month Periods Ended
 
 
 
 
 
 
Three Month Periods Ended
 
 
 
 
 
(In thousands)
 
At June 24,
2017
 
 
June 24,
2017
 
 
 
 
 
 
At June 25,
2016
 
 
June 25,
2016
 
 
 
 
 
 
 
Assets
 
 
Net Sales
 
 
Net Income
(Loss)
 
 
Assets
 
 
Net Sales
 
 
Net Income
(Loss)
 
Giga-tronics Division
  $
6,153
    $
297
    $
(1,849
)   $
8,233
    $
2,125
    $
(554
)
Microsource
   
2,907
     
1,694
     
591
     
3,887
     
1,317
     
452
 
Total
  $
9,060
    $
1,991
    $
(1,258
)   $
12,120
    $
3,442
    $
(102
)
 
During the
first
quarter of fiscal
2018,
one
customer accounted for
43%
of the Company’s consolidated revenues and was included in the Microsource segment. A
second
customer accounted for
37%
and was also included in the Microsource segment. During the
first
quarter of fiscal
2017,
one
customer accounted for
30%
of the Company’s consolidated revenues and was included in the Microsource segment. A
second
customer accounted for
22%
and was included in the Giga-tronics Division. A
third
customer accounted for
17%
of the Company’s consolidated revenue and was also included in the Giga-tronics Division.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Income Taxes
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
(
13
)          Income Taxes
 
The Company accounts for income taxes using the asset and liability method as codified in Topic
740.
Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards.
 
The Company recorded
no
tax expense for the
three
months ended
June 24, 2017
and
June 25, 2016.
The effective tax rate for the
three
months ended
June 24, 2017
and
June 25, 2016
was
0%
respectively, primarily due to a valuation allowance recorded against the net deferred tax asset balance.
 
As of
June 24, 2017,
the Company had recorded
$120,000
for unrecognized tax benefits related to uncertain tax positions. The unrecognized tax benefit is netted against the non-current deferred tax asset on the Consolidated Balance Sheet. The Company does
not
expect the liability for unrecognized tax benefits to change materially within the next
12
months. The Company does have a California Franchise Tax Board audit that is currently in process. The Company is working with the California Franchise Tax Board to resolve all audit issues and does
not
believe any material taxes, penalties and fees are due. However, as a result of the on-going examination, the Company recorded an estimated associated tax liability of
$45,000
in the
first
quarter of fiscal
2015.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Warranty Obligations
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Product Warranty Disclosure [Text Block]
(
14
)       
Warranty Obligations
 
The Company records a liability in cost of sales for estimated warranty obligations at the date products are sold. Adjustments are made as new information becomes available. The following provides a reconciliation of changes in the Company’s warranty reserve. The Company provides
no
other guarantees.
 
(In thousands)
 
Three Months
Ended
June 24,
2017
 
 
Three Months
Ended
June 25,
2016
 
Balance at beginning of period
  $
123
    $
60
 
Provision, net
   
1
     
112
 
Warranty costs incurred
   
(33
)
   
(112
)
Balance at end of period
  $
91
    $
60
 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Preferred Stock [Text Block]
(
15
)       Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants
 
On
November 10, 2011,
the Company received
$2,199,000
in cash proceeds from Alara Capital AVI II, LLC, a Delaware limited liability company (the “Investor”), an investment vehicle sponsored by Active Value Investors, LLC, under a Securities Purchase Agreement entered into on
October 31, 2011.
Under the terms of the Securities Purchase Agreement, the Company issued
9,997
shares of its Series B Convertible Voting Perpetual Preferred Stock (“Series B Preferred Stock”) to the Investor at a price of
$220
per share. The Company has recorded
$2.0
million as Series B Preferred Stock on the consolidated balance sheet which is net of stock offering costs of approximately
$202,000
and represents the value attributable to both the convertible preferred stock and warrants issued to the Investor. After considering the value of the warrants, the effective conversion price of the preferred stock was greater than the common stock price on date of issue and therefore
no
beneficial conversion feature was present.
  
On
February 19, 2013,
the Company entered into a Securities Purchase Agreement pursuant to which it agreed to sell
3,424.65
shares of its Series C Convertible Voting Perpetual Preferred Stock (“Series C Preferred Stock”) to the Investor, for aggregate consideration of
$500,000,
which is approximately
$146.00
per share. The Company has recorded
$457,000
as Series C Preferred Stock on the consolidated balance sheet, which is net of stock offering costs of approximately
$43,000.
After considering the reduction in the value of the warrant, the effective conversion price of the preferred stock was greater than the common stock price on the date of issue and therefore
no
beneficial conversion feature was present.
  
On
July 8, 2013
the Company received
$817,000
in net cash proceeds from the Investor under a Securities Purchase Agreement. The Company sold to the Investor
5,111.86
shares of its Series D Convertible Voting Perpetual Preferred Stock (Series D Preferred Stock) and a warrant to purchase up to
511,186
additional shares of common stock at the price of
$1.43
per share. The allocation of the
$858,000
in gross proceeds from issuance of Series D Preferred Stock based on the relative fair values resulted in an allocation of
$498,000
(which was recorded net of
$41,000
of issuance costs) to Series D Preferred Stock and
$360,000
to Common Stock.  In addition, because the effective conversion rate based on the
$498,000
allocated to Series D Preferred Stock was
$0.97
per common share which was less than the Company’s stock price on the date of issuance, a beneficial conversion feature was present at the issuance date. The beneficial conversion feature totaled
$238,000
and was recorded as an increase of common stock and an increase to accumulated deficit. 
 
Each share of Series B, Series C and Series D Preferred Stock is convertible into
one hundred
shares of the Company’s common stock. In connection with the preferred stock issuance described above, the Company issued to the investor warrants to purchase a total of
1,017,405
common shares at an exercise price of
$1.43
per share. These warrants were exercised in
February 2015,
and
May 2015.
The Company received funds from Alara in separate closings dated
February 16, 2015
and
February 23, 2015.
Alara exercised a total of
1,002,818
of its existing Series C and Series D warrants to purchase common shares, all of which had an exercise price of
$1.43
per share for total cash proceeds of
$1,434,000,
which was recorded net of
$42,000
of stock issuance costs. As part of the consideration for this exercise, the Company sold to Alara
two
new warrants to purchase an additional
898,634
and
194,437
common shares at an exercise price of
$1.78
and
$1.76
per share, respectively, for a total purchase price of
$137,000
or
$0.125
per share. The new warrants have a term of
five
years and
may
be paid in cash or through a cashless net share settlement. The Company and Alara amended the remaining
14,587
warrants as part of the
February
closings. On
May 14, 2015,
Alara exercised the remaining
14,587
warrants by acquiring
7,216
of shares of the Company’s common stock through a cashless net share settlement.
 
The table below present information for the periods ended
June 24, 2017
and
March 25, 2017:
 
Preferred Stock
                       
As of
June 24, 2017
and
March 25, 2017
 
  
                           
Liquidation
 
   
Designated
Shares
   
Shares
Issued
   
Shares
Outstanding
   
Preference
(in thousands)
 
Series B
   
10,000.00
     
9,997.00
     
9,997.00
    $
2,309
 
Series C
   
3,500.00
     
3,424.65
     
3,424.65
     
500
 
Series D
   
6,000.00
     
5,111.86
     
5,111.86
     
731
 
Total
   
19,500.00
     
18,533.51
     
18,533.51
    $
3,540
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 16 - Private Placement Offering
3 Months Ended
Jun. 24, 2017
Notes to Financial Statements  
Private Placement Offering [Text Block]
(
1
6
)
      
Private
Placement Offering
 
On
January 19, 2016,
the Company entered into a Securities Purchase Agreement for the sale of
2,787,872
Units, each consisting of
one
share of common stock and a warrant to purchase
0.75
shares of common stock, to approximately
20
private investors. The purchase price for each Unit was
$1.24375.
Gross proceeds were approximately
$3.5
million. Net proceeds to the Company after fees was approximately
$3.1
million. The portion of the purchase price attributable to the common shares included in each Unit was
$1.15,
the consolidated closing bid price for the Company’s common stock on
January 15, 2016.
The warrant price was
$.09375
per Unit (equivalent to
$0.125
per whole warrant share), with an exercise price of
$1.15
per share. The term of the warrants is
five
years from the date of completion of the transaction. Emerging Growth Equities, Ltd also received warrants to purchase
292,727
shares of common stock at an exercise price of
$1.15
per share as part of its consideration for serving as placement agent in connection with the private placement.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant Accounting Policies (Policies)
3 Months Ended
Jun. 24, 2017
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
The consolidated financial statements include the accounts of Giga-tronics and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation.
Derivatives, Policy [Policy Text Block]
Derivatives
The Company accounts for certain of its warrants and embedded debt features as derivatives. Changes in fair values are reported in earnings as gain or loss on adjustment of these instruments to fair value. 
Software Development Costs, Policy [Policy Text Block]
Software Development Costs
Development costs included in the research and development of new software products and enhancements to existing software products are expensed as incurred, until technological feasibility in the form of a working model has been established. Capitalized development costs are amortized over the expected life of the product and evaluated each reporting period for impairment.
Discontinued Operations, Policy [Policy Text Block]
Discontinued Operations
The Company reviews its reporting and presentation requirements for discontinued operations in accordance with the guidance provided by ASC
205
-
20
as it moves to newer technology within the test and measurement market from legacy products to the newly developed Advanced Signal Generator. The disposal of these product line sales represent an evolution of the Company’s Giga-tronics Division to a more sophisticated product offered to the same customer base. The Company has evaluated the sales of product lines (see Note
9,
Sale of Product Lines) concluding that each product line does
not
meet the definition of a “component of an entity” as defined by ASC
205
-
20.The
Company is able to distinguish revenue and gross margin information as disclosed in Note
9,
Sale of Product Lines to the accompanying financial statements however, operations and cash flow information is
not
clearly distinguishable and the Company is unable to present meaningful information about results of operations and cash flows from those product lines.
New Accounting Pronouncements, Policy [Policy Text Block]
New Accounting Standards
In
November 2015,
the FASB issued ASU
2015
-
17
Income Taxes (Topic
740
): “Balance Sheet Classification of Deferred Taxes”.
Topic
740
is effective for public business entities for financial statements issued for annual periods beginning after
December 15, 2016,
and interim periods within those annual periods. For all other entities, the amendments are effective for financial statements issued for annual periods beginning after
December 15, 2017,
and interim periods within annual periods beginning after
December 15, 2018.
The amendments
may
be applied prospectively to all deferred tax liabilities and assets or retrospectively to all periods presented. The amendments in ASU
2015
-
17
eliminates the current requirement for organizations to present deferred tax liabilities and assets as current and noncurrent in a classified balance sheet. Instead, organizations will be required to classify all deferred tax assets and liabilities as noncurrent. The adoption of this guidance did
not
have a material impact on the Company’s consolidated financial statements.
 
In
March 2016,
the FASB issued ASU
2016
-
09
(“ASU
2016
-
09”
),
Compensation - Stock Compensation (Topic
718
): Improvements to Employee Share-Based Payment Accounting.
ASU
2016
-
09
simplifies several aspects of the accounting for employee share-based payments, including accounting for income taxes, forfeitures, statutory tax withholding requirements, and classification on the statement of cash flows. The amendments in this ASU are effective for annual periods beginning after
December 15, 2016,
with early adoption permitted. The Company adopted this standard in the
first
quarter ended
June, 24, 2017,
the adoption of this guidance did
not
have a material impact on the Company’s consolidated financial statements.
 
In
May 2017,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2017
-
09
(“ASU
2017
-
09”
), 
Compensation—Stock Compensation (Topic
718
): Scope of Modification Accounting
. ASU
2017
-
09
was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The amendments in this ASU are effective for annual periods beginning after
December 15, 2017.
The Company does
not
expect that the standard will have a material effect on its consolidated financial statements and will apply this guidance to applicable transactions after the adoption date.
 
In
February 2016,
the FASB issued ASU
2016
-
02
(“ASU
2016
-
02”
), Leases. ASU
2016
-
02
requires that lessees recognize assets and liabilities for the rights and obligations for leases with a lease term of more than
one
year. The amendments in this ASU are effective for annual periods ending after
December 15, 2018.
Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU
2016
-
02
on its consolidated financial statements.
 
In
May 2014,
the FASB issued ASU
2014
-
09
(“ASU
2014
-
09”
), Revenue from Contracts with Customers. ASU
2014
-
09
establishes a broad principle that would require an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this principle, an entity identifies the contract with a customer, identifies the separate performance obligations in the contract, determines the transaction price, allocates the transaction price to the separate performance obligations and recognizes revenue when each separate performance obligation is satisfied. ASU
2014
-
09
was further updated in
March,
April,
May,
and
December 2016
to provide clarification on a number of specific issues as well as requiring additional disclosures. ASU
2014
-
09
may
be applied either retrospectively or through the use of a modified-retrospective method. The full retrospective method requires companies to recast each prior reporting period presented as if the new guidance had always existed. Under the modified retrospective method, companies would recognize the cumulative effect of initially applying the standard as an adjustment to opening retained earnings at the date of initial application. On
July 9, 2015,
the FASB approved a
one
year deferral of the effective date of ASU
2014
-
09
to annual reporting periods beginning after
December 15, 2017.
The Company has
not
yet completed its evaluation of the impact of ASU
2014
-
09
on its past and future revenue recognition and related disclosure.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventories (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
(In thousands)
 
June 24,
2017
 
 
March 25,
2017
 
Raw materials
  $
1,411
    $
1,775
 
Work-in-progress
   
2,931
     
2,155
 
Finished goods
   
239
     
473
 
Demonstration inventory
   
408
     
408
 
Total
  $
4,989
    $
4,811
 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Term Loan, Revolving Line of Credit and Warrants (Tables)
3 Months Ended
Jun. 24, 2017
PFG Loan [Member]  
Notes Tables  
Schedule of Debt Discount [Table Text Block]
Fees paid to the lender and third parties
  $
44,000
 
Backend fee
   
76,000
 
Estimated fair value of embedded equity forward
   
49,000
 
Fair value of 190,000 shares of common stock issued to lender
   
157,000
 
Aggregate discount amount
  $
326,000
 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Fair Value Measurements as of
June 24, 2017
(In Thousands):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Warrant liability
  $
    $
    $
222
 
Equity forward
   
     
46
     
 
Total
  $
    $
46
    $
222
 
Fair Value Measurements as of March 25, 2017
(In Thousands):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
Warrant liability
  $
    $
    $
222
 
Total
  $
    $
    $
222
 
Fair Value, Measured on Recurring Basis, Gain (Loss) Included in Earnings [Table Text Block]
 
 
Quarter
Ended
 
 
Quarter
Ended
 
(In thousands)
 
June 24,
2017
 
 
June 25,
2016
 
Warrant liability at beginning of year
  $
222
    $
353
 
Gains on adjustment of warrant liability to fair value
   
     
(46
)
Losses on adjustment of warrant liability to fair value
   
     
 
Warrant liability at end of period
  $
222
    $
307
 
Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
June
24, 2017
 
Valuation Technique(s)
 
Unobservable Input
 
 
 
 
Warrant liability
 
Monte Carlo
 
Discount rate
   
30%
 
March 25, 2017
 
Valuation Techniques(s)
 
Unobservable Input
 
 
 
 
Warrant liability
 
Monte Carlo
 
Discount rate
   
24%
 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Sale of Product Lines (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Asset Purchase Agreement [Table Text Block]
(In thousands)
 
Quarter Ended
June 25,
2016
 
Cash received from Astronics
  $
850
 
Cash paid to buy out future commission obligation
   
(170
)
Employee severance
   
(97
)
Legal fees
   
(13
)
Commissions
   
(46
)
Warranty Liability released
   
278
 
Net gain recognized in the quarter
  $
802
 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Loss Per Common Share (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
 
 
Three Months Ended
 
(In thousands except per share data)
 
June 24,
2017
 
 
June 25,
2016
 
Net loss
  $
(1,258
)
  $
(102
)
                 
Weighted average:
               
Common shares outstanding
   
9,715
     
9,550
 
Potential common shares
   
     
 
Common shares assuming dilution
   
9,715
     
9,550
 
                 
Loss per common share – basic
  $
(0.13
)
  $
(0.01
)
Loss per common share – diluted
  $
(0.13
)
  $
(0.01
)
Stock options not included in computation that could potentially dilute EPS in the future
   
1,104
     
1,529
 
Restricted stock awards not included in computation that could potentially dilute EPS in the future
   
350
     
 
Issuable shares for interest on loan
   
55
     
 
Convertible preferred stock not included in computation that could potentially dilute EPS in the future
   
1,853
     
1,853
 
Warrants not included in computation that could potentially dilute EPS in the future
   
3,737
     
3,737
 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
 
 
Three Months Ended
 
 
 
June 2
4
,
201
7
 
 
June 25,
2016
 
Dividend yield
   
     
 
Expected volatility
   
     
98.95
%
Risk-free interest rate
   
     
1.38
%
Expected term (years)
   
     
8.36
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
           
Weighted
Average
   
Weighted
Average
Remaining
Contractual
   
Aggregate
Intrinsic
 
   
Shares
   
Exercise Price
   
Terms (Years)
   
Value
 
Outstanding at March 26, 2016
   
1,592,200
    $
1.52
     
6.8
    $
69
 
Granted
   
148,000
     
0.97
     
 
     
 
 
Exercised
   
     
     
 
     
 
 
Forfeited / Expired
   
635,700
     
1.57
     
 
     
 
 
Outstanding at March 25, 2017
   
1,104,500
    $
1.41
     
6.1
    $
3
 
Granted
   
     
     
 
     
 
 
Exercised
   
     
     
 
     
 
 
Forfeited / Expired
   
     
     
 
     
 
 
Outstanding at June 24, 2017
   
1,104,500
    $
1.41
     
6.1
    $
3
 
                                 
Exercisable at June 24, 2017
   
812,050
    $
1.45
     
5.2
    $
 
                                 
At June 24, 2017 expected to vest in the future
   
1,006,157
    $
1.42
     
5.7
    $
 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
   
Shares
   
Weighted
Average
Fair Value
 
Non-Vested at March 26, 2016
   
    $
 
Granted
   
44,500
     
0.66
 
Vested
   
44,500
     
0.66
 
Forfeited or cancelled
   
     
 
Non-Vested at March 25, 2017
   
    $
 
Granted
   
350,450
     
 
 
Vested
   
     
 
 
Forfeited or cancelled
   
     
 
Non-Vested at June 24, 2017
   
350,450
    $
 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Significant Customer and Industry Segment Information (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
 
 
Three Month Periods Ended
 
 
 
 
 
 
Three Month Periods Ended
 
 
 
 
 
(In thousands)
 
At June 24,
2017
 
 
June 24,
2017
 
 
 
 
 
 
At June 25,
2016
 
 
June 25,
2016
 
 
 
 
 
 
 
Assets
 
 
Net Sales
 
 
Net Income
(Loss)
 
 
Assets
 
 
Net Sales
 
 
Net Income
(Loss)
 
Giga-tronics Division
  $
6,153
    $
297
    $
(1,849
)   $
8,233
    $
2,125
    $
(554
)
Microsource
   
2,907
     
1,694
     
591
     
3,887
     
1,317
     
452
 
Total
  $
9,060
    $
1,991
    $
(1,258
)   $
12,120
    $
3,442
    $
(102
)
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Warranty Obligations (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Product Warranty Liability [Table Text Block]
(In thousands)
 
Three Months
Ended
June 24,
2017
 
 
Three Months
Ended
June 25,
2016
 
Balance at beginning of period
  $
123
    $
60
 
Provision, net
   
1
     
112
 
Warranty costs incurred
   
(33
)
   
(112
)
Balance at end of period
  $
91
    $
60
 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Tables)
3 Months Ended
Jun. 24, 2017
Notes Tables  
Schedule of Stock by Class [Table Text Block]
                           
Liquidation
 
   
Designated
Shares
   
Shares
Issued
   
Shares
Outstanding
   
Preference
(in thousands)
 
Series B
   
10,000.00
     
9,997.00
     
9,997.00
    $
2,309
 
Series C
   
3,500.00
     
3,424.65
     
3,424.65
     
500
 
Series D
   
6,000.00
     
5,111.86
     
5,111.86
     
731
 
Total
   
19,500.00
     
18,533.51
     
18,533.51
    $
3,540
 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Going Concern and Management's Plan (Details Textual) - USD ($)
3 Months Ended
Apr. 27, 2017
Mar. 13, 2014
Jun. 24, 2017
Jun. 25, 2016
Jul. 31, 2017
Mar. 25, 2017
Jul. 30, 2016
Jun. 24, 2016
Jun. 27, 2015
Mar. 28, 2015
Net Income (Loss) Attributable to Parent     $ (1,258,000) $ (102,000)            
Retained Earnings (Accumulated Deficit)     (26,839,000)     $ (25,581,000)   $ (26,800,000)    
Net Cash Provided by (Used in) Operating Activities     (1,107,000) (589,000)            
Line of Credit, Current     582,000     $ 582,000        
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year                   $ 6,500,000
Proceeds from Advance Payment Arrangements     160,000              
Gigatronics Division [Member]                    
Net Income (Loss) Attributable to Parent     (1,849,000) (554,000)            
Gigatronics Division [Member] | Real-Time TEmS [Member]                    
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Next Twelve Months             $ 1,900,000      
Proceeds from Sale and Collection of Receivables     314,000              
Gigatronics Division [Member] | Real-Time TEmS [Member] | Subsequent Event [Member]                    
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year         $ 1,700,000          
Microsource [Member]                    
Net Income (Loss) Attributable to Parent     $ 591,000 $ 452,000            
Microsource [Member] | YIG Production Order [Member]                    
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year                 $ 10,000,000  
Microsource [Member] | YIG Production Order [Member] | Subsequent Event [Member]                    
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year         $ 875,000          
PFG Loan [Member]                    
Debt Instrument, Face Amount $ 1,500,000 $ 2,000,000                
Debt Instrument, Debt Default, Rate 6.00%   6.00%              
Debt Instrument, Term 2 years 3 years                
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Revenue Recognition (Details Textual) - USD ($)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Mar. 28, 2015
Unbilled Receivables, Not Billable, Amount Expected to be Collected in Remainder of Fiscal Year     $ 6,500,000
Revenue Recognition, Milestone Method, Revenue Recognized $ 0 $ 145,000  
Minimum [Member]      
Warranty Term 1 year    
Maximum [Member]      
Warranty Term 1 year 180 days    
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventories (Details Textual) - USD ($)
$ in Millions
Jun. 24, 2017
Mar. 25, 2017
Inventory Valuation Reserves $ 3.4 $ 3.4
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventories - Inventories, Net of Reserves (Details) - USD ($)
$ in Thousands
Jun. 24, 2017
Mar. 25, 2017
Raw materials $ 1,411 $ 1,775
Work-in-progress 2,931 2,155
Finished goods 239 473
Demonstration inventory 408 408
Total $ 4,989 $ 4,811
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Software Development Costs (Details Textual) - USD ($)
3 Months Ended
Sep. 03, 2015
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Capitalized Software Development Costs for Software Sold to Customers   $ 582,000   $ 733,000
Capitalized Computer Software, Amortization   0    
OLS Technology [Member]        
Research and Development Expense, Software (Excluding Acquired in Process Cost) $ 1,200,000      
OLS Technology [Member] | Aerospace Company [Member]        
Royalties Percentage 7.00%      
Software Development Costs, Amortization Method [Member]        
Capitalized Computer Software, Amortization   $ 151,000 $ 0  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Accounts Receivable Line of Credit (Details Textual) - USD ($)
Jun. 01, 2015
Jun. 24, 2017
Mar. 25, 2017
Line of Credit, Current   $ 582,000 $ 582,000
New Amended Credit Facility 2 [Member]      
Long-term Line of Credit $ 2,500,000    
Advance Rate 80.00%    
Debt Instrument, Variable Interest Rate   4.25%  
Debt Instrument, Interest Rate, Effective Percentage   5.75%  
Line of Credit Facility, Commitment Fee Amount $ 12,500    
Asset Coverage Ratio 150.00%    
Accounts Receivable, Aging from Invoice Date 90 days    
New Amended Credit Facility 2 [Member] | Prime Rate [Member]      
Debt Instrument, Basis Spread on Variable Rate 1.50%    
New Amended Credit Facility 2 [Member] | Borrowing Base for International Services Sub-Limit [Member]      
Line of Credit Facility, Maximum Borrowing Capacity $ 2,500,000    
New Amended Credit Facility 2 [Member] | Formula-Basis Sub-Limit [Member]      
Line of Credit Facility, Maximum Borrowing Capacity 2,000,000    
New Amended Credit Facility 2 [Member] | Non-Formula Basis Sub-Limit [Member]      
Line of Credit Facility, Maximum Borrowing Capacity $ 500,000    
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Term Loan, Revolving Line of Credit and Warrants (Details Textual) - USD ($)
3 Months Ended
Apr. 27, 2017
Jun. 16, 2014
Mar. 14, 2014
Mar. 14, 2014
Mar. 13, 2014
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Jan. 15, 2016
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 1.15
Fair Value Adjustment of Warrants           $ (46,000)    
Amortization of Debt Discount (Premium)           22,000 11,000    
Partners For Growth IV, L.P. [Member] | Revolving Credit Facility [Member]                  
Line of Credit Facility, Maximum Borrowing Capacity   $ 500,000              
PFG Loan [Member]                  
Debt Instrument, Deferred Interest Rate 6.50%                
Debt Instrument, Maximum Fee Amount to be Paid upon Maturity $ 100,000                
Debt Instrument, Fee Amount 76,000                
Debt Instrument, Remaining Fee Amount 24,000                
Debt Instrument, Remaining Fee Amount, Per Month $ 1,000                
Debt Instrument, Reduction in Fee Amount Contingent on Meeting or Exceeding Minimums 25.00%                
Number of New Shares to be Issued, Maximum 250,000                
Stock Issued During Period, Shares, New Issues 190,000                
Number of New Shares to be Issued, Remaining 60,000                
Number of New Shares to be Issued, Remaining, Per Month 2,500                
Long-term Debt $ 1,576,000                
Debt Instrument, Unamortized Discount 326,000                
Derivative Liability, Fair Value, Gross Liability               $ 222,000  
Amortization of Debt Discount (Premium) $ 11,000       $ 0 22,000      
Derivative, Gain (Loss) on Derivative, Net           $ 500      
Debt Instrument, Debt Default, Rate 6.00%         6.00%      
Debt Instrument, Term 2 years       3 years        
Debt Instrument, Face Amount $ 1,500,000       $ 2,000,000        
Proceeds from Issuance of Debt   $ 500,000 $ 1,000,000 $ 1,000,000          
Debt Instrument, Interest Rate, Stated Percentage 16.00%   9.75% 9.75%          
Debt Instrument, Cash Interest Rate 9.50%                
PFG Loan [Member] | Common Stock [Member]                  
Class of Warrant or Right, Term       5 years          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 1.42 $ 1.42          
PFG Loan [Member] | Achievement of Performance Milestones First Half of Fiscal 2015 [Member]                  
Line of Credit Facility, Remaining Borrowing Capacity     $ 1,000,000 $ 1,000,000          
PFG Loan [Member] | Under First Draw [Member] | Common Stock [Member]                  
Class of Warrant or Right, Outstanding     180,000 180,000          
Class of Warrant or Right, Exchanged for Cash, Amount     $ 150,000 $ 150,000          
PFG Loan [Member] | Amendment [Member] | Common Stock [Member]                  
Class of Warrant or Right, Outstanding   80,000              
Class of Warrant or Right, Exchanged for Cash, Amount     $ 67,000 $ 67,000          
PFG Loan [Member] | Partners For Growth IV, L.P. [Member]                  
Line of Credit Facility, Maximum Borrowing Capacity   $ 500,000              
PFG Loan [Member] | Partners For Growth IV, L.P. [Member] | Revolving Credit Facility [Member]                  
Debt Instrument, Term   2 years 270 days              
Debt Instrument, Interest Rate, Stated Percentage   12.50%              
Warrant Debt [Member]                  
Fair Value Adjustment of Warrants           $ 0 $ 46,000    
Warrant Debt [Member] | Under First Draw [Member]                  
Derivative Liability, Fair Value, Gross Liability           $ 133,000      
Warrant Debt [Member] | Amendment [Member]                  
Derivative Liability, Fair Value, Gross Liability               $ 89,000  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) - PFG Loan [Member]
Apr. 27, 2017
USD ($)
Aggregate discount amount $ 326,000
Fees Paid to Lenders and Third Parties [Member]  
Aggregate discount amount 44,000
Backend Fees [Member]  
Aggregate discount amount 76,000
Estimated Fair Value of Derivatives [Member]  
Aggregate discount amount 49,000
Equity Issued to Lenders [Member]  
Aggregate discount amount $ 157,000
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) (Parentheticals)
Apr. 27, 2017
shares
PFG Loan [Member]  
Common stock issued to lender (in shares) 190,000
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value (Details Textual) - USD ($)
$ in Thousands
3 Months Ended
Jun. 24, 2017
Mar. 25, 2017
Assets, Fair Value Disclosure, Nonrecurring $ 0 $ 0
Assets, Fair Value Disclosure, Recurring 0 0
Liabilities, Fair Value Disclosure, Nonrecurring $ 0 $ 0
Long-term Debt [Member] | Fair Value, Measurements, Recurring [Member]    
Fair Value Assumptions, Expected Term 1 year 255 days  
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Measurements, Recurring [Member]    
Fair Value Assumptions, Expected Volatility Rate 101.10%  
Fair Value Assumptions, Risk Free Interest Rate 1.26%  
Fair Value Inputs, Discount Rate 30.00%  
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value - Fair Value Measurements (Details) - USD ($)
$ in Thousands
Jun. 24, 2017
Mar. 25, 2017
Fair Value, Inputs, Level 1 [Member]    
Total  
Fair Value, Inputs, Level 2 [Member]    
Total  
Fair Value, Inputs, Level 3 [Member]    
Total   222
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
Total  
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
Total 46  
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]    
Total 222  
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 1 [Member]    
Derivative liabilities
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 2 [Member]    
Derivative liabilities
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 3 [Member]    
Derivative liabilities 222 $ 222
Fair Value, Measurements, Recurring [Member] | Equity Contract [Member] | Fair Value, Inputs, Level 1 [Member]    
Derivative liabilities  
Fair Value, Measurements, Recurring [Member] | Equity Contract [Member] | Fair Value, Inputs, Level 2 [Member]    
Derivative liabilities 46  
Fair Value, Measurements, Recurring [Member] | Equity Contract [Member] | Fair Value, Inputs, Level 3 [Member]    
Derivative liabilities  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value - Summary of Changes in Gains and Losses (Details) - Fair Value, Inputs, Level 3 [Member] - Warrant [Member] - Derivative Financial Instruments, Liabilities [Member] - USD ($)
$ in Thousands
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Warrant liability at beginning of year $ 222 $ 353
Gains on adjustment of warrant liability to fair value (46)
Losses on adjustment of warrant liability to fair value
Warrant liability at end of period $ 222 $ 307
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Fair Value - Quantitative Information (Details)
3 Months Ended 12 Months Ended
Jun. 24, 2017
Mar. 25, 2017
Warrant [Member] | Fair Value, Inputs, Level 3 [Member] | Derivative Financial Instruments, Liabilities [Member] | Monte Carlo [Member]    
Fair Value Inputs, Discount Rate 30.00% 24.00%
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Sale of Product Lines (Details Textual) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 12 Months Ended
Jul. 28, 2016
Jun. 20, 2016
Dec. 15, 2015
Jun. 30, 2016
Aug. 31, 2016
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Revenue, Net           $ 1,991,000 $ 3,442,000  
Gross Profit           466,000 925,000  
Proceeds from Sales of Business, Affiliate and Productive Assets           1,225,000  
Gain (Loss) on Sale of Business, Affiliated and Productive Assets           802,000  
Gigatronics Division [Member]                
Revenue, Net           297,000 2,125,000  
Switch Product Line [Member]                
Revenue, Net           0 1,100,000  
Gross Profit             437,000  
Power Meters, Amplifiers, and Legacy Signal Generators [Member]                
Gross Profit               $ 0
Power Meters, Amplifiers, and Legacy Signal Generators [Member] | Gigatronics Division [Member] | Operating Segments [Member]                
Revenues           95,000 275,000  
Astronics Test Systems Inc [Member] | Switch Product Line [Member]                
Cash Paid to Buy Out Future Commission Obligation       $ 170,000     170,000  
Proceeds from sale of Inventory         $ 500,000      
Proceeds from Sales of Business, Affiliate and Productive Assets   $ 850,000         850,000  
Gain (Loss) on Sale of Business, Affiliated and Productive Assets             802,000  
Standard Product Warranty Accrual, Period Increase (Decrease)             $ (278,000)  
Sales Commision             3.00%  
Sales Commission, Term             4 years  
Spanawave [Member]                
Loss Contingency, Estimate of Possible Loss             $ 440,000  
Proceeds from sale of Inventory       $ 275,000        
Return of Payment $ 375,000              
Proceeds from Sales of Business, Affiliate and Productive Assets $ 375,000   $ 1,500,000     $ 375,000   $ 750,000
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Sale of Product Lines - Asset Purchase Agreement (Details) - USD ($)
1 Months Ended 3 Months Ended
Jun. 20, 2016
Jun. 30, 2016
Jun. 24, 2017
Jun. 25, 2016
Cash received from Astronics     $ 1,225,000
Net gain recognized in the quarter     802,000
Astronics Test Systems Inc [Member] | Switch Product Line [Member]        
Cash received from Astronics $ 850,000     850,000
Cash paid to buy out future commission obligation   $ (170,000)   (170,000)
Employee severance       (97,000)
Legal fees       (13,000)
Commissions       (46,000)
Warranty Liability released       278,000
Net gain recognized in the quarter       $ 802,000
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Loss Per Common Share - Net Income (Loss) and Common Shares Used in Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Net loss $ (1,258,000) $ (102,000)
Basic (in shares) 9,715 9,550
Common shares assuming dilution (in shares) 9,715 9,550
Loss per common share - basic (in dollars per share) $ (0.13) $ (0.01)
Loss per common share - diluted (in dollars per share) $ (0.13) $ (0.01)
Equity Option [Member]    
Anti-dilutive securities excluded from computation of earning per share (in shares) 1,104 1,529
Restricted Stock [Member]    
Anti-dilutive securities excluded from computation of earning per share (in shares) 350
Common Shares Issuable for Debt Interest [Member]    
Anti-dilutive securities excluded from computation of earning per share (in shares) 55
Convertible Debt Securities [Member]    
Anti-dilutive securities excluded from computation of earning per share (in shares) 1,853 1,853
Warrant [Member]    
Anti-dilutive securities excluded from computation of earning per share (in shares) 3,737 3,737
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Employee Stock Option [Member] | Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     4 years
Employee Stock Option [Member] | Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     5 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     0
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 350,450 0 44,500
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0 0 44,500
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options $ 204,000    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 357 days    
Allocated Share-based Compensation Expense $ 9,000 $ 0  
2000 Stock Option Plan and 2005 Equity Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized     2,850,000
Percent Of Fair Market Value Of Common Stock At Date Of Grant     100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 934,677    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 156,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 29,500 28,500  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 33,000 $ 1,000  
Proceeds from Stock Options Exercised $ 0 0  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 3 years 21 days    
Allocated Share-based Compensation Expense $ 37,000 $ 72,000  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans - Weighted Average Assumptions (Details)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Dividend yield
Expected volatility 98.95%
Risk-free interest rate 1.38%
Expected term (years) (Year) 8 years 131 days
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Stock Options Outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Jun. 24, 2017
Mar. 25, 2017
Mar. 26, 2016
Outstanding (in shares) 1,104,500 1,592,200  
Outstanding (in dollars per share) $ 1.41 $ 1.52  
Outstanding (in dollars per share) $ 1.41 $ 1.41 $ 1.52
Outstanding (Year) 6 years 36 days   6 years 292 days
Outstanding $ 3   $ 69
Exercisable (in shares) 812,050    
Exercisable (in dollars per share) $ 1.45    
Exercisable (Year) 5 years 73 days    
Exercisable    
Expected to vest in the future (in shares) 1,006,157    
Expected to vest in the future (in dollars per share) $ 1.42    
Granted (in shares) 148,000  
Granted (in dollars per share) $ 0.97  
Exercised (in shares)  
Exercised (in dollars per share)  
Forfeited / Expired (in shares) 635,700  
Forfeited / Expired (in dollars per share) $ 1.57  
Outstanding (in shares) 1,104,500 1,104,500 1,592,200
Expected to vest in the future (Year) 5 years 255 days    
Expected to vest in the future    
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Nonvested Restricted Stock Awards Outstanding (Details) - Restricted Stock [Member] - $ / shares
3 Months Ended 12 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Non-vested (in shares)
Non-vested (in dollars per share)  
Granted (in shares) 350,450 0 44,500
Granted (in dollars per share)     $ 0.66
Vested (in shares) 0 0 44,500
Vested (in dollars per share)     $ 0.66
Non-vested (in shares) 350,450  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Significant Customer and Industry Segment Information (Details Textual)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Number of Reportable Segments 2  
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Microsource [Member] | First Customer [Member]    
Concentration Risk, Percentage 43.00% 30.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Microsource [Member] | Second Customer [Member]    
Concentration Risk, Percentage 37.00%  
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Gigatronics Division [Member] | Second Customer [Member]    
Concentration Risk, Percentage   22.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Gigatronics Division [Member] | Third Customer [Member]    
Concentration Risk, Percentage   17.00%
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Significant Customer and Industry Segment Information - Breakdown of Customer and Segment Information (Details) - USD ($)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Mar. 25, 2017
Net Income (Loss) Attributable to Parent $ (1,258,000) $ (102,000)  
Assets 9,060,000 12,120,000 $ 9,074,000
Revenue, Net 1,991,000 3,442,000  
Gigatronics Division [Member]      
Net Income (Loss) Attributable to Parent (1,849,000) (554,000)  
Assets 6,153,000 8,233,000  
Revenue, Net 297,000 2,125,000  
Microsource [Member]      
Net Income (Loss) Attributable to Parent 591,000 452,000  
Assets 2,907,000 3,887,000  
Revenue, Net $ 1,694,000 $ 1,317,000  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Income Taxes (Details Textual) - USD ($)
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Mar. 26, 2016
Income Tax Expense (Benefit) $ 0 $ 0  
Effective Income Tax Rate Reconciliation, Percent 0.00% 0.00%  
Unrecognized Tax Benefits $ 120,000    
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued     $ 45,000
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Warranty Obligations - Reconciliation of Company's Estimated Warranty Obligations (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Balance at beginning of period $ 123 $ 60
Provision, net 1 112
Warranty costs incurred (33) (112)
Balance at end of period $ 91 $ 60
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Details Textual)
12 Months Ended
Jan. 19, 2016
May 14, 2015
shares
Feb. 23, 2015
USD ($)
$ / shares
shares
Jul. 08, 2013
USD ($)
$ / shares
shares
Jul. 08, 2013
USD ($)
$ / shares
shares
Feb. 19, 2013
USD ($)
$ / shares
shares
Nov. 10, 2011
USD ($)
$ / shares
shares
Mar. 25, 2017
USD ($)
shares
Jun. 24, 2017
USD ($)
shares
Jan. 15, 2016
$ / shares
May 31, 2015
shares
Feb. 28, 2015
$ / shares
shares
Feb. 16, 2015
$ / shares
shares
Warrant Term 5 years                        
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                   $ 1.15      
Alara Capital AVI II, LLC [Member]                          
Class of Warrant Or Right Exercised in Period   14,587                      
Shares Issued Upon Cashless Warrant Exercise | shares   7,216                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares                     1,017,405 1,017,405  
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares                       $ 1.43  
New Warrant [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares       511,186 511,186                
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares       $ 1.43 $ 1.43                
Series B Preferred Stock [Member]                          
Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants             $ 2,199,000            
Preferred Stock, Shares Issued | shares             9,997   9,997        
Sale of Stock, Price Per Share | $ / shares             $ 220            
Preferred Stock, Value, Issued               $ 2,000,000          
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs               $ 202,000          
Series C Preferred Stock [Member]                          
Preferred Stock, Shares Issued | shares           3,424.65     3,424.65        
Proceeds from Issuance of Preferred Stock and Preference Stock           $ 500,000              
Sale of Stock, Price Per Share | $ / shares           $ 146              
Preferred Stock, Value, Issued           $ 457,000              
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs           $ 43,000              
Series D Preferred Stock [Member]                          
Preferred Stock, Shares Issued | shares       5,111.86 5,111.86       5,111.86        
Proceeds from Issuance of Convertible Preferred Stock       $ 858,000                  
Series D Preferred Stock [Member] | SPA [Member]                          
Debt Instrument, Convertible, Beneficial Conversion Feature         $ 238,000                
Payments of Stock Issuance Costs       41,000                  
Series D Preferred Stock [Member] | SPA [Member] | Unallocated [Member]                          
Proceeds from Issuance of Convertible Preferred Stock       $ 817,000                  
Series D Preferred Stock [Member] | SPA [Member] | Allocated [Member]                          
Debt Instrument, Convertible, Conversion Price | $ / shares       $ 0.97 $ 0.97                
Proceeds from Issuance of Convertible Preferred Stock       $ 498,000                  
Proceeds from Issuance of Common Stock       $ 360,000                  
Series B, C, and D Preferred Stock [Member]                          
Preferred Stock, Shares Issued | shares               18,533.51 18,533.51        
Preferred Stock, Value, Issued               $ 2,911,000 $ 2,911,000        
Convertible Preferred Stock, Shares Issued upon Conversion | shares               100          
Series C and D Warrants [Member] | Alara Capital AVI II, LLC [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares     1,002,818                    
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.43                    
Proceeds from Warrant Exercises     $ 1,434,000                    
Payments of Stock Issuance Costs     $ 42,000                    
New Warrant [Member] | Alara Capital AVI II, LLC [Member]                          
Number of Warrants Sold | shares     2                    
Warrant Purchase Price     $ 137,000                    
Warrant Purchase Price Per Share | $ / shares     $ 0.125                    
Warrant Term     5 years                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares     194,437                   898,634
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares     $ 1.76                   $ 1.78
Additional Warrant [Member] | Alara Capital AVI II, LLC [Member]                          
Class of Warrant or Right, Outstanding | shares     14,587                    
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants - Preferred Stock Information (Details) - USD ($)
$ in Thousands
Jun. 24, 2017
Mar. 25, 2017
Jul. 08, 2013
Feb. 19, 2013
Nov. 10, 2011
Designated shares (in shares) 1,000,000 1,000,000      
Series B Preferred Stock [Member]          
Preferred Stock, Shares Issued 9,997       9,997
Shares outstanding (in shares) 9,997        
Liquidation preference $ 2,309        
Designated shares (in shares) 10,000        
Series C Preferred Stock [Member]          
Preferred Stock, Shares Issued 3,424.65     3,424.65  
Shares outstanding (in shares) 3,424.65        
Liquidation preference $ 500        
Designated shares (in shares) 3,500        
Series D Preferred Stock [Member]          
Preferred Stock, Shares Issued 5,111.86   5,111.86    
Shares outstanding (in shares) 5,111.86        
Liquidation preference $ 731        
Designated shares (in shares) 6,000        
Series B, C, and D Preferred Stock [Member]          
Preferred Stock, Shares Issued 18,533.51 18,533.51      
Shares outstanding (in shares) 18,533.51 18,533.51      
Liquidation preference $ 3,540 $ 3,540      
Designated shares (in shares) 19,500 19,500      
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 16 - Private Placement Offering (Details Textual)
$ / shares in Units, $ in Millions
Jan. 19, 2016
USD ($)
$ / shares
shares
Jan. 15, 2016
$ / shares
Securities Purchase Agreement, Units Issued | shares 2,787,872  
Number of Common Stock Per Unit | shares 1  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares 0.75  
Number of Private Investors 20  
Securities Purchase Agreement, Net Proceeds | $ $ 3.1  
Securities Purchase Agreement, Purchase Price $ 1.24375  
Securities Purchase Agreement, Gross Proceeds | $ $ 3.5  
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 1.15
Warrant Term 5 years  
Emerging Growth Equities, Ltd [Member]    
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1.15  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares 292,727  
Common Stock [Member]    
Securities Purchase Agreement, Purchase Price $ 1.15  
Warrant [Member]    
Securities Purchase Agreement, Purchase Price 0.09375  
Securities Purchase Agreement, Price of One Common Share $ 0.125  
EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 71 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 172 278 1 false 71 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.gigatronics.com/20170624/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.gigatronics.com/20170624/role/statement-condensed-consolidated-balance-sheets-unaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.gigatronics.com/20170624/role/statement-condensed-consolidated-balance-sheets-unaudited-parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.gigatronics.com/20170624/role/statement-condensed-consolidated-statements-of-operations-unaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.gigatronics.com/20170624/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Organization and Significant Accounting Policies Sheet http://www.gigatronics.com/20170624/role/statement-note-1-organization-and-significant-accounting-policies Note 1 - Organization and Significant Accounting Policies Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Going Concern and Management's Plan Sheet http://www.gigatronics.com/20170624/role/statement-note-2-going-concern-and-managements-plan Note 2 - Going Concern and Management's Plan Notes 7 false false R8.htm 007 - Disclosure - Note 3 - Revenue Recognition Sheet http://www.gigatronics.com/20170624/role/statement-note-3-revenue-recognition Note 3 - Revenue Recognition Notes 8 false false R9.htm 008 - Disclosure - Note 4 - Inventories Sheet http://www.gigatronics.com/20170624/role/statement-note-4-inventories Note 4 - Inventories Notes 9 false false R10.htm 009 - Disclosure - Note 5 - Software Development Costs Sheet http://www.gigatronics.com/20170624/role/statement-note-5-software-development-costs Note 5 - Software Development Costs Notes 10 false false R11.htm 010 - Disclosure - Note 6 - Accounts Receivable Line of Credit Sheet http://www.gigatronics.com/20170624/role/statement-note-6-accounts-receivable-line-of-credit Note 6 - Accounts Receivable Line of Credit Notes 11 false false R12.htm 011 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants Sheet http://www.gigatronics.com/20170624/role/statement-note-7-term-loan-revolving-line-of-credit-and-warrants Note 7 - Term Loan, Revolving Line of Credit and Warrants Notes 12 false false R13.htm 012 - Disclosure - Note 8 - Fair Value Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value Note 8 - Fair Value Notes 13 false false R14.htm 013 - Disclosure - Note 9 - Sale of Product Lines Sheet http://www.gigatronics.com/20170624/role/statement-note-9-sale-of-product-lines Note 9 - Sale of Product Lines Notes 14 false false R15.htm 014 - Disclosure - Note 10 - Loss Per Common Share Sheet http://www.gigatronics.com/20170624/role/statement-note-10-loss-per-common-share Note 10 - Loss Per Common Share Notes 15 false false R16.htm 015 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans Note 11 - Share-based Compensation and Employee Benefit Plans Notes 16 false false R17.htm 016 - Disclosure - Note 12 - Significant Customer and Industry Segment Information Sheet http://www.gigatronics.com/20170624/role/statement-note-12-significant-customer-and-industry-segment-information Note 12 - Significant Customer and Industry Segment Information Notes 17 false false R18.htm 017 - Disclosure - Note 13 - Income Taxes Sheet http://www.gigatronics.com/20170624/role/statement-note-13-income-taxes Note 13 - Income Taxes Notes 18 false false R19.htm 018 - Document - Note 14 - Warranty Obligations Sheet http://www.gigatronics.com/20170624/role/statement-note-14-warranty-obligations Note 14 - Warranty Obligations Uncategorized 19 false false R20.htm 019 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants Sheet http://www.gigatronics.com/20170624/role/statement-note-15-series-b-c-d-convertible-voting-perpetual-preferred-stock-and-warrants Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants Uncategorized 20 false false R21.htm 020 - Disclosure - Note 16 - Private Placement Offering Sheet http://www.gigatronics.com/20170624/role/statement-note-16-private-placement-offering Note 16 - Private Placement Offering Uncategorized 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.gigatronics.com/20170624/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 4 - Inventories (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-4-inventories-tables Note 4 - Inventories (Tables) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-7-term-loan-revolving-line-of-credit-and-warrants-tables Note 7 - Term Loan, Revolving Line of Credit and Warrants (Tables) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 8 - Fair Value (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value-tables Note 8 - Fair Value (Tables) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 9 - Sale of Product Lines (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-9-sale-of-product-lines-tables Note 9 - Sale of Product Lines (Tables) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 10 - Loss Per Common Share (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-10-loss-per-common-share-tables Note 10 - Loss Per Common Share (Tables) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans-tables Note 11 - Share-based Compensation and Employee Benefit Plans (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 12 - Significant Customer and Industry Segment Information (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-12-significant-customer-and-industry-segment-information-tables Note 12 - Significant Customer and Industry Segment Information (Tables) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 14 - Warranty Obligations (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-14-warranty-obligations-tables Note 14 - Warranty Obligations (Tables) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Tables) Sheet http://www.gigatronics.com/20170624/role/statement-note-15-series-b-c-d-convertible-voting-perpetual-preferred-stock-and-warrants-tables Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Tables) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 2 - Going Concern and Management's Plan (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-2-going-concern-and-managements-plan-details-textual Note 2 - Going Concern and Management's Plan (Details Textual) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 3 - Revenue Recognition (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-3-revenue-recognition-details-textual Note 3 - Revenue Recognition (Details Textual) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 4 - Inventories (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-4-inventories-details-textual Note 4 - Inventories (Details Textual) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 4 - Inventories - Inventories, Net of Reserves (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-4-inventories-inventories-net-of-reserves-details Note 4 - Inventories - Inventories, Net of Reserves (Details) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 5 - Software Development Costs (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-5-software-development-costs-details-textual Note 5 - Software Development Costs (Details Textual) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 6 - Accounts Receivable Line of Credit (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-6-accounts-receivable-line-of-credit-details-textual Note 6 - Accounts Receivable Line of Credit (Details Textual) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-7-term-loan-revolving-line-of-credit-and-warrants-details-textual Note 7 - Term Loan, Revolving Line of Credit and Warrants (Details Textual) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-7-term-loan-revolving-line-of-credit-and-warrants-debt-discont-details Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) (Parentheticals) Sheet http://www.gigatronics.com/20170624/role/statement-note-7-term-loan-revolving-line-of-credit-and-warrants-debt-discont-details-parentheticals Note 7 - Term Loan, Revolving Line of Credit and Warrants - Debt Discont (Details) (Parentheticals) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 8 - Fair Value (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value-details-textual Note 8 - Fair Value (Details Textual) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 8 - Fair Value - Fair Value Measurements (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value-fair-value-measurements-details Note 8 - Fair Value - Fair Value Measurements (Details) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 8 - Fair Value - Summary of Changes in Gains and Losses (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value-summary-of-changes-in-gains-and-losses-details Note 8 - Fair Value - Summary of Changes in Gains and Losses (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 8 - Fair Value - Quantitative Information (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-8-fair-value-quantitative-information-details Note 8 - Fair Value - Quantitative Information (Details) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 9 - Sale of Product Lines (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-9-sale-of-product-lines-details-textual Note 9 - Sale of Product Lines (Details Textual) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 9 - Sale of Product Lines - Asset Purchase Agreement (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-9-sale-of-product-lines-asset-purchase-agreement-details Note 9 - Sale of Product Lines - Asset Purchase Agreement (Details) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 10 - Loss Per Common Share - Net Income (Loss) and Common Shares Used in Per Share Computations (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-10-loss-per-common-share-net-income-loss-and-common-shares-used-in-per-share-computations-details Note 10 - Loss Per Common Share - Net Income (Loss) and Common Shares Used in Per Share Computations (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans-details-textual Note 11 - Share-based Compensation and Employee Benefit Plans (Details Textual) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Weighted Average Assumptions (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans-weighted-average-assumptions-details Note 11 - Share-based Compensation and Employee Benefit Plans - Weighted Average Assumptions (Details) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Stock Options Outstanding (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans-changes-in-stock-options-outstanding-details Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Stock Options Outstanding (Details) Uncategorized 50 false false R51.htm 050 - Disclosure - Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Nonvested Restricted Stock Awards Outstanding (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-11-sharebased-compensation-and-employee-benefit-plans-changes-in-nonvested-restricted-stock-awards-outstanding-details Note 11 - Share-based Compensation and Employee Benefit Plans - Changes in Nonvested Restricted Stock Awards Outstanding (Details) Uncategorized 51 false false R52.htm 051 - Disclosure - Note 12 - Significant Customer and Industry Segment Information (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-12-significant-customer-and-industry-segment-information-details-textual Note 12 - Significant Customer and Industry Segment Information (Details Textual) Uncategorized 52 false false R53.htm 052 - Disclosure - Note 12 - Significant Customer and Industry Segment Information - Breakdown of Customer and Segment Information (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-12-significant-customer-and-industry-segment-information-breakdown-of-customer-and-segment-information-details Note 12 - Significant Customer and Industry Segment Information - Breakdown of Customer and Segment Information (Details) Uncategorized 53 false false R54.htm 053 - Disclosure - Note 13 - Income Taxes (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-13-income-taxes-details-textual Note 13 - Income Taxes (Details Textual) Uncategorized 54 false false R55.htm 054 - Disclosure - Note 14 - Warranty Obligations - Reconciliation of Company's Estimated Warranty Obligations (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-14-warranty-obligations-reconciliation-of-companys-estimated-warranty-obligations-details Note 14 - Warranty Obligations - Reconciliation of Company's Estimated Warranty Obligations (Details) Uncategorized 55 false false R56.htm 055 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-15-series-b-c-d-convertible-voting-perpetual-preferred-stock-and-warrants-details-textual Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants (Details Textual) Uncategorized 56 false false R57.htm 056 - Disclosure - Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants - Preferred Stock Information (Details) Sheet http://www.gigatronics.com/20170624/role/statement-note-15-series-b-c-d-convertible-voting-perpetual-preferred-stock-and-warrants-preferred-stock-information-details Note 15 - Series B, C, D Convertible Voting Perpetual Preferred Stock and Warrants - Preferred Stock Information (Details) Uncategorized 57 false false R58.htm 057 - Disclosure - Note 16 - Private Placement Offering (Details Textual) Sheet http://www.gigatronics.com/20170624/role/statement-note-16-private-placement-offering-details-textual Note 16 - Private Placement Offering (Details Textual) Uncategorized 58 false false All Reports Book All Reports giga-20170624.xml giga-20170624.xsd giga-20170624_cal.xml giga-20170624_def.xml giga-20170624_lab.xml giga-20170624_pre.xml true true ZIP 76 0001437749-17-013836-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-17-013836-xbrl.zip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�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end